ML041270291
| ML041270291 | |
| Person / Time | |
|---|---|
| Site: | River Bend  |
| Issue date: | 03/10/2003 |
| From: | Entergy Operations |
| To: | Office of Nuclear Reactor Regulation |
| References | |
| G12.1.17 RSP-0008, Rev 12 | |
| Download: ML041270291 (112) | |
Text
- G12 1.17
- lw ENTERGY RIVER BEND STATION STATION OPERATING MANUAL
- RADIATION SECTION PROCEDURE
- OFFSITEJDOSECALCULA TION MANUAL (ODCM)
PROCEDURE NUMBER: *RSP-0008 REVISION NUMBER: *12 Effective Date:
- MAR 1 0 2003 NOTE: SIGNATURES ARE ON FILE.
- INDEXING INFORMATION RECEIVED ApR 1 0 2003 INFORMATION USE - DOCUMENT CONTROL
TABLE OF CHANGES LETTER DESIGNATION DETAILED DESCRIPTION OF CHANGES TRACKING NUMBER I
i . . .
RSP-0008 REV- 12 PAGE 1 OF 103
TABLE OF CONTENTS SECTION PAGE NO.
I PURPOSE/OBJECTIVES ....................................................... 5 2 REFERENCES ....................................................... 6 3 DEFINITIONS ....................................................... 7 4 RESPONSIBILITIES ....................................................... 8 5 PRECAUTIONS AND LIMITATIONS .9..................... .................................. .
6 PREREOUISITES ........................................................ 9 7 LIOUID EFFLUENT METHODOLOGY ........................................................ .9 7.1 River Bend Site Description ....... I.............................................. 9 7.2 Compliance with IOCFR20 (Liquids) ...................................... ............... 10 7.3 Determination of Setpoints for Radioactive Liquid Effluent Monitors ........................ 11 7.4 Determining the Dose for Radioactive Liquid Effluents .............................................. 13 7.5 Projecting Dose for Radioactive Liquid Effluents ........................................................ 15 8 GASEOUS EFFLUENT METHODOLOGY . .15 8.1 Introduction .15 8.2 Data Requirements for Gaseous Effluents .6 8.3 Instantaneous Release Rate and Setpoint Determination .16 8.4 Cumulative Dose Determination for Radioactive Gaseous Effluents .24 8.5 Dose Proiection - Determination of Need to Operate Ventilation Exhaust Treatment System......................................................................................................... 30 9 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM .. 32 10 4OCFR190 CONSIDERATIONS...........................................................................................32 10.1 Compliance with 40CFR190 .32 10.2 Calculations Evaluating Conformance with 40CFRI90 .32 10.3 Calculations of Total Body Dose .33 10.4 Thyroid Dose .34 10.5 Organ Dose (other than thyroid and sldn. 34 10.6 Skin Dose .35 I1I INTERLABORATORY COMPARISON STUDIES.............................................................36 11.1 Requirement .36 11.2 Program ......... ....................................................... .......................36 3.......6..
RSP-0008 REV -12 PAGE 2 OF 103
ATTACHMENT 1- TABLE 4.1 - RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM ........................... 37 ATTACHMENT 2- ECL VALUES .41 ATTACHMENT 3- TABLE B-: LIQUID ENVIRONMENTAL DOSE TRANSFER FACTORS .42 ATTACHMENT 4- TABLE C-1: NOBLE GAS DOSE TRANSFER FACTORS .44 ATTACHMENT 5- RESERVED)................................................... 45 ATTACHMENT 6- XIO AND D/O VALUES FOR RESTRICTED AREA BOUNDARY .46 ATTACHMENT 7- TABLE E-1: ANNUAL AVERAGE CHI/Q VALUES FOR RESTRICTED AREA BOUNDARY .50 ATTACHMENT 8 - TABLE E-2: ANNUAL AVERAGE DIG VALUES FOR RESTRICTED AREA BOUNDARY .51 ATTACHMENT 9- TABLE F-1: ATMOSPHERIC DISPERSION AND DEPOSITION RATES FOR THE MAXIMUM INDIVIDUAL DOSE CALCULATIONS . 52 ATTACHMENT 10 - TABLE G-1: DOSE FACTOR CALCULATION PARAMETERS. 53 ATTACHMENT 11 - TABLE G-2: STABLE ELEMENT TRANSFER FACTORS .54 ATTACHMENT 12 - TABLE G-3: BIOACCUMULATION FACTORS .56 ATTACHMENT 13 - TABLE G-4: INDirIDUAL USAGE FACTORS .58 ATTACHMENT 14 - TABLE H-1: ASSIUMTIONS/PARAMETERS FOR DOSES TO A MEMBER OF THE PUBLIC INSIDE SITE BOUNDARY .59 ATTACHMENT 15 - TABLE I-1: DOSE FACTOR TABLE: P m - ADULT, IWHALATION......................................................................................................... 60 ATTACHMENT 16 - TABLE 1-2: DOSE FACTOR TABLE: P (1)- TEEN, INHALATION ......... , 62 ATTACHMENT 17 - TABLE I-3: DOSE FACTOR TABLE: P (D) - CHILD.
INHALATI ON .............. .........................64 6............
ATTACHMENT 18- TABLE 1-4: DOSE FACTOR TABLE: P (I) - INFANT.
RiHALATION ...................... 66 6............
ATTACHMENT 19- TABLE I-5: DOSE FACTOR TABLE: R (I) - ALL, GR. PLANE 68 ATTACHMENT 20- TABLE 1-6: DOSE FACTOR TABLE: R (I) - ADULT. COWS MLK.. ..................................................
I........................................ ......................... 70 ATTACHMENT 21 - TABLEI-7: DOSE FACTOR TABLE: R (I) - TEEN. COWS MLK ............
I.............
- ......................... 72 ATTACHMENT 22 -TABLE I-8
- DOSE FACTOR TABLE R (I) - CHILD. COWS MILK .74 RSP-0009 REV - 12 1 AG 3OF PAGE O 103 0 RSP-00l ----
ATTACHMENT 23 - TABLE 1-9: DOSE FACTOR TABLE: R (I) - INFANT. COWS MILK ........................................................................................................................... ........................
76 ATTACHMENT 24 - TABLE 1-10: DOSE FACTOR TABLE: R (D) - ADULT, GOATS MILK .................................................... 78 ATTACHMENT 25 - TABLE I-11: DOSE FACTOR TABLE: R (D - TEEN. GOATS MILK ... ..................................................... 800 ATTACHMENT 26 - TABLE I-12: DOSE FACTOR TABLE: R () - CHILD, GOATS MILK ... ..................................................... 82 82 ATTACHMENT 27 - TABLE I- 13: DOSE FACTOR TABLE: R (1)- FANT. GOATS MILK ......................................................... 84 ATTACHMENT 28 - TABLE I-14: DOSE FACTOR TABLE: R (1) - ADULT. MEAT ............. 86 ATTACHMENT 29 - TABLE 1-15: DOSE FACTOR TABLE: R d) - TEEN. MEAT ............... 88 ATTACHMENT 30 - TABLE 1-16: DOSE FACTOR TABLE: R - CID. L MEAT ............. 90 ATTACHMENT 31 - TABLE I-17: DOSE FACTOR TABLE: R ( - ADULT, VEGETATION ............................................................... 92 ATTACHMENT 32 - TABLE I-18: DOSE FACTOR TABLE: R (D - TEEN.
VEGETATION ............................................................... 94 ATTACHMENT 33 - TABLE I-19: DOSE FACTOR TABLE: R (I) - CHILD.
VEGETATION.............................................................................................................96 ATTACHMENT 34 - FIGURE 1: RESTRICTED AREA AND NEAR-FIELD ENVIRONMENTAL MONITORING LOCATIONS .................................................. 98 ATTACHMENT 35 - FIGURE 2: SCHEMATIC OF GASEOUS RADWASTE SYSTEM ................................................................................ 99 ATTACHMENT 36 - FIGURE 3: EFFLUENT RELEASE POINTS ......................... 1...............too00 ATTACHMENT 37 - FIGURE 4: SCHEMATIC OF LIQUID RADWASTE SYSTEM....i ..... 101 ATTACHMENT 38 - FIGURE 5: FAR-FIELD RADIOLOGICAL ENVIRONMENTAL MONITORING LOCATIONS ............................................................... 102 ATTACHMENT 39 - FIGURE 6: SCHEMATIC OF THE SOLID WASTE TREATMENT SYSTEM............................................................................................103 114ZP-Aing RE.V - I1 PA Pi' A as' 1 fll
1 PURPOSF/OBJECTIVES 1.1 This manual provides a concise description of the environmental dose models and techniques used to calculate offsite doses resulting from measured or projected releases of radioactive materials from River Bend Nuclear Station. It also provides the methodology for calculating effluent monitoring setpoints and allowable release. rates to ensure compliance with the Radiological Effluent Technical Requirements of River Bend Station. This manual also contains a description of the Radiological Environmental Monitoring Program that includes sample point descriptions for both onsite and offsite locations and sampling and analysis frequencies.
1.2 The ODCM follows the methodology and models suggested by the "Guidance Manual for Preparation of Radiological Effluent Technical Specifications for Nuclear Power Plants" (NUREG-0133, dated October 1978) and "Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purpose of Evaluating Compliance with 10 CFR Part 50, Appendix I" (Regulatory Guide 1.109, Rev. 1, dated October 1977). Alternate calculational methods may be used from those presented as long as the overall methodology does not change or as long as the alternative methods provide results that are more limiting. Also, as available, the most, up-to-date revision of Regulatory Guide 1.109 dose conversion factors and site-specific environmental criteria may be used.
1.3 The description of information that should be included in the Annual Radiological Environmental Operating Report is located in Section 5.6.2 of the Technical Requirements Manual. The description of information that should be included in the Radioactive Effluent Release Report is located in Section 5.6.3 of the Technical Requirements Manual and states as follows:
Annual Effluent Release Report Routine Annual Radioactive Effluent Release Report covering the operation of the unit during the previous 12 months of operation shall be submitted as required by Technical Specification 5.6.3 The Annual Radioactive Effluent Release Report shall include a summary of the quantities of radioactive liquid and gaseous effluents and solid waste released from the facility as outlined in Regulatory Guide 1.21, "Measuring, Evaluating, and Reporting Radioactivity in Solid Wastes and Releases of Radioactive Materials in Liquid and Gaseous Effluents from Light Water-Cooled Nuclear Power Plants," Revision 1, June 1974, with data summarized on a quarterly basis following the format of Appendix B thereof. For solid wastes, the format for Table 3 in Appendix B shall be supplemented with three additional categories: class of solid wastes (as defined by 10 CFR Part 61),
type of container (e.g., LSA, Type A, Type B, Large Quantity) and SOLIDIFICATION agent or absorbent (e.g., cement, urea formaldehyde)
RSP-0008 REV- 12 PAGE 5 OF 103
The Annual Radioactive Effluent Release Report shall include a summary of hourly meteorological data collected over the previous year. This summary may be either in the form of an hour-by-hour listing on magnetic tape of wind speed, wind direction and atmospheric stability, and precipitation (if measured), or in the form of joint frequency distributions of wind speed, wind direction, and atmospheric stability. This same report shall include an assessment of the radiation doses due to the radioactive liquid and gaseous effluents released from the unit or station during the previous calendar year. The report shall also include an assessment of the radiation doses from radioactive liquid and gaseous effluents to MEMBERS OF THE PUBLIC due to their activities inside the SITE BOUNDARY (USAR section 2.1) during the report period. All assumptions used in making these assessments (i.e., specific activity, exposure time and location) shall be included in these reports. The assessment of radiation doses shall be performed in accordance with the methodology and parameters of the ODCM.
The Annual Radioactive Effluent Release Report shall also include an assessment of radiation doses to the likely most-exposed MEMBER OF THE PUBLIC from reactor releases and other nearby uranium fuel cycle sources (including doses from primary effluent pathways and direct radiation) for the previous calendar year to show conformance with 40 CFR Part 190, Environmental Radiation Protection Standards for Nuclear Power Operation. Acceptable methods for calculating the dose contribution from liquid and gaseous effluents are given in NUREG-0133, "Preparation of Radiological Effluent Technical Specifications for Nuclear Power Plants," Rev. 0, October 1978.
The Annual Radioactive Effluent Release Report shall include list and'description of unplanned releases from the site to UNRESTRICTED AREAS of radioactive materials in gaseous and liquid effluents made during the reporting period.
The Annual Radioactive Effluent Release Report shall include any changes made during the reporting period to the PROCESS CONTROL PROGRAM (PCP) and to the ODOM, as well as a listing of new locations for dose calculations and environmental monitoring identified by the land use census pursuant to Requirement 3.12.2.
2 REFERENCES' 2.1.1. NUREG 0133; Guidance Manual for Preparation of Radiological Effluent Technical Specifications for Nuclear Power Plants; October, 1978 2.1.2. REG. GUIDE 1.109, Rev. 1, October, 1977; Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purpose of Compliance with I0 CFR Part 50, Appendix I 2.1.3. River Bend Environmental Report, OLS 2.1.4. River Bend Environmental Report, CPS 2.1.5. River Bend Station USAR RSP-0008 REV -12 PAGE 6 OF 103
- 2. 116. River Bend Technical Specifications 2.1.7. River Bend Technical Requirements Manual (TRM) 2.1.8. River Bend Station Radiological Environmental Operating Report for 1985 2.1.9. REG. GUIDE 1.111; Methods for Estimating Atmospheric Transport and Dispersion of Gaseous Effluents in Routine Releases from Light-Water -
Cooled Reactors 2.1.10. U.S. Code of Federal Regulations; l OCFR20 2.1.11 . U.S. Code Of Federal Regulations, 10CFR50 2.1.12. U.S. Code of Federal Regulations, 40CFR190 2.1.13. NUREG 0543, Methods for Demonstrating LWR Compliance with the EPA Uranium Fuel Cycle Standard (40 CFR Part 190) 3 DEFINITIONS 3.1 MEMBER(S) OF THIE PUBLIC shall include all persons who are not occupationally associated with the plant. This category does not include employees of the utility, its contractors or vendors. Also excluded from this category are persons who enter the site to service equipment or to make deliveries. This category does include persons who use portions of the site for recreational, occupational or other purposes not associated with the plant.
3.2 The OFFSITE DOSE CALCULATION MANUAL shall contain the methodology and parameters used in the calculation of offsite doses due to radioactive gaseous and liquid effluents and in the calculation of gaseous and liquid effluent monitoring alarm/trip setpoints. It shall also contain a table and figure defining current radiological environmental monitoring sample locations.
3.3 The SITE BOUNDARY shall be that line beyond which the land is not owned, leased, or otherwise controlled by the licensee.
3.4 An UNRESTRICTED AREA shall be any area at or beyond the SITE BOUNDARY access to which is not controlled by the licensee for purposes of protection of individuals from exposure to radiation and radioactive materials, or any area within the site boundary used for residential quarters or for industrial, commercial, institutional, and/or recreational purposes.
RSP-0008 REV - 12 PAGE 7 OF 103
3.5 A VENTILATION EXHAUST TREATMENT SYSTEM is any system designed and installed to reduce gaseous radioiodine and/or radioactive material in particulate form in effluents by passing ventilation or vent exhaust gases through charcoal adsorbers and HEPA filters prior to the release to the enviromnent (such a system is not considered to have any effect on noble gas effluents). Engineered Safety Feature (ESF) atmospheric cleanup systems are not considered to be VENTILATION EXHAUST TREATMENT SYSTEM components.
4 RESPONSIBILITIES 4.1 The Superintendent - Radiation Protection or designee is responsible for the development and implementation of the "Offsite Dose Calculation Manual [ODCM] Procedure",
which involves review of REMP-related ESPs and program changes, as well as coordination of revisions to the ODCM necessitated by results of the REMP and/or annual Land Use Census. The Superintendent - Radiation Protection or designee, reviews the ODCM and Annual Radiological Environmental Operating Report prior to its submission for approval by the General Manager - Plant Operations. The Superintendent
- Radiation Protection or designee, coordinates the preparation of other reports for which the ODCM may provide input (e.g., special reports on excessive doses to members of the public in unrestricted areas attributable to RBS effluents).
4.2 The Manager - Operations is responsible for the development and upkeep of the RBS Technical Requirements and Surveillance Test Procedure Cross Reference matrix that includes applicable STP's.
4.3 The Director - Nuclear Safety Assurance is responsible for identifying proposed changes to the Technical Requirements and other regulatory documents which would alter the Surveillance Test Program requirements.
4.4 The Manager - Planning & Scheduling Outages is responsible for developing, maintaining, and adjusting a station-wide schedule for performance of Surveillance Test Procedures.
4.5 The Superntendent - Chemisy has overall responsibility for the development and implementation of the Radiological Environment Monitoring Program (REMP) to include, as a minimum: developing ODCM related procedures, sampling, report generation, and immediate notification to the Superintendent - Radiological Programs of any REMP result which indicates that a reporting level has been exceeded.
4.6 The Supervisor - P Shi has responsibility for supervising the day to day performance and documentation of SIrveillance of the ODCM.
RSP-0008 REV- 12 PAGE 8 OF 103
4.7 The HP/Chern Specialist has responsibility for the implementation of surveillances and documentation of the ODCM. This responsibility includes timely notification of the Supervisor - HP Shift of any problem which impacts, or might impact, fulfillment of the Radiological Effluent Technical Requirements and the ODCM.
5 PRECAUTIONS AND LIMITATIONS 5.1 Licensee-initiated changes to the ODCM shall be made per Reference 2.1.6 § 5.5.1.
5.2 No changes(s) shall be made to the ODCM that will reduce the accuracy or reliability.of dose calculations or setpoint determinations.
5.3 A change to the ODCM may cause a deviation from methodologies used in the implementing procedures. Any change to RSP-0008 shall have an independent Review from Chemistry, as a minimum, and also requires Chemistry and Radiation Control to meet and discuss changes to RSP-0008 prior to approval to ensure ODCM methodology compliance.
6 PREREQUISITES 6.1 None 7 LIQUID EFFLUENT METHODOLOGY 7.1 River Bend Site Description The River Bend Station Updated Safety Analysis Report (USAR) contains the official description of the site characteristics. The description that follows is a brief summary for dose calculation purposes:
-The River Bend Station (RBS) is on a site in West Feliciana Parish, Louisiana, located approximately 24 miles north-northwest of Baton Rouge, Louisiana. This site is just east of the
- MississippiRiver, which is used as the source of the RBS major water requirements and which receives the RBS liquid effluents.
The reactor is a General Electric boiling water reactor of the BWR-6 or 1972 product line.
Containment is of the Mark 3 design, a free-standing cylindrical steel structure surrounded by a reinforced concrete shield building.
RSP-0008 REV- 12 PAGE 9 OF 103
7.2 Compliance with 10CFR20 (Liquids) 7.2.1. Requirements In accordance with Technical Requirements 3.11.1.1, the concentration of radioactive material released in liquid effluents to Unrestricted Areas (Figure 1 shall be limited to ten times the concentrations specified in I OCFR20, j3 Appendix B, Table 2, Column 2 for radionuclides other than dissolved or entrained noble gases. For dissolved or entrained noble gases, the concentration shall be limited to 2 x 10o4 pCi/ml total activity. The concentration of radionuclides in liquid waste is determined by sampling and analysis in accordance with Technical Requirements.
7.2.2. Methodology This section describes the calculational method to be used to determine FL, the fraction of 10CFR20 limits of release concentrations of liquid radioactive effluents.
I. General Approach Liquid effluent releases from River Bend Station are discharged through the cooling tower water blowdown, which is directed to the Mississippi River. Principal sources of radwaste are from floor drains, phase separators/backwash tank subsystem, recovery sample tanks, and reactor water cleanup (as shown in Figure 4). The liquid radwaste system is operated as a batch system. Only one tank of liquid radwaste is released at a time and is considered a batch.
The radioactive content of each batch release will be determined prior to release in accordance with Table 3.11.1.1.-1 of the RBS Technical Requirements. Compliance with TLCO 3.11.1.1 limits will be determined with the following equation:
NOTE Jf shall be administrativelycontrolled to maintain FL to *0.3 for most discharges, as identified. If X 10%ELi<0.3 or if the calculatedfi > 75 j -t GPMfi=75 GPM ForFL > 0.3, other administrativecontrols should be implemented to ensure dischargesshall not exceed Technical Requirement limits.
A Ci FL 7.2.2.1-1 RSP-0008 REV- 12 PAGE 10 OF 103
660 Where:(fC< 0 0.3 l .'S FL = The fraction of Technical Requirement limits resulting from the release source being discharged f, = The undiluted release rate at monitor location, in gpm f2 = The cooling tower blowdown release rate, in gpm CQ = The undiluted concentration of nuclide (i), in gCi/ml from sample assay.
(I OECL)i = Ten times the Effluent Concentration Limit of nuclide (i) from Attachment 2, in +/-Ci/ml
/ 3-As long as FL is less than 10, the concentration of the tank is within compliance with TLCO 3.11.1.1 limits.
- 2. Simplified Approach For purposes of simplifying the calculations, the value of 1 x 10-8 gCi/ml (unidentified 10CFR20 ECL value) could be substituted for (BCL)i and the cumulative concentration (C-Total = sum of all identified radionuclide concentrations) or the gross beta-gamma concentration should be substituted for C;. As long as the diluted concentration (C-Total x fI/(f1 +
-f) is less than 1 x 104 JCi/ml, the nuclide by nuclide calculation is not required to demonstrate compliance with 10CFR20 ECL limits.
7.3 Determination of Setpoints for Radioactive Liquid Effluent Monitors 7.3.1. Requirements Technical Requirements 3.3.11.2 requires the radioactive liquid effluent monitor be operable with their high alarm/trip setpoints set to ensure that limits of Technical Requirements 3.11.1.1 are not exceeded. The high alarm/trip setpoints shall be determined and adjusted by the methodology which follows:
The high alarm setpoint for the liquid effluent radiation monitor is derived from ten times the concentration limit provided in IOCFR2O, Appendix B, Table 2, Column 2 applied at the restricted area boundary where the discharge flows into the Mississippi River.
RSP-0008 REV- 12 PAGE 11 OF 103
Liquid Monitor Setpoints calculated in accordance with the methodology presented in this section will be regarded as upper bounds for the actual high alarm setpoints. That is, a lower high alarm setpoint may be established on the monitor, if desired. Alert level setpoints should be established at an appropriate level to give sufficient warning prior to reaching the high alarm setpoint.
- 1. Liquid Effluent Monitor A General Atomics liquid monitor (radwaste effluent RMS-RE107) equipped with a RD-53 detector with sufficient range (10l to 10 cpm) is provided to ensure compliance with Technical Requirements limits for liquid releases. The RD-53 is an offline gamma scintillation (Nal) detector designed for detecting radioactivity in liquids. The monitor consists of a removable sample canister surrounded by Pb shielding. A well inside the canister holds the detector within the sample fluid 7.3.2. Methodology The high alarm setpoint does not consider dilution, dispersion, or decay of radioactive material beyond the site boundary. That is, the alarm setpoint is based on a concentration limit at the end of the blowdown line.
- 1. Liquid Radwaste Effluent Monitor (RMS-RE1 07)
A sample of each batch of liquid radwaste is analyzed for 1-13 1 and other principal gamma emitters as specified in Table 3.11.1.1-1 of Technical Requirements 3.11.1.1, for total activity concentration prior to release.
The fraction, FL, of the TLCO 3.11.1.1 limits for unrestricted areas is determined in accordance with the preceding section for the activity concentration released.
NOTE A change to the 6DCM may cause a deviationfrom methodologies used in implementingprocedures(i.e., CSP-0110). Any change to RSP-0008 shall have an independentReviewfrom Chemistry, as a minimum, to ensure ODCM methodology compliance.
The liquid radwaste effluent monitor will terminate a liquid radwaste discharge if activity levels exceed the Technical Requirements limits. The automatic actions associated with a trip of the monitor are:
- 1) LWS-A0V257 closes
- 2) LWS-AOV258 opens An alarm will also be annunciated in the main control room.
RSP-0008 REV- 12 PAGE 12 OF 103
The liquid radwaste effluent line radiation monitor alarm setpoint is determined with the equation:
S =F. xgxM 7.3.2.1-1 FL Where:
S = the radiation monitor setpoint (cpm. or gCi/ml)
A = the sum of concentrations of gamma-emitting radionuclides in the sample, as measured in the laboratory.
FL = the fraction of TLCO 3.11.1.1 limits resulting from the release source being discharged.
g "Instrument Correction Factor"; the ratio of effluent radiation monitor counting rate to laboratory counting rate or activity concentration in a given batch of liquid (cpm per cpm/ml, cpm per pCi/ml, or RCi/m1 per +/-Ci/ml)
M "Setpoint Adjustment Factor", error associated with monitor accuracy NOTE A/FL represents the counting rateof a liquid waste stream that would have the same radionuclidedistribution as the given batch, but that would produce a concentration of 10 ECL at the point of discharge into the UnrestrictedArea.
NOTE A background determinationshould be performedprior to each release.
Backgroundsubtractionmay beperformed in accordance with the applicable Chemistryprocedures.
7.4 Determining the Dose for Radioactive Liquid Effluents 7.4.1. Requirements Technical Requirements 3.11.1.2 requires the dose or dose commitment to a member of the public from radioactive material released in liquid effluents be determined on a cumulative basis at least every 31 days. Dose or dose commitment shall be limited to:
RSP-0008 REV - 12 PAGE 13 OF 10-3 PAGE13OFTO3 RSP-0008 REV-fl
- 1. Less than or equal to 1.5 mrem to the total body and to less than or equal to 5 mrcm to any organ, during any calendar quarter; and
- 2. Less than or equal to 3 mrem to the total body and less than or equal to 10 mrem to any organ during any calendar year.
7.4.2. Methodology This section provides the methodology to calculate dose to all age groups and organs from all radionuclides identified in the liquid effluents.
The method is based on the methodology suggested by Sections 4.3 and 4.3.1 of NUREG-0133, Rev. 1, November 1978. The dose factors Ai, for all viable pathways are listed in Attachment 3.
The following equation provides a dose calculation to the total body or any organ for a given age group based on actual release conditions.
Dir =
Air
- At
- Q; 7.4.2-1 iT DF*D w
[TOTALr Z Dr 7.4.2-2 i=,
Where:
D TOTALt = The total dose commitment to the organ (r) due to all releases during the desired time period in mrem.
Di,= Dose commitment from radionuclide (i) received by organ (T) of the adult age group during the time period (mrem).
AjC= Site related dose commitment factor to the total body or any organ (t) for each identified radionuclide (i). The Air values listed in Attachment 3 are site-related to RBS (mrernvhr per p+/-Ci/ml).
At = The total time for all batch releases that occurred in the period (brs).
Qi = The total quantity of nuclide (i) released during the interval At (pCi).
Dw The near field dilution factor. Site specific value is 136.
DF = The total volume of dilution that occurred during the time period (Ol).
The doses associated with each isotope may then be summed to provide the cumulative dose over a desired time period (e.g., sum all doses during a 31 day period, calendar quarter, or a year).
RSP-0008 REV -12 PAGE 14 OF 103
7.5 Projecting Dose for Radioactive Liquid Effluents 7.5.1. Requirements Technical Requirement 3.11.1.3 requires the liquid radwaste treatment system be used to reduce the radioactive materials in liquid wastes prior to their discharge when projected doses due to liquid effluents, to unrestricted areas (Figure 1) would exceed 0.06 mrem to the total body or 0.2 mrem to any organ in a 31 day period.
7.5.2. Methodology The following calculational methodology shall be performed at least once per 31 day period; LPD- *31+D 7.5.2-1 XD DTOTAL, =The total dose commitment to the organ (') due to all releases during the desired time period.
LPD = Projected dose commitment (mrem) to organ (X)during the 31 day period from liquid effluents.
XD = Number of days to date in the current quarter DA The anticipated dose contribution to the total body or any organ x, due to planned activities during the next 31 day period, if those activities will result in liquid releases that are in addition to routine liquid effluents. If only routine liquid effluents are anticipated, DPA
-0.
8 GASEOUS EFFLUENT METHODOLOGY 8.1 Introduction River Bend Station discharges gaseous effluents through the Main Plant Exhaust Duct, Fuel Building Exhaust Duct, and Radwaste Building Exhaust Duct. The location of these release points in relation to the River Bend site is found in Figure 3. The gaseous effluent streams, radioactivity monitoring points, ahd effluent discharge points are shown schematically in Figure
- 2. All gaseous effluent releases ftom the Radwaste Building Exhaust Duct and Fuel Building Exhaust Duct are assumed to be ground level releases. The Main Plant Exhaust Duct routine releases are treated as a wake split (conditionally elevated) release.
RSP-0008 REV -12 PAGE 15 OF 103
8.2 Data Requirements for Gaseous Effluents For the purpose of estimating offsite radionuclide concentrations and radiation doses, measured radionuclide concentrations in gaseous effluents and in ventilation air exhausted from the station are used. Table 3.11.2.1-1 in the Technical Requirements identifies the radionuclides in gaseous discharges for which sampling and analysis is done.
When a nuclide concentration is below the LLD for the analysis, it is not reported as being present in the sample.
Historical annual average meteorological information will be used to calculate off-site dose and monitor set points. Modeling will be performed in accordance with the methodologies described in Reg. Guide 1.111 Rev. 1.
8.3 Instantaneous Release Rate and Setpoint Determination 8.3.1. Instantaneous Release Rate Determination The instantaneous release rate determination is performed to show compliance with the limits set forth in the TRM.
- 1. Requirements Technical Requirements 3.11.2.1 states that the dose rate due to radioactive materials released in gaseous effluents from the site to areas at and beyond the site boundary (see Figure 1) shall be limited to the following:
- 1) For noble gases: Less than or equal to 500 mrem/year to the total body and less than or equal to 3,000 mremlyear to the skin; and
- 2) For 1-131, 1-133, tritium, and for all radionuclides in particulate form with half-lives greater than 8 days: less than or equal to 1,500
-nrem/year to any organ.
- 2. Methodology D) Total Body and Skin Instantaneous Dose Rate Calculations To determine the dose rate from noble gases in unrestricted areas, the following formulae are used:
-i 8 ,
RtSP-0008 RS 8 12 REV- PAGE 16 OF 103
I, __ _
DR9S =E(L, +1.L4I)(X/Q)(Q1 ) 8.3.1.2.1-2 l-1 Where:
DR sKNi = Dose rate to the skin in mrem/year DR TB Dose rate to the total body in mrem/year K i = The total body dose factor due to gamma emissions for each identified noble gas radionuclide (i) in mremlyr per gCi/M3 Attachment 4 L= Skin dose factor due to beta emissions for each identified noble gas radionuclide (i) in mremlyr per ,tCi/m 3 Attachment 4 M T=he air dose factor due to gamma emissions for each identified noble gas radionuclide (i) in nrad/yr per pCi/M3 Attachment 4 XI Q =The highest calculated annual average relative dispersion factor for any area at or beyond the unrestricted area boundary for all Sectors (sec/m 3 ). Attachment 9 Q.= The release rate of radionuclide (i) in gaseous effluents from all releases in gCi/sec 1.1 = Conversion factor for Mi from mrad to Inrem In order to comply with the limits of the TRM, DRTB 500 mrem/year and DRMsn *3,000 mremlyear must be met at the most limiting location, at or beyond the site boundary.
The (X/Q) values utilized in equations 8.3.1.2.1-1 and 8.3.1.2.1-2 are based upon maximum long-term annual average X(xiQ) in the unrestricted area. Attachment 9 lists the maximum (X/Q) values for the RBS release points at the appropriate receptor locations.
To select the most limiting location, the highest (XIt Q) for each release point is used (from Attachment 9):
(X/)M = 3.31 x 106 sec/m3 RSP-O0008 REV - 12 PAGE 17 PAGE 17 OF OF 103 103 IISP-0008 REV -12
(XYQ)GRD = 4.21 x IO-5 sec/m3 where:
(X I Q)MM = Chi/Q for Main Plant exhaust duct (mixed mode)
(X/Q) R0D = Chi/Q for Radwaste Building exhaust duct (ground level) and for Fuel Building exhaust duct (ground level)
(Attachment 9 contains the maximum (Xi Q) and DIQ values used in calculating individual doses.)
Release rates for all release points must be considered at the same time. If releases are occurring at the same time, the total instantaneous dose for all releases must be less than the limits of Technical Requirements 3.11.2.1. An administrative control limits the release rates for each of the three release points to 1/3 the total Technical Requirements doses.
- 2) Radioiodine, Tritium, and 8-day Particulate Dose Rate Calculations The following calculational method is provided for determining the dose rate from radioiodine (1-131, I-133), Tritium and particulates with half-lives greater than 8 days and to determine if they are within the limits listed in Section 8.3.1.1.2).
In the calculation to show compliance with the TRM, only the inhalation pathway is considered, since it is the most limiting pathway.
Inhalation Pathway:
DRr&SDPr =X( tQ( J 8.3.1.2.2-1 where:
DR = Dose rate to the organ X for the age group of interest from radioiodines (1-131 and I-133), tritium and 8 day particulates via the inhalation pathway (mnrem/yr).
Q. =Release rate of nuclide (i), (gCilsec).
REV - 12 OF 103 RSP-0008 RSP-0008 REV 12 - PAGE 18 PAGE 18 OF 103
(X IQ) = The highest calculated annual average relative dispersion factor for any area at or beyond the unrestricted area boundary for all sectors (sec/r 3 ). Attachment 9.
Pi=The dose factor for applicable environmental pathway (mrem/yr per pCi/m 3 ). Attachment 15 through Attachment 18.
Values for Pi were calculated for all age groups using the inhalation pathway methodology of NUREG-0 133.
8.3.2. Setpoint Determination
- 1. Requirements Instrumentation is provided to monitor beta-gamma radiation from radioactive materials released from the River Bend Station in gaseous effluents. Each release point process monitor listed in the TRM includes an alarm (HIGH ALAR) that is set to report when the radioactive noble gas in gaseous effluents (Main Plant exhaust duct, Fuel Building exhaust duct and/or Radwaste Building exhaust duct) is expected to cause a noble gas concentration at ground level offsite resulting in a dose rate equal to or greater than 500 mrem/yr to the total body and/or 3000 mrem/yr to the skin.
The ALERT alarm is set to report when the radioactive noble gas in gaseous effluents (Main Plant exhaust duct, Fuel Building exhaust duct and/or Radwaste Building exhaust duct) is expected to cause a noble gas concentration at ground level offsite that would result in meeting or exceeding either the 5 mrad per quarter gamma air dose or 10 mrad per quarter beta air dose limit (Technical Requirements 3.11.2.2). It is permissible to set the ALERT alarm at twice (2.0) normal (approximately 100 % unit power) detector background if nuisance alarms would result from setpoints based on gamma and beta air dose.
The distribution of radioactive noble gases in a gaseous effluent stream is determined by gamma spectrum analysis of identifiable radionuclides in.
effluent gas sample(s). Results of one or more previous analyses may be averaged to obtain a representative sample. In the event the distribution is unobtainable from measured data, the distribution of radioactive noble gases based on past data or calculated by the BWR-GALE code may be used.
To allow for multiple sources of releases from the three different release points, the allowable operating setpoints will be administratively controlled to allocate one-third (1/3) of the total allowable release to each of the release sources.
RSPA009 RE-V- 12 19 OF PAGE 190 PAGE IQ-'
OF 103 lISP-ODOR REV -12
- 2. Methodology
- 1) HIGH ALARM Setpoint Determination This section describes the methodology for determining and adjusting HIGH ALARM setpoints for the three release points:
a) Wide Range Gas Monitor (WRGM)
Step 1. Determine QT8 as follows:
Q 500 8.3.2.2-1 (X/ Qt(Kx i) where:
QT2 = maximum acceptable total release rate of all noble gas radionuclides in the gaseous effluent (jxCi/sec).
(X/Q) = The highest calculated annual average relative dispersion factor for any area at or beyond the unrestricted area boundary for all Sectors (sec/n 3 ).
Attachment 9 Ki = The total whole body dose factor due to gamma emissions from noble gas radionuclide (i) mrem/yr per gCi/m3 )
from Attachment 4.
f= Fraction of noble gas radionuclide (i) to total noble gas concentration.
500 Whole body exposure limits of 500 miern/year.
Step 2. Determine Q. as follows:
Q (3000) 8.3.2.2-2 (xIQt[(L, + l r )fI]
'a' where:
Q=the maximum acceptable release rate of all gas radionuclides in the gaseous effluent [gCi/sec]
RS3P-0008 REV - 12 PAGE PGE0F 20 OF 103 RS-008 RV-l
L, + 1.1Mi = Calculated total skin dose factor due to emission from noble gas radionuclide (i) mrem/yr/lpCi/m 3 from Attachment 3.
fi = Fraction of noble gas radionuclide (i) to total noble gas concentration (x/I) = The highest calculated annual average relative dispersion factor for any area at or beyond the unrestricted area boundary for all Sectors (sec/r 3 ), Attachment 9.
3000 = Skin exposure limit of 3000 mrem/year Step 3. Select the lower of the Q values (QTB or Qs) obtained in Step l and Step 2.
NOTE Actual alarm setpoint in the data base may be modified to accountfor loop accuracy.
Step 4. Multiply the Q value selected in Step 3 by 0.33. By multiplying the Q value by a factor of 0.33, the allowable operating setpoints will be administratively controlled to allocate one-third (1/3) of the total allowable release rate to each of the release points. The resultant product will be the actual ODCM release rate HIGH ALARM setpoint for the appropriate WRGM Monitor.
b) Particulate and Gas Monitor (P&G) (gas channel only).
Stp 1. Perform Steps 1 through 3 of Section 8.3.2.2.1)a) above.
Step 2. Determine C. (the maximum acceptable total radioactivity concentration of all noble gas radionuclides for all release points in the gaseous effluent [gtCi/cc]):
C (2.12x10-3 ) Q 8.3.2.2-3 F
where:
2A12 x 1o3 = Unit conversion factor to convert gCi/sec/cftn to MCi/cc Q = Lower of the two Q values, Q-M or Qs RSP-00flg REV - 12 PA GE 21 OF 103 21 OF 103 RSP-0008 REV 12- PAGE
F =The maximum acceptable effluent flow rate at the point of release based on design flow rates (cfin)
NOTE Actual alarm setpoint in the databasemay be modified to accountfor loop accuracy.
Step 3. Multiply the C value determined in Step 2 by 0.33. By multiplying the CQ value by a factor of 0.33, the allowable .
operating setpoints will be administratively controlled to allocate one-third (1/3) of the total allowable release to each of the release points. The resultant product will be the actual ODCM activity concentration HIGH ALARM setpoint for the appropriate P&G monitor gas channel.
- 2) ALERT Setpoint Determination (Reference 2.1.6)
This section describes the methodology for determining and adjusting ALERT setpoints for the three release points.
a) Wide Range Gas Monitor (WRGM)
Step 1. Determine QG-A utilizing one of the following methods:
QG- = (X)8.3.2.2-4 (7Q) MIA where:
QC-A = The maximum acceptable total release rate of all noble gas radionucdides in the gaseous effluent [guCi/sec]
(x/Q) = The highest calculated annual average relative dispersion factor for any area at or beyond the unrestricted area boundary for all Sectors .(sec/M3 ),
Attachment 9 5 =5 mrads/quarter gamma air dose limit at the unrestricted area boundary i= The gamma air dose factor for radioactive noble gas
- I nuclide (i) in mrad-m34aCi-yr, Attachment 4
= The fractional abundance of noble gas radionuclide i RSP-0008
_E
_S-OO RtEV -112 PAGE 22 OF 103 PAGEZ__FO_
4 = Number of Quarters Per Year Step 2. Determine QB-A utilizing one of following methods:
- (4X10) 8.3.2.2-5 (xIQ) Nfi i=]
Where:
QB-A = maximum acceptable total release rate of all noble gas radionuclides in the gaseous effluents pCi/sec)
(XIQ) = The highest calculated annual average relative dispersion factor for.an area at or beyond the unrestricted area boundary for all sectors (sec/m3 ), Attachment 9 10 = 10 mrad/quarter (92 days) beta air dose limit at the unrestricted area boundary Ni = The air dose factor due to beta emissions from each noble gas radionuclide (i) in Attachment 4 f= The Factional abundance of noble gas radionuclide i 4 Number of Quarters Per Year Step 3. Select the lower of the Q values obtained in Steps 1 and 2,Neither QG-A or QB-A.
Step 4. Multiply the Q value selected in Step 3 by 0.33. By multiplying the Q value by this factor, the allowable operating setpoints will be administratively controlled to allocate one-third (1/3) of the total allowable release rate to each of the release points. The resultant product will be the actual ODCM ALERT setpoint to be entered into the applicable WRGMs RM-80.
Sten 5. If the actual ODCM ALERT setpoint determined in Step 4 is less than two times (2.0) the detector background, it is permissible to enter an ALERT setpoint equal to two times (2.0) the normal (approximately 100% unit power) detector background to reduce the possibility of nuisance alarms. the twice background setpoint should provide sufficient indication that an offsite dose limit could possibly be exceeded.
'R~qPnflfl RliV_ 127 PAGCR oARIl3 1
1WV 17 PACJ? flfll? lOt
b) Particulate and Gas Monitor (P&G) (gas channel only)
Step 1. Perform Steps 1 through 3 of Section 8.3.2.2.2)a) above.
Step 2. Determine Cm (the maximum acceptable total radioactivity concentration of all noble gas radionuclides for all release points in gaseous effluent [jxCi/cc]):
C=(2.12xl0 3 Q 8.3.2.2-6 Where:
2.12 x 10-3 = Unit conversion factor to convert jsCi/sec/cfin to gci/cc.
Q = Lower of the two Q values, QGA or QB-A F = The maximum acceptable effluent flow rate at the point of release based on design flow rates (cfin).
Sten 3. Multiply the Cm value determined in Step 2 by 0.33. By multiplying the C. value by this factor, the allowable operating setpoints will be administratively controlled to allocate (1/3) of the total allowable release to each of the release points. The resultant product will be the actual ODCM activity concentration ALERT setpoint. This value is the setpoint to be entered into the applicable P&G monitor's RM-80.
Step 4. If the actual ODCM ALERT setpoint determined in Step 3 is less than two times (2.0) the gas detector background, it is permissible to enter an ALERT setpoint equal to two times (2.0) the normal (approximately 100% unit power) gas detector background to reduce the possibility of nuisance alarms. The twice background setpoint should provide sufficient indication that an offsite dose limit could possibly be exceeded.
8.4 Cumulative Dose Determination for Radioactive Gaseous Effluents 8.4.1. Noble Gases
- 1. Air Dose
- 1) Requirements Technical Requirements 3.11.2.2 states that the air dose due to noble gases released in gaseous effluents to areas at and beyond the site boundary (see Attachment 34) shall be limited to the following:
RSP-0008 REV- 12 PAGE 24 OF 103
a) During any calendar quarter: less than or equal to 5 mrads for gamma radiation and less than or equal to 10 mrads for beta radiation; and b) During any calendar year: less than or equal to 10 mrads for gamma radiation and less than or equal to 20 mrads for beta radiation.
- 2) Methodology This section provides the methodology to calculate the gamma and beta air doses to a maximum receptor location at the site boundary from all noble gas radionuclides identified in the gaseous effluents.
The method is based on the methodology suggested by sections 5.3 and 5.3.1 of NJREG-0133, Rev. 1, November 1978. The dose factors for beta and gamma air dose are listed in Attachment 4 and are obtained from Table B-1 of RG 1.109, Revision 1, October 1977.
The following equations provide for air dose calculations based on actual noble gas releases during a specific time interval for radioactive gaseous release sources at the site boundary:
Da =3.17E-8 (M; XX/QXQi) 8.4.1.1.2-1 DBetaAir =3.l7E -8 (No
)(XQxQi) 8.4.1.1.2-2
- i=1 where:
D The gamma air dose from radioactive noble gases in CGanmi-Adr mrad.
M; = The gamma air dose factor for radioactive noble gas nuclide (i) in mrad-m 3 /jtCi-yr (Attachment 4) 3.17-8 = Inverse of number of Seconds Per Year in Year/Sec XI ) = The highest calculated annual average relative dispersion factor for an area at or beyond the unrestricted area boundary for all sectors (sec/m 3 ), Attachment 9
= The quantity of ,uCi of nuclide (i) released during the period of interest RSP-0008 REV -12 PAGE 25 OF 103
D = Beta air dose from radioactive noble gases in mrad Beta-Ar Ni = The beta air dose factor for radioactive noble gas nuclide (i) in mrad-m 3/pjCi-yr (Attachment 4), Table C-1
- 2. Total Body and Skin Dose
- 1) Requirements a) Technical Requirements 3.11.4 states that the annual (calendar year) dose or dose commitment to any MEMBER OF THE PUBLIC, due to releases of radioactivity and to radiation from uranium fuel cycle sources, shall be limited to less than or equal to 25 mrem to the total body or any organ, except the thyroid, which shall be limited to less than or equal to 75 mrem.
b) Technical Specification 5.5.4.j requires the limitations on the annual dose or dose commitment to any member of the public due to releases of radioactivity and to radiation from uranium fuel cycle sources, conforming to 40 CFR 190.
Cumulative doses from liquid effluents and gaseous pathways (radioiodines (1-131, I-133), Tritium and particulates with T 1/2
> 8 days) are determined in accordance with Sections 7.4.2 and 8.4.1.3. Cumulative total body and skin doses from noble gas releases are determined in accordance with Section 8.4.1.2.2).
- 2) Methodology This section provides the methodology to calculate the total body and skin doses to the likely most-exposed MEMBER OF THE PUBLIC from all noble gas radionuclides identified in the gaseous effluents.
The method is based on the methodology suggested in section C.2 and Appendix B of NRC Regulatory Guide 1.109, revision 1, October 1977 and is used to calculate the doses in this section. The dose transfer factors required for the calculations are listed in Attachment 4 of this document and are-obtained from Table B-I of RG 1.109, Revision 1, October 1977.
Doses to the total body and to the skin, due to actual noble gas releases during a specific time interval, at the location of the likely most, exposed MEMBER OF THE PUBLIC, are calculated as follows:
DThaBod =(SFXFO X3.17E - 8)X. 0KXI7kQ 1) 8-4.1.2.2 -1
' ' i-l RREV- 12 PAGE 26 PAGE (W 103-'
26 (IF 1(fl REV- 12
Dsk =(F0 X3.17E -8) +1M(SF)) 1(x/QXQj) 8.4.1.2.2-2 i'=1 Where:
DTotal Body = The total body dose from radioactive noble gases in mrem K= The total whole body dose factor due to gamma emissions from noble gas radionuclide (i) (mrem/yr per uCi/m3 ) from Attachment 4, Table C-1 (XIQ) = The highest calculated annual average relative dispersion factor for an area at or beyond the unrestricted area boundary for all sectors (sec/m 3 ) (Attachment 9)
NOTE When calculatingDTO:t, B0dY and Dskn for determining 40CFRJ190 compliance as reportedin the Annual Radioactive Effluent Release Report, (XQ) values based on either historicalannual-average meteorologicaldata, or on datafor the actualperiodof release, may be used.
Qj = The number of pCi of noble gas nuclide (i) released during the period of interest Dski.= The skin dose from radioactive noble gases in nirem Mi= The gamma air dose factor due to gamma emissions from each noble gas radionuclide (i) released Attachment 4, Table C-I Fo = Occupancy factor determined for the receptor at the given location (default = 1.0)
NOTE If a time period is less than onefull year, determine the fraction ofa year and multiply thefraction by 3.1 7E-8 for use in equations 8.4.1.2.2-1 and -2.
3.17E-8 Inverse of the number of seconds per year in yrisec I,='The skin dose factor due to beta emissions from noble gas I radionuclide (i) (mrem/yr per pCi/m3 ) from Attachment 4, Table C-I
-RqP-0(1()R RRV - 12 PAGE 27 PAGEF OF 103 27 or 103 RSP-Ofl08 REV - 12
1.1 = Average ratio of tissue to air energy absorption coefficients SF= 1.0, attenuation factor accounting for shielding provided by residential structures for maximally exposed individual
- 3. Radioiodine, Tritium, and 8 Day Particulate Dose to Any Organ from Cumulative Releases
- 1) Requirements a) Technical Requirements 3.11.2.3 states that the dose to a Member of the Public from Radioiodines (I-13 1, I- 133), Tritium, and Particulates with Ti/2> 8 days in gaseous effluents released to areas at and beyond the site boundary shall be limited to the following:
- i. During any calendar quarter: less than or equal to 7.5 mrem to any organ; and ii. During any calendar year: less than or equal to 15 mrem to any organ.
The dose to a member of the Public shall be determined at least once per 31 days for the current calendar quarter and current calendar year.
b) Technical Requirement 3.11.4 states that the Annual (Calendar year) dose or dose commitment to any Member of the Public, due to releases of radioactivity and to radiation from Uranium Fuel Cycle sources, shall be limited to less than or equal to 25 mrem to the total body or any organ, except the thyroid, which shall be limited to less than or equal to 75 mrem.
- 2) Methodology a) The following calculational method is provided for determining the organ dose due to releases of radioiodines (I131, 1133),
tritium and particulates. It is based on Section 5.3.1 of NUREG-0133, Rev. 1, November 1978. The equation can be used for any age group provided that the appropriate dose factors are used and the total dose reflects only those pathways that are applicable to the age group. The total dose to an organ can then be determined by summing the pathways that apply to the receptor. The equations are:
flRP-flflR 1VRV - I1 PACV. 172 n1W in';
NOTE When calculatingor an doses due to the release of C-14 and/or tritium (H-3), (Xi Q) values, not (pD 1Q) values, must be usedfor cow milk, goat milk, meat and vegetationpathway calculations, Inhalation Pathways:
D1&SDPr =(3.17x10- XF,)X(PIXX/QXQi) 8.4.1.3-1 Ground Plane Pathway:
Dr&SDP=r :(3.17xl ° - XZ)) (R1, ,D/ QQ)iQ) 8.4.1.3-2 1-1 Contaminated Forage/Cow/Milk Pathway:
Dl&8DPr = (3. 17x1O- XFO ) (Ri#XD /QXQ,) 8.4.1.3-3 i..I Contaminated Forage/Goat/Milk Pathway:
DI&8Dpr=(3.17AlO 8Xl, (2RjD-1QXQ,) 8.4.1.3 -4 Contarminated Forage/Meats:
D,&BDpr =(3.17xlO-BXFO) (RiXD/QXQ1 ) 8.4.1.3-5
,=,
Fresh Fruits and Vegetables:
DI&SDPr =(3-17xlOsXFO ) (Ri )D /QQ 8.4.1.3-6 i-I Total Dose:
Dr =zDI&8DPr 8.4.1.3-7 z=l Where:
1RSP-0008 REV -12 RS-08 PAGE 29OF 103
DI&8Dp, = Dose to the organ (-c) for the age group of interest from radioiodines (I-131, I-133), tritium and 8-day particulates via the pathway of interest Fo = Occupancy factor defined for the receptor at the given location
,= Total dose in mrem to the organ (t) of a specified age group summed over all applicable pathways (Z) z = All the applicable pathways for the age group of interest Pi, = Inhalation dose conversion factor mrem/yr per jLCi/m 3 Qi= The number of jLCi of nuclide (i) released during the year of interest Rig= The dose factor for nuclide (i) for pathway (Z) to organ (X) of the specified age group. For tritium, a site-specific absolute humidity (H) value of 12.9 gmln 3 was used for calculation. (See Attachment 15 through Attachment 33.)
The units are:
Ae-in for pathways using (X/Q) or 2
mremM - _m-se for pathways using (DJ Q)
'UCi -yr (DJIQ) = A long-term relative deposition value for elevated and ground level releases (on2 )
(X / Q) = The highest calculated annual average relative dispersion factor for an area at or beyond the unrestricted area boundary for all sectors (sec/r ), Attachment 9.
3.17X10 4 = The inverse.of the number of seconds per year (years/sec).
8.5 Dose Projection - Determination of Need to Operate Ventilation Exhaust Treatment System RSP-0008 REV - 12 PAGE 30 OF 103 PAGE300F103 RP-OOOR REV-12
8.5.1. Requirement Technical Requirements 3.11.2.5 requires that the ventilation exhaust treatment system be used to reduce radioactive material in waste prior to discharge when the projected dose due to gaseous effluents (radioiodines (I-131, I-133),
particulates T 1/2 > 8 days and H-3) would exceed 0.3 mrem to any organ in a 31 day period.
NOTE The ventilation exhaust treatmentsystem does not reduce the noble gas concentrationin plant effluents (See Definition 3.5).
8.5.2. Methodology The following calculation method is provided for determining the projected doses:
G =kk* 3 1+D 8.5.2-1 PD X PA D
Where:
G = Projected dose due to radioiodines (1-131, 1-133), particulates with T 1/2
> 8 days and H-3 during the current 31 day period (mnrem)
XD = The number of days to date in the current quarter D, = Cumulative total dose due to radioiodines (I-131, 1-133), particulates with T 1/2 > 8 days and H-3 during the current quarter (mrem)
DPA= The anticipated dose contribution to the total body or any organ -rdue to planned activities during the next 31 day period, if those activities will result in gaseous releases that are in addition to routine gaseous effluents. If only routine effluents are anticipated, DPA 0. This value may be adjusted to account for any changes in operating conditions that could significantly alter actual releases, such as failed fuel or changes in ventilation flow rate.
A dose projection would be based on the latest results of the monthly calculations of the dose due to radioiodines (I-131, I-133), particulates with T 1/2 > 8 days, and H-3 (Section 8.4.1.3).
RSP-0008 REV- 12 PAGE 31 OF 103
9 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM Attachment I contains the sample point description, sampling and collection frequency, analysis, and analysis frequency for various exposure pathways in the vicinity of RBS for the Radiological Environmental Monitoring Program. Attachment 34 and Attachment 38 indicate the locations of the various onsite and offsite sampling points and TLD locations.
This section describes only those elements of the Radiological Environmental Monitoring Program required by the RBS Technical Requirements Manual. Additional exposure pathways, sample points, analyses, and/or frequencies may be performed as described in Reference 2.1.3 Section 6.2.
Samples of groundwater are taken from onsite wells located to intercept any potential contamination of the Upland Terrace Aquifer so that any such contamination would be detected before migrating beyond RBS site boundaries.
10 40CFR190 CONSIDERATIONS 10.1 Compliance with 40CFR190 Compliance with 40CFR190 as prescribed by Technical Requirements 3.11.4 is to be demonstrated onlywhen one ormore of Technical Requirement(s) 3.11.1.2.a, 3.11.1.2.b, 3.11 .2.2.a, 3.11 .2.2.b, 3.11 .2.3a, and 3.11.2.3 .b, including direct radiation are exceeded by a factor of 2. Once this occurs, EOI has 30 days to submit a report in accordance with Requirement 3.11.4.
10.2 Calculations Evaluating Conformance with 40CFR1 90 To perform the calculations to evaluate conformance with 40CFR190, an effort is made to develop doses that are realistic by removing assumptions that lead to overestimates of dose to a Member of the Public (i.e., calculations for compliance with 10CFR50 Appendix I). To accomplish this, the following calculational rules are used:
10.2.1 . Doses to Members of the Public via the liquid release pathway are considered to be < 1 mrem/yr (Ref NUREG-0543).
I0.2.2. Doses to a member of the Public due to a milk pathway will be evaluated only as can be shown to exist. Otherwise, doses via this pathway will be estimated as Cl mrem/yr.
10.2.3. Environmental sampling data that demonstrate that no pathway exists may be used to delete a pathway to man from a calculation.
10.2.4. To sum numbers represented as "less than" (<), use the value of the largest number in the group.
RSP-0008 RIEV- 12 PAGE 32 OF 103
e.g., <5+ <1 + <1 + <3 = <5 10.2.5. When doses via direct radiation are added to doses via inhalation pathway, they will be calculated for the same distance in the same sector.
10.2.6. The calculational locations for a Member of the Public will only be at residences or places of employment.
NOTE Additional assumptions may be used to provide situation specific parameters,provided they are documented along with their concomitantbases.
NOTE Estimatesfor each ofthe calculationsbelow will be made for each of thefollowing exposure pathways to the same location by age class. Only those age classes known to
- exist at a location are considered.
10.3 Calculations of Total Body Dose 10.3.1. Direct Radiation (from storage tanks, N-16 sources, etc.)
The component of dose to a Member of the Public due to direct radiation will be determined by thennoluminescent dosimeters (TLDs).
10.3.2. Inhalation Dose The inhalation dose will be determined at the calculational locations for each age group according to the methods outlined in Section 8 of this manual.
10.3.3. Ingestion Pathway (cow milk, goat milk, meat, vegetation)
The dose via the ingestion pathway will be calculated at the consumer locations for the consumers at risk. If no milk pathway exists in a sector, the dose via this pathway will be treated as < 1 mrem/yr.
10.3.4. Total Body Noble Gas Imnersion Dose This dose will be calculated in accordance with Section 8.4.1.2.2). for the maximally exposed MEMBER OF THE PUBLIC in the limiting sector.
10.3.5. Ground Plane Deposition 10.3.6. Other Uranium Fuel Cycle Sources RSP-0008' RSP000 REV - 12
=AGE3-OF1O
=E-1 PAGE 33 OF 103
The dose from other fuel sources will be treated as < 1 mrem/yr.
10.4 Thyroid Dose The dose to the thyroid will be calculated for the limiting sector as the sum of:
10.4.1. Direct Radiation (from storage tanks, N-16 sources, etc.)
The component of dose to the thyroid due to direct radiation will be determined by thermoluminescent dosimeters (TLDs).
10.4.2. Inhalation Dose The inhalation dose to the thyroid will be determined at the calculational locations for each age group according to the methods outlined in Section 8 of this manual.
10.4.3. Ingestion Pathway (cow milk, goat milk, meat, vegetation)
The dose to the thyroid via the ingestion pathway will be calculated at the consumer locations for the consumers at risk. If no milk pathway exists in a sector, the dose via this pathway will be treated as < 1 mremlyr.
10.4.4. Noble Gas Immersion Dose It is assumed that an external total body dose from noble gases irradiates internal body organs at the same numerical rate (Reference 2.1.8). This dose for the thyroid will therefore be equal to the dose calculated in Step 10.3.4 above.
10.4.5. Ground Plane Deposition 10.4.6. Other Uranium Fuel Cycle Sources The dose from other fuel cycle sources will be treated as <1 mrem/yr.
10.5 Organ Dose (other than thyroid and skin)
The dose to any organ will be calculated for the limiting sector as the sum of:
10.5.1. Direct Radiation (from storage tanks, N-16 sources, etc.)
The component of dose to an organ due to direct radiation will be determined by thermoluminescent dosimeters (TLDs).
10.5.2. Inhalation Dose RSP-0008 R1EV -12 PAGE 34 OF 103
The inhalation dose to an organ will be determined at the calculational locations for each age group according to the methods outlined in Section 8 of this manual.
10.5.3. Ingestion Pathway (cow milk, goat milk, meat, vegetation)
The dose to an organ via the ingestion pathway will be calculated at the consumer locations for the consumers at risk. If no milk pathway exists in a sector, the dose via this pathway will be treated as < 1 mrem/yr.
10.5.4. Noble Gas Immersion Dose It is assumed that an external total body dose from noble gases irradiates internal body organs at the same numerical rate (Reference 2.1.8). This dose for an organ will therefore be equal to the dose calculated in Step 10.3.4 above.
10.5.5. Ground Plane Deposition 10.5.6. Other Uranium Fuel Cycle Sources The dose from other fuel cycle sources will be treated as < 1 mrem/yr.
10.6 Skin Dose The dose to the skin will be calculated for the limiting sector as the sum of:
10.6.1. Direct Radiation (from storage tanks, N-16 sources, etc.)
The component of dose to the skin due to direct radiation will be determined by thermoluminescent dosimeters (TLDs).
10.6.2. Inhalation Dose The inhalation dose to the skin (only tritium is considered) will be determined at the calculational locations for each age group according to the methods outlined in Section 8 of this manual.
10.6.3. Ingestion Pathway (cow milk, goat milk, meat, vegetation)
The dose to the skin via the ingestion pathway (only titium and 0-14 considered) will be calculated at the consumer locations for the consumers at risk. If no milk pathway exists in a sector, the dose via this pathway will be treated as < I mrem/yr.
10.6.4. Skin Noble Gas Immersion Dose This dose will be calculated in accordance with Section 8.4.1.2.2) for the maximally exposed MEMBER OF THE PUB3LIC in the limiting sector(s).
RSP-0008 REV -12 PAGE 35 OF 103
10.6.5. Ground Plane Deposition 10.6.6. Other Uranium Fuel Cycle Sources This dose from other fuel cycle sources will be treated as < 1 mrem/yr.
11 INTERLABORATORY COMPARISON STUDIES 11.1 Requirement Technical Requirements 3.12.3 states that analyses shall be performed on radioactive materials, that correspond to samples required by Table 3.12.1-1, supplied as part of an Jnterlaboratory Comparison Program.
11.2 Program 11.2.1. Environmental Sample Analyses Comparison Program Environmental samples from the River Bend Station are to be analyzed by the River Bend Station Environmental Services Group or by a qualified contracting laboratory. These laboratories will participate in an Environmental Radioactivity Laboratory Intercomparison Studies (Crosscheck) Program. This participation will include all of the determinations (sample-radionuclide combinations) that are included in the licensee's Radiological Environmental Monitoring Program. Results of the Interlaboratory Program will be included in the Annual Radiological Environmental Operating Report.
11.2.2. Effluent Release Analyses Program RBS Chemistry Group will perform sample analyses for gamma-emitting radionuclides in effluent releases. The radiochemistry laboratory will participate annually in a corporate interlaboratory comparison study or an equivalent study. The results of these studies will be provided to the NRC upon request.
11.2.3. Abnormal Results The RBS laboratory values and the vendor laboratory "known values" should be compared by some evaluation criteria such as the EPA method, where the acceptable result lies between +/- three normalized standard deviations from the "known value"; or the NIST traceability method, where the difference between the RBS value and the "known value" should be less than the total propagated uncertainty of the difference. If deviations from such criteria exist, an evaluation will be performed to identify any recommended remedial actions to reduce anomalous errors. Complete documentation on the evaluation will be provided to the NRC upon request, RSP-0008 REV -12 PAGE 36 OF 103
ATTACHMENT I PAGE I OF 4 TABLE 4.1 - RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM Exposure Pathway Sample Point, Description, Sampling and Type and Frequency and/or Sample Distance, and Direction Collection Frequency of Analysis
- 1. Airborne Particulates and 1- Samples from 4 locations:
-131 API. Behind River Bend Station Activity Continuous air sampler with filter collection Charcoal cartridge: analysis every two weeks Center; 0.9 kIn WNW. every two weeks, or as required by dust loading, for 1-1331 Particulate sampler: gross beta whichever is more fiequent. activity following filter changes every two weeks.
AQS2. St. Francis Substation on US Hwy.
(Bus.) 61 in St. Francisville; 5.8 km NW (Community Location).
AGC. Entergy Service Center compound in Zachary; 17 kn SE (Control)
ANI. RBS site Hwy 965; 0.4 km south of Activity Center; 0.9 km W.
- 2. Direct Radiation Measurements from 24 locations:
INDICATOR STATIONS Thermoluminescence dosimeters (TLDs); mR exposure quarterly.
TAL. River Bend Training Center; 1.7 km N.
deployment/retrieval quarterly.
TB1. Utility pole near River Bend Station cooling tower yard area; 0.5 km NNE.
TCI. Stub pole at Jet US Hwy. 61 and Old Highway 61; 1.7 kan NE.
TD1. Stub pole along WF7, 150m S of Jct WF7andUSHwy. 61; 1.6kmENE.
TE I. Stub pole along WF7,1 km S of Jct. WF7 and US Hwy. 61; 1.3 kn E.
TF1L Stub pole along WF7, 1.6km S of Jct.
WF7 and US Hwy. 61; 1.3kmESE.
TGI. Stub pole along WF7, 2 kn S of Jet. WF7 and US Hwy. 61; 1.6 km SE.
RSP-0008 REV -12 PAGE 37 OF 103
ATTACHMENT 1 PAGE2OF4 TABLE 4.1 - RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM Exposure Pathway Sample Point, Description, Sampling and Type and Frequency and/or Sample Distance, and Direction Collection Frequency of Analysis THiL. Stub pole at power line crossing of WF7 (near Grants Bayou); 1.7 km SSE.
TJI. Stub pole near River Bend Station Gate
- 23 on Powell Station Road (LA Hwy. 965); 1.5 km S.
TKI. Utilitypole on Powell Station Road (LA Hwy. 965), 20 m S of River Bend Station River Access Road; 0.9 Ian SSW.
TLI. First utility pole on Powell Station Road (LA Hwy. 965) S offormer Illinois Central Gulf RR crossing; 1.0 km SW.
TMI. Third utility pole on Powell Station Road (LA Hwy. 965) N of former Illinois Central Gulf RR crossing, 0.9 km WSW.
mNl. Utility pole along Powell Station Road (LA Hwy. 965), near garden and ANI air sampler location; 0.9 kn W.
TP I. Behind River Bend Station Activity Center at API air sampler location; 0.9 km WNW.
TQI. Across from MAI on RBS North Access Road; 0.6 km NW.
TRI. River Bend Station North Access Road across from Main Plant entrance; 0.8 km NNW.
CONTROLUSPECIAL STATIONS TAC. Utility pole at Jt. of US Hwy. 61 and LA Hwy. 421, 7.9 km north of Bains; 15.8 km N.
(Control)
TQSL. Utility pole front of Pentecostal church (opposite West Feliciana Parish Hospital) near Jct. US Hwy. 61 and Ferdinand Street; 4 km NW (Special)
RSP-0008 REV -12 PAGE 38 OF 103
ATTACHMENT 1 PAGE 3 OF 4 TABLE 4.1 - RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM Exposure Pathway *. Sample Point, Description, Sampling and Type and Frequency and/or Sample Distance, and Direction Collection Frequency of Analysis TQS2. St. Francis Substation on business US Hwy.61 in St. Francisville; 5.8 km NW (Special).
TNS. Utility pole with electrical meter at west bank ferry landing (LA Hwy. 10); 6.0 kmn W.
(Special)
TEC. Stub pole at jct. of Hwy. 955 and Midway Road, 4.8 km North of lot. of Hwys 955 and 964; 16 km E. (Control)
TCS. Utility pole at gate to East Louisiana State Hospital in Jackson; 12.3 km NE. (Special)
TGS. Entergy Service Center compound in Zachary; 17 km SE (Special).
TRS. Stub pole at Jct. of US Hwy. 61 and WF2 near Bains. (West Feliciana High School); 9.2 km NNW. (Special)
- 3. Waterbome SURFACE WATER (1)
SWU. Mississippi River about 4 km upstream Quarterly grab.
from the plant liquid discharge outfall, near LA Quarterly: gamma isotopic analysis; quarterly Hwy. 10 ferry crossing. (5km, W) tritium analysis.
SWD. Mississippi River about 4 km downstream from plant liquid discharge outfall, near paper mill. (7.75 kmn, S)
GROUND WATER WU. Upland Terrace Aquifer well upgradient Semiannual grab from plant, about 470 m NNE. Gamma isotopic and tritium analysis .
semiannually.
WD. Upland Terrace Aquifer well downgradient from plant, about 470 m SW.
RSP-0008 i REV -12 PAGE 39 OF 103
ATTACHMENT 1 PAGE 4 OF 4
. C TABLE 4.1 - RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM Exposure Pathway Sample Point, Description, Sampling and Type and Frequency and/or Sample Distance, and Direction Collection Frequency of Analysis SHORELINE SEDIMENT SEDD. Mississippi River downstream from Annual grab Gamma isotopic analysis annually.
plant liquid discharge outfall, near paper mill.
(7.75 kin, S)
- 4. Ingestion(2) FISH AND INVERTEBRATES FU. One sample of a commercially and/or Annually. Gamma isotopic analysis on edible portions recreationally important species from upstream annually.
area not influenced by plant discharge. (4 km,
.WSW)
FD. One sample of a commercially and/or recreationally important species from downstream area influenced by plant discharge.
(7.75 km, S)
FOOD PRODUCTS (iNI. One sample of leafy vegetation from Quarterly during growing season. Gamma isotopic and 1-131 analyses quarterly.
onsite garden near site boundary in sector of highest calculated average ground level D/Q, (0.9km, W)
GQC. One sample of similar vegetation from LA State Penitentiary at Angola, 32 km NW (Control).
NOTES:
- 1. The upstream sample will be taken at a distance beyond signifcant influence of theplant discharge. The downstream sample will be taken in an area beyond but near the mixing zone.
2 If milk-producing animalsbecome available within a 8-km radiusof the plant, sampling will beperformedin accordancewith Table 3.12.1-1, Section 4.a of the TechnicalRequirements Manual.
RSP-0008 REV - 12 PAGE 40 OF 103
ATTACHMENT 2 PAGE I OF I ECL VALUES EFFLUENT CONCENTRATION LIMIT (gCi/ml)
NUCLIDE AIR- WATER NUCLIDE AIR WATER H-3 1-07 1E-03 SB-126 7E-10 7f-06 BE-7 3E-08 6E-04 SB-127 1E-09 IE-05 C-14 3E-09 3E-05 TE- 127M 4E-10 9E-06 NA-24 7E-09 5E-05 TE-127 2E-08 1E-04 P-32 5E-10 9E-06 TE-129M 3E-IO 7E-06 CR-51 3E-08 5E-04 TE-129 9E-08 4E-04 MN-54 lE-09 3E-05 TE-131M 1E-09 8E-06 MN-56 2E-08 7E-05 TE-131 2E-08 SE-05 FE-55 3E-09 1B-04 TE-132 9E-10 9E-16 FE-59 5E-10 15-05 1-130 3E-09 2E-05 C0-56 3B-10 6E-06 1-131 2E-10 IE-06 CO-57 9E-10 6E-05 1-132 2E-08 I E-04 CO-58 IE-09 2E-05 1-133 IE-09 7E-06 CO-60 SE-lI 3E-06 1-134 6E-08 4E-04 Nl-63 I E-09 IE-04 1-135 6E-09 3E-05 NI-65 2B-08 IE-04 CS-134 2E-10 9E-07 CU-64 3E-08 2E-04 CS-135 2E-09 I E-05 ZN-65 4E-10 5E-06 CS-136 9E-10 6E-06 ZN-69 2B-07 8E-04 CS-137 2E-10 IB-06 ZN-69M IE-08 6E-05 CS-138 SE-08 4E-04 SE-75 8E-10 7E-06 BA-133 9E-10 2E-05 BR-82 5E-09 4E-05 BA-139 4E-08 2E-04 BR-83 9B-os 9E-04 BA-140 2E-09 8E-06 BR-84 8E-08 4E-04 BA-141 IE-07 3E-04 R86 1E-09 7E-06 BA-142 2E-07 7E-04 RB-88 9E-08 4E-04 LA-140 2E-09 9E-06 RB-89 2E-07 9E-04 LA-142 3E-08 IE-04 SR-85 2E-09 4E-05 CE-139 9E-10 7E-05 SR-89 2E-10 8E-06 CE-141 8E-10 3E-05 SR-90 62-12 SE-07 CE-143 2E-09 2E-05 SR-91 5E-09 2B.05 CE-144 2E-11 3E-06 SR-92 9E-09 4E-05 PR-143 9E-10 2E-05 Y-88 3E-10 IE-05 PR- 144 2E-07 6B-04 Y-90 9E-10 7E-06 ND-147 I E-09 2E-05 Y-91M 2E-07 2M-03 EU-152 3E-11 1F-05 Y-91 2E-10 8E-06 W-187 IE-08 3E-05 Y-92 I-08 4E-05 NP-239 3E-09 2E-05 Y-93 3E-09 2E-05 AR-41 1E-08 OE+00 ZR-95 4E-10 2E-05 KR-83M 5E-05 0+00 ZR-97 2E-09 9E-06 KR-85M IE-07 OE+00 NB-94 2E-11 1E-05 KR-85 7E-07 0E+00 NB-95 2B-09 3B-05 KR-87 2E-08 OB+00 NB-97 I-07 3E-04 KR-88 9E-09 OE+00.
MO-90 6E-09 3E-05 KR-89 IE-09 OE+00 MO-99 25-09 2E-05 KR-90 I E-09 OE+00 TC-99M 2E-07 IB-03 XE-131M 2E-06 0+00 TC-101 5E-07 2E-03 XE-133M 6E-07 OE+00 RU-103 9E-10 3E-05 XE-133 5E-07 OE+00 RU-105 2E-08 7E-05 XE-135M 4E-08 OE+00 RU-106 25-11 3E-06 XE-135 7E-08 OE+00 AG-I IOM 1210 6E-06 XE-137 IE-09 OE+00.
CD-109 7E-1 I 6E-06 XE-138 28-08 OE+00 CD-1 13M 5E-12 5E-07 G-APLHA IE-15 2E-09 SN-1 13 8E-10 3B-05 G-BETA 1E-12 IE-08 SN-117M 2E-09 3E-05 OMER OE+00 OE+00 SB- 122 2E-09 IE-05 RHI-105 8E-09 5E-05 SB-124 3E-10 7E-06 SC-46 3E-10 1ES05 SB-125 7E-10 3E-05 AS-76 2E-09 1E-05 RSP-0008 REV- 12 PAGE 41 OF 103
ATTACHMENT 3 PAGE 1 OF 2 TABLE B-i: LIQUID ENVIRONMENTAL DOSE TRANSFER FACTORS Ai, Table B-1 DOSE FACTOR TABLE: Ai, - Adult, liquid Units are mremlhr per gCi/ml Nuclide Bone Liver Thody . Thyroid Kidney Lung GI Tract Skin H-3 O.OOE+00 2.81E-01 2.81E-01 2.81E-01 2.81E-01 2.81E-01 2.81B-01 0.OOE+00 C-14 4.618+04 9.22E+03 9.22E+03 9.22E+03 9.22E+03 9.22E+03 9.22E+03 O.OOEt00 NA-24 6.02E+02 6.02E+02 6.02E+02 6.02E+02 6.02E+02 6.02E+02 6.02E+02 O.OOE+00 P-32 4.85E+07 3.01E+06 1.87E+06 O.OOE+00 O.OOE+00 0.008+00 5.45E+06 0.00E+00 CR-51 0.ooE+0o 0.00E+00 4.31E+00 2.58E+00 9.50E-01 5.72E+00 1.08E+03 O.OOE+00 MN-54 0.OOE+0O 2.39E+05 4.56E+04 O.OOE+00 7.12E+04 O.OOE+00 7.33E+05 O.OOE+00 MN-S6 O.OOE+00 6.02E+03 1.07E+03 O.OOE+00 7.64E+03 0.00E+00 1.92E+05 O.OOE+00 FE-55 5.68E803 3.93E+03 9.16E+02 O.OOE+00 0.00E+00 2.19E+03 2.25E+03 0.00E+00 FF-59 8.97E+03 2.11B+04 8.08E+03 O.OOE+00 O.OOE+00 5.89E+03 7.03E+04 O.OOE+00 C0-57 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 C0-58 0.00E+00 1.74E+02 3.91E+02 O.OOE+00 O.OOE+00 O.OOE+00 3.54E+03 0.00E+00 C0-60 0.00+00 5.01B+02 1.1IE+03 O.OOE+00 O.OOB+00 O.OOE+00 9.41E+03 O.OOB+00 NI-63 3.86E+04 2.68E+03 1.29E+03 O.OOE+00 O.OOE+00 0.00E+00 5.58E+02 O.OOE+00 NI-65 1.57E+02 2.04E+O1 9.29E+00 O.OOE+00 O.OOE+00 0.00E+00 5.17E+02 O.OOE+00 CU-64 O.OOE+00 2.90E+01 L.36E+01 O.OOE+00 7.31E+01 0.00+00 2.47E+03 O.OOE+00 ZN-65 5.09E+04 1.62E+05 7.3 1E+04 O.OOE+00 1.08E+05 0.00E+00 1.02E+05 O.OOE+0O ZN-69 1.0SE+02 2.07E+02 1.44E+01 O.OOE+00 1.34E+02 O.OOE+00 3.1 1E+01 O.O+00 ZN-69M O.OOE+00 O.OOE+00 0.00O+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00+00 BR-82 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 0.00E+00 BR-83 0.00E+00 O.OOE+00 4.81E+01 O.OOE+00 O.OOE+00 0.00E+00 6.92E+01 O.OOE+00 BR-84 O.OOE+00 O.OOE+00 6.23E+01 O.OOE+00 O.OOE+00 O.OOE+00 4.89E-04 O.OOE+00 BR-85 O.OOE+00 O.OOE+00 2.56E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 RB-86 O.OOE+00 1.13E+05 5.28E+04 O.OOE+00 O.OOE+00 O.OOE+00 2.23E+04 O.OOE+00 RB-88 O.OOE+00 3.258+02 1.72E+02 0.00E+00 O.OOE+00 O.OOE+00 4.49E-09 0.008+00 RB-89 0.00E+00 2.15E+02 1.51E+02 0.00E+00 O.OOE+00 0.00E+00 1.25E-11 O.OOE+00 SR-89 3.97E+04 O.OOE+00 1.14E+03 0.0OE+00 O.OOE+00 O.OOE+00 6.38E+03 0.0OE+00 SR-90 9.78E+05 0.00E+00 2.40E+05 O.OOE+OO O.OOE+00 O.OOE+00 2.83E+04 O.OOE+00 SR-91 7.32E+02 O.OOE+00 2.96E+01 O.OOE+00 O.OOE+00 O.OOE+O 3.48E+03 0.00E+00 SR-92 2.77E+02 O.OOE+00 1.20E+01 O.OOE+00 O.OOE+00 O.OOE+00 5.50E+03 O.OOE+00 Y-90 6.07E+00 O.OOE+00 1.63E-01 O.OOE+00 0.OOE+00 O.OOE+00 6.44E+04 O.OOE+00 Y-91M 5.74E-02 O.OOE+00 2.22E-03 O.OOE+00 O.OOE+00 O.OOE+00 1.68E-01 O.OOE+00 Y-91 8.90E+01 0.00E+00 2.38E+00 0.00E+00 O.OOE+00 0.OOE+00 4.90E+04 O.OOE+00 Y-92 5.33E-01 O.OOE+00 1.56E-02 O.OOE+00 O.OO+00 O.OOE+000 9.34E+03 O.OOE+00 Y-93 1.69B+00 0.00E+00 4.67E-02 O.OO+00 O.OO8+00 O.OOE+00 5.36E+04 O.OOE+00 ZR-95 3.57E-01 1.14E-01 7.75E-02 O.OOE+00 1.80E-01 O.OOE+00 3.638+02 O.OOE+00 ZR-97 I.97E-02 3.98E-03 1.828-03 0.00E+00 6.01E-03 0.00E+00 1.23E+03 0.008+00 NB-95 4.48E+02 2.49E+02 1.34E+02 O.OOE+00 2.46E+02 O.OOE+00 1,51E+06 O.OOE+00 NB-97 O.OO+00 O.OOE+00 0.008+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 MO-99 O.OOE+00 1.28E+02 2.44E+01 O.OOE+00 2.90E+02 0.00E+00 2.97E+02 O.OOE+00 TC-99M 9.59E-03 2.71E-02 3.45E-01 O.OOE+00 4.12E-01 1.33E-02 1.60E+01 0.00E+00 TC-I01 9.86E-03 1.42E-02 1.39E-01 O.OOE+00 2.56E-01 7.26E-03 4.27E-14 O.OOE+00 RU-103 3.61E+01 O.OO+00 1.56E+01 O.OOE+00 1.38E+02 O.OOE+00 4.22E+03 O.OOE+00 RU-105 3.01E+00 O.OOE+00 1.19E+00 O.OOE+00 3.89E+01 O.0E+00 1.84E+03 O.OOE+00 RU-106' 5.37E+02 0.OOE+00 6.80E+01 O.OOE+00 1.04E+03 O.OOE+00 .3.48E+04 O.OOE+00 AG-Il OM 5.38E-04 4.98E-04 2.95E-04 O.OOE+00 9.78E-04 O.OOE+00 2.03E-01 O.OOE+00 SB-124 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+09 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 SB-125 O.OO+00 O.OOE+O0 0.008+00 0.008+00 O.OO+00 O.OOE+00 O.OOE+00 O.OOE+00 TE-125M 1.19E+04 4.31E+03 1.59E+03 3.58E+03 4.84E+04 O.OOE+00 4.75E+04 O.OOE+00 TB-127M 3.01E+04 1.08E+04 3.66t+03 7.69E+03 1.22E+05 O.OOE+00 1.01E+05 O.OOE+00 TE-127 4.89E+02 1.75E+02 1.068+02 3.628+02 1.998+03 0.00E+00 3.86E+04' O.OO+00 RSP-0008 REV -12 PAGE 42 OF 103
ATTACHMENT 3 PAGE 2 OF 2 TABLE B-i: LIQUID ENVIRONMENTAL DOSE TRANSFER FACTORS Nucide Bone Liver Tbody Thyroid Kidney Lung GI. Tract Skin TE-t29M 5.11E+04 1.91E+04 8.09E+03 1.75E+04 2.13E+05 O.OOE+00 2.57E+05 O.OOE+00 TE-129 1.39E+02 5.24E+01 3.40E+01 1.07E+02 5.86E+02 0.008+00 1.05E+02 O.OOE+00 TE131M 7.69E+03 3.76E+03 3.13E+03 5.95E+03 3.81E+04 O.OOE+00 3.73E+05 O.OOE+00 TE-131 8.75E+01 3.66E+01 2.76E+01 7.20E+01 3.83E+02 O.OOE+00 1.24E+01 O.OOE+00 TE-132 1.12E+04 7.24E+03 6.80E+03 8.00E+03 6.97E+04 O.OOE+00 3.43E+05 O.OOE+00 1-130 2.94E+01 8.66E+01 3.42E+01 7.34E+03 1.35E+02 0.00E+00 7.46E+01 0.00E+00 1-131 1.62E+02 2.31E+02 1.32E+02 7.57E+04 3.96E+02 O.OOE+00 6.10E+OI 0.00E+OO 1-132 7.88E+00 2.1 IE+0I 7.38E+00 7.38E+02 3.36E+01 O.OOE+00 3.96E+00 O.OOE+00 1-133 5.51E+01 9.59E+01 2.92E+01 1.41E+04 1.67E+02 O.OOE+00 8.62E+01 0.00E+00 1-134 4.12E+00 1.12E+01 4.00E+00 1.94E+02 1.78E+01 O.OOE+00 9.75E-03 0.00E+00 1-135 1.72E+01 4.50E+01 1.66E+01 2.97E+03 7.22E+01 O.OOE+00 5.09E+01 O.OOE+00 CS-134 3.348+05 7.94E+05 6.49E+05 O.OOE+00 2.57E+05 8.53E+04 1.39E+04 O.OOE+00 CS-136 3.49E+04 1.38E+05 9.93E+04 O.OOE+00 7.68E+04 1.05E+04 1.57E+04 0.008+00 CS-137 4.28E+05 5.85E+05 3.83E+05 O.OOE+00 1.99E+05 6.60E+04 1.13E+04 0008E+OO CS-138 2.96E+02 5.85E+02 2.90E+02 0.00E+OO 4.30E+02 4.258+01 2.50E-03 O.OOE+00 BA-139 1.20E+01 8.55E-03 3.52E-01 0.00E+OO 8.008-03 4.85E-03 2.13E+01 0.00E+00 BA-140 2.51E+03 3.16E+00 1.65E+02 O.OOE+00 1.07E+00 1.81E+00 5.17E+03 O.OOE+00 BA-141 5.83E+00 441E-03 1.97E-01 O.OO+00 4.10E-03 2.50E-03 2.758-09 O.OOE+00 BA-142 2.64E+00 2.71E-03 1.66E-01 O.OOE+OO 2.29E-03 1.54E-03 3.71E-18 O.OOE+00 LA-140 1.58E+00 7.958-01 2.108-01 O.OOE+OO O.OOE+00 O.OOE+00 5.848+04 0.00E+OO LA-142 8.08E-02 3.67E-02 9.15E-03 O.OO+00 0.008E+00 0.00E+00 2.68E+02 0.00E+00 CE-141 5.37E+00 3.63E+00 4.12E-01 O.OOE+00 1.69E+00 O.OOE+00 1.39E+04 0.00E+0 C0-143 9.46E-01 7.00E+02 7.74E-02 0.00E+OO 3.08E-01 0.00E+00 2.61E+04 O.OOE+00 CE-144 2.80E+02 1.17E+02 1.50E+01 O.OOE+00 6.94E+01 O.OOE+00 9.46E+04 0.0OE+00 PR-143 5.80E+00 2.33E+00 2.88E-01 0.008+00 1.34E+00 0.00E+00 2.54+04 0.008+00 PR-144 1.90E-02 7.89E-03 9.65E-04 O.OOE+00 4.45E-03 O.OOE+00 2.73E-09 O.OOE+00 ND-147 3.97E+00 4.598+00 2.74E-01 O.OOE+00 2.68E+00 0.00E+00 2.20E+04 0.008+00 W-187 2.97E+02 2.48E+02 8.68E+01 O.OOE+00 O.OOE+00 O.OOE+00 8.13E+04 0.00E+00 NP-239 3.00E-01 2.958-02 1.63E-02 O.OO+00 9.218-02 O.OOE+00 6.06E+03 O.8OE+00 RSP-0008 REV -_ 2_ PAGE 43 OF 103 PAGE43OF1O3 RSP-0008 REV-12
ATTACHMENT 4 PAGE I OF I TABLE C-i: NOBLE GAS DOSE TRANSFER FACTORS TABLE C-1 FACTOR FOR EXPOSURE TO A SEMI-IFNTE CLOUD DOSE TO PEOPLE + DOSE OF AIR #
Nuclide Gamma-Body Beta-Skdn Gamma Beta K(i) L(i) M i) N )
AR-41 8.840E+03 2.690E+03 9.300E+03 3.280E+03 KR-83M 7.560E-02 O.OOOE+00 1.930E+01 2.880E+02 KR-S5 1.610E+O1 1.340E+03 1.720E+01 1.950E+03 KR-85M I. 170E+03 1.460E+03 1.230E+03 1.970E+03 KR-87 5.920E+03 9.730E+03 6.170E+03 1.030E+04 KR-88 1.470E+04 2.370E+03 1.520E+04 2.930E+03 KR-89 1.660E+04 1.0lOE+04 1.730E+04 1.060E+04 KR-90 1.560E+04 7.290E+03 I.630E+04 7.830E+03 XE-13iM 9.1 50E+O1 4.760E+02 1.560E+02 I. I 1OE+03 XE-133 2.940E+02 3.060E+02 3.530E+02 1.050E+03 XE-133M 2.5 1OE+02 9.940E+02 3.270E+02 1.480E+03 XE-135 1.8tOE+03 1.860E+03 1.920E+03 2.460E+03 XE-135M 3.120E+03 7.1 10E+02 3.360E+03 7.390E+02 XE-137 1.420E+03 1.220E+04 1.5 IOE+03 1.270E+04 XE-138 8.830E+03 4.130E+03 9.210E+03 4.750E+03
+ -- mnremyr per ,uCi/cu.m.
- nirad/yr per p.Cilcu.m.
IRSPAG04}
RSP-41008 REVY - 12 REV-12 PAGE 44 OF 103-PAGE44OFI(13
ATTACHMENT 5 PAGE l OF I (RESERVED)
RSP-0008 REV - 12 PAGE 45 OF 103 PAGE4SOF1O3 RSP-0008 REV¶12
ATTACHMENT 6 PAGE 1 OF 4 X/Q AND D/Q VALUES FOR RESTRICTED AREA BOUNDARY Long Term Diffusion Estimates E. 1 Obiective Annual average CHIIQ and D/Q estimates for continuous and intermittent releases were calculated for each of the sixteen 22.5-degree sectors at receptor locations used to determine the maximum individual and population dose receptors.
The methodology described in Regulatory Guide 1.111, Rev. 1 provided guidance for the aforementioned analysis. The resultant CHIIQ and D/Q values for the maximum individual dose receptors are displayed in Attachment 9.
E.2 Calculation Techniques Nomenclature 2.032= (2 1r)"2(2 7r/ 16)-' (DIMENSIONLESS) 7= 3.14159... (DIMENSIONLESS)
EXP= 2.71828 (DIMENSIONLESS)
ET = ENTRAINMENT COEFFICIENT (DIMENSIONLESS) nT= TERRAIN RECIRCULATION FACTOR (DIMENSIONLESS)
X= DOWNWIND RECEPTOR DISTANCE CFz = VERTICAL DISPERSION (PLUME SPREAD) COEFFICIENT (M)
Lim = 30-FT AVERAGE WIND SPEED CORRESPONDING TO A (M SEC')
GIVEN HOUR OF ONSITE METEOROLOGICAL DATA U=50 150-FT AVERAGE WIND SPEED CORRESPONDING T A GIVEN HOUR OF ON-SITE METEOROLOGICAL DATA (CHI/Q) = AVERAGE CONCENTRATION NORMAL-IZED BY SOURCE (SEC M-3 )
STRENGTH (CHI/QD) DEPLETED CHI/Q (SEC M-')
FM = MOMENTUM FLUX (M4 SEC 3 )
H3 = MAXIMUM ADJACENT BUILDING HEIGHT (M)
HR = RELEASE HEIGHT M)
HE = EFFECTIVE RELEASE HEIGHT HPR= NONBUOYANT PLUME RISE (M)
HT = TOPOGRAPHIC HEIGHT OF RECEPTOR ABOVE PLANT GRADE D- STACK OR VENT DIAMETER UE= EFFLUX VELOCITY (M 5EC1')
N TOTAL NUMBER OF VALID HOURS OF ONSITE WIND DATA (DIMENSIONLESS)
IN ALL SECTORS FOR APPLICABLE AVERAGING PERIOD 8/Q = RELATIVE DEPOSITION RATE NORMALIZED BY SOURCE STRENGTH D/Q = RELATIVE DEPOSITION PER UNIT AREA NORMALIZED BY (M-2)
SOURCE STRENGTH 0 -GROUND RELEASE (SUBSCRIPT) (DIMENSIONLESS)
RSP-0008 REV- 12 PAGE 46 OF 103
ATTACHMENT 6 PAGE 2 OF 4 X/Q AND DIQ VALUES FOR RESTRICTED AREA BOUNDARY I= INDEX FOR ATMOSPHERIC STABILITY GROUP (CLASSES A (DIMENSIONLESS)
THROUGH G)
J= INDEX FOR NUMBER OF HOURS (DIMENSIONLESS)
K= INDEX FOR A PARTICULAR RECEPTOR DISTANCE (DIMENSIONLESS)
£= INDEX FOR A PARTICULAR 22.5-DEGREE SECTOR (DIMENSIONLESS)
N= NUMBER OF HOURS ONSITE WIND DATA IN A (DIMENSIONLESS)
PARTICULAR 22.5-DEGREE SECTOR S= STABILITY PARAMETER (SECri E.3 CHIIO Modeling Technique Annual average values of relative concentration were calculated for continuous gaseous releases of activity from the containment building vent and the radwaste building vent according to the straight-line airflow (Gaussian) model described in Regulatory Guide 1.1 11, Rev. 1. An adjustment was made to the model to characterize the regional airflow pattern. The equation of this model is as follows:
(C+
Q-
=
2.032 i NJ-1 x)
F
- 3o(a' - chb/-)2 I
(1-EE )explIr U150az
] E.3-1 Since the River Bend Station site is located in relatively open terrain, the terrain recirculation factor (2k) (presented in Figure 2 of Regulatory Guide 1.1 11) was applied.
The entrainment coefficient (ET) is a function of the ratio of efflux velocity (ue) to elevated wind speed (ui so) for the conditionally elevated release points.
For vent releases occurring below the level of a nearby structure, 100 percent downwash (total entrainment) is conservatively assumed (ET = 1). For vent releases occurring between I and 2 times the height of a nearby structure, a conditionally elevated release is assumed, and the entrainment coefficient is defined as follows:
ET = 0.0 when ue/ui50 Ž 5.0 (totally elevated)
ET = 0.30-0.06 when 1.5 < uJulo $ 5.0 (partially entrained)
ET = 2.58-1.58 when 1.0
- u/u 150 < 1.5 (partially entrained)
ET = 1.0 when u,/u 50 $ 1.0 (totally entrained)
Within 5 km in each downwind sector, Equation E.3-1 was evaluated by sector at the property and
- restricted area boundaries and nearest regident, vegetable garden, milk cow, and meat animal. There were no goats whose milk is consumed in the area of interest. This evaluation was performed for each continuously emitting release point and the intermittent release from the mechanical vacuum pump with onsite data collected during the period of March 17, 1977 through March 16, 1979.
RSP-0008 REV -12 PAGE 47 OF 103
ATTACHMENT 6 PAGE 3 OF 4 X/Q AND D/Q VALUES FOR RESTRICTED AREA BOUNDARY The effective release height was computed from the following equation:
h, = (hr - ht)k + hpr E.3-2 Where the downwash correction factor (as defined by Equation (5) in Regulatory Guide 1.111, Rev.
- 1) is included in the equation for hpr (see Equation E.34).
Values of topographic heights were conservatively assessed as the maximum height within a particular annulus-sector (annsect). An annsect is an area bounded by a 22.5-degree sector and any two radial distances from the release point.
For A-D stability conditions, plume rise for nonbuoyant sources was calculated by the following algorithm:
when:
ue l u150 > 1.5 hpr = 1.44(ue /u,50) 23 (x/d)" 3 d E.3-3 when:
u 0 I u 150 < 15 hpr= l.44(u, /u50) 2/ 3 (x/d)"3 (d-3) [l.5-(u0 /u 150)d] E.3-4
- and, h, <3(u 0 /U150 ) E.3-5 The result from Equation E.3-3 or E.3-4 (whichever condition exists) is then compared to Equation E.3-5 and the smaller value of hp, is used.
For E-G stability conditions, Equations E.3-3, E.3-4, and E.3-5 are compared with:
hpr =4F and hpr =1l.5(Fm / U:5 o)Y"s-Iz6 where:
(uJ 2 d2 4
and the smallest value was chosen.
RSP-0008 REV- 12 PAGE 48 OF 103
ATTACHMENT 6 PAGE 4 OF 4 X/Q AND D/Q VALUES FOR RESTRICTED AREA BOUNDARY In the ground level portion of Equation E.3-1, the vertical dispersion term:
2 (ar +O.5hb / z)" 2 was constrained to be less than or equal to 1.732 _zik E.4 (CHI/O) and D/O Modeling Techniques Annual average depleted relative concentration values were conservatively assumed to be equal to annual average relative concentration values (CHJ/Q = (CHIIQ)D). Therefore, no credit was taken for attendant plume depletion of radioiodines and particulates.
Annual average relative deposition values were calculated using Regulatory Guide 1.111, Rev. 1 with the following equation:
(2Dk =XC*t( 1)Ty'{ [{(aJET + -L[I- (ET)i nJ.JJ]} E.4-1 For the conditionally elevated release points, Figures 6 through 9 of Regulatory Guide 1.111, Rev. 1 were used to calculate the ( 6 /QJG and (&/Q)i values, while for the ground level release points, Figure 6 (Attachment 39) was utilized to calculate the (S/Q)G value.
E.5 Methodologv Employed for Intermittent Release The methodology employed in the calculation of intermittent release CHJIQs and D/Qs was as follows:
- 1. Two-hour sector-averaged CHI/Q values were calculated without terrain recirculation factors.
- 2. The 15 percent, I hour value was plotted at 2 hours2.314815e-5 days <br />5.555556e-4 hours <br />3.306878e-6 weeks <br />7.61e-7 months <br /> on log-log coordinates, while the annual average value was plotted at 8,760 hr. A straight line connecting the two points was drawn.
- 3. Log-log interpolation based on total ground intermittent release hours versus annual hours yielded a CHJ/Q multiplier.
- 4. The multiplier was applied to annual average CHIIQ and D/Q values to obtain intermittent CHIYQ and D/Q values.
For River Bend Station, a 320 hr/yr intermittent release through the containment building vent from the mechanical vacuum pump was evaluated RSP-0008 REV -12 PAGE 49 OF 103
ATTACHMENT 7 PAGE I OF I TABLE E-1: ANNUAL AVERAGE CHIIQ VALUES FOR RESTRICTED AREA BOUNDARY TABLE E-1 ANNUAL AVERAGE CIT/Q VALUES x 107 (sec/m 3)
FOR RESTRICTED AREA BOUNDARY Sector Mixed Mode Releases Ground Level Releases (coniuous) Exhaust (Continuous)
S 11.4 105 SSW 19.7 186 SW 16.4 215 WSW 19.5 326 W 23.6 654 WNW 33.1 421 NW 15.7 262 NNW 14.8 138 N 18.8 180 NNE 24.9 211 NE 16.6 150 ENE -12.2 146 E 9.07 168 ESE 10.4 154 SE 8.19 93.1 SSE 7.69 45.6 RSP-0008 RSP-0008 REV - 12 REV-12 -PAGE 50 OF 103 PAGE5OOF1o3
ATTACHMENT 8 PAGE 1 OF 1 TABLE E£4: ANNUAL AVERAGE D/Q VALUES FOR RESTRICTED AREA BOUNDARY TABLE E-2 ANNUAL AVERAGE D/Q VALUES x 1lo (MI)
FOR RESTRICTED AREA BOUNDARY Sector Mixed Mode Releases Ground Level Releases (Continuous) (Continuous)
S 7.61 21.4 SSW 11.3 39.6 SW 10.4 36.1 WSW 9.79 38.5 W 13.8 68.8 WNW 18.0 50.3 NW 8.68 40.8
- NNW 10.5 24.7 N 11.8 28.6 NNE 11.2 27.1 NE 8.26 22.3 ENE 9.73 22.7 E 7.75 23.0 ESE 7.76 24.6 SE 6.60 17.2 SSE 5.34 11.8 RSP-OOO8 RSP-0008 REV-12 REV - 12 PAGE51OFlO3 PACE 51 OF 163
ATTACHMENT 9 PAGE 1 OF I TABLE F-i: ATMOSPHERIC DISPERSION AND DEPOSITION RATES FOR THE MAXIMUM INDIVIDUAL DOSE CALCULATIONS TABLE F-1 ATMOSPHERIC DISPERSION AND DEPOSITION RATES FOR TEE MAXIMUM INDIVIDUAL DOSE CALCULATIONS Analysis Location Ground level Mixed Mode (meters) Releases Releases Gamma air dose (3) and Beta 994 m WNW (Containment) CHIIQ - 421.0 CBII/Q - 33.1 Air Dose Maximum Receptor (4) 994 m WNW CHIQ - 421.0 CHIIQ - 33.1 Resident D/Q - 50.3 D/Q - 18.1 Garden Meat animal Immersion Milk animal (5) 7,000 m WNW CHB/Q - 3.58 CHI/Q - .870 DIQ - 0.38 DIQ - .223 Other on-site Receptors (6) 115 m ENE CHI/Q - 5977.0 CHI/Q - 407.5 DIQ - 529.7 D/Q - 46.9 275 mN CHI/Q - 1644.0 CHI/Q - 169.1 DIQ - 345.6 D/Q - 68.4 500 WNW CHI/Q - 916.7 CHI/Q - 105.4 DIQ - 148.1 DIQ - 45.6 2500 SW CHJ/Q- 34.45 CHYQ - 4.65 DIQ - 3.35 D/Q - 1.40
- Reference 2.1.8 and 2.1.6 Notes:
(1) All CHI/Q = 0-7 sec/rM3 (2) All D/Q = I0-9"m 2 (3) Maximum offsite location (property boundary) with highest CHI/Q (unoccupied).
(4) Maximum hypothetical occupied offsite location with highest CHI/Q and D/Q.
(5) No milk animal within 5 miles radius, hypothetical location in worst sector.
(6) Other on-site receptors.
RSP-0008 REV-12 PAGE 52 OF 103
ATTACEIMENT 10
. PAGE IlOF I TABLE G-1: DOSE FACTOR CALCULATION PARAMETERS CODE DESCITON . VALE UIS Csf Harvest stored feed to cow 7.776]E+06 seconds (cfs) dN v Drinking Water Dilution Factor 2.4801E+04 none (dw) es f Stored feed exp. to deposition 5.184] 2+06 seconds (esf) fg Fraction Stored Veg. Intake 7.600]2-01 none (fg) fi Fraction Vegetation Irrigated 1.000] 2-01 none (fi) fl Fraction Leafy Veg. Intake 1.O001 2+00 none (fi) c Fraction Year Cow On Pasture 1.0001E+00 none g Fraction Year Goat On Pasture 1.0001 1+00 none (fpg) fshc Fraction Cow Feed-Pasture Grass 1.0001E+00 none (fsc) fsj Fraction Goat Feed-Pasture Grass 1.0001E+00 none (fsg) gs f Harvest stored feed to goat 7.7761 2+06 seconds (gst) h Absolute Humidity 1.2901 ,+01 gnl/m3 kc Water to sediment xfer coeff. 7.2201 2E-02 L/kg hr (c) f Liq conv fact pCi*rm*yr/4Ci*1 *hr 1.1421E+05 (ksl) thv 1w Water content of Leafy Veg 9.2001 2E-01 LJkg (Iv)
- Surface Weather Decay Constant 5.73012-07 I/seconds (lwv)
(Lw) 1wr Iodine Surface Wx Decay Constant 5.7301i-07 I/seconds (lwr) tl v Mass density of sediment 4.0001 E+01 kg/m2 (mtv)
Effective surface density, soil 2.4001 2+02 kg/m2 (p )
P1 4 Fractional equilibrium ratio 1.00012+00 none (P14)-
c Cows Feed Consumption Rate 5.0001 2+01 kg/day (qfc) gf, Goafs Feed Consumption Rate 6.0001 2+00 kglday (qfg) ri Fraction Deposited Liquid 2.5001 2-01 none (rI )
yp Fraction Deposited Particulate 2.0001 E-01 none (rp) rr Fraction Deposited Radioiodine 1.0001E+00 none (rr) sf Shielding Factor 1.0001E+00 none ** (sf)
Long term sediment exposure 0.00012+00 seconds (tb) tbl tm Long term sediment exp. liquid 4.7161 E+08 seconds (thl) tei Veg. Exposure in Growing Season 5.1841 2+06 seconds (tei)
Ps term Seasonal forage exposure (milk) 2.5921E+06 seconds (tern) tei%v Seasonal crop exposure (veg) 8.0001 E+06 seconds (tev) tfb* Fresh Fish Transit Time 0.0001E+00 seconds (tfh3 tgr m Time, goat milking to receptor 1.728E'+05 seconds (tgm) thi Transit Time-Harvest Irrig. Veg 8.640EE+04 seconds (thi) v Transit Time-Harvest-Stored Veg 5.184E1+06 seconds {thv) tin Fresh Non-Fish Transit Time 0.000E +-00 seconds ti (ti)
Transit Time-Harvest-Leafy Veg 8.6401 E+04 seconds (tl) tmi o Time, cow miling to receptor 1.728EE+05 seconds (tmc) ts Time, slaughter to consumer 1.728EE+06 seconds (ts) tw Drinking Water Transit Time O.OOOEE+00 seconds (tw)
Irrigated Veg. Areal Density 2.000E:+OO kg/m2 (yiv) yp Pasture Grass Areal Density 7.000E :-oI kg/m2 (yP)
.ys Stored Feed Areal Density 2.000EE+00 kg/m2 (ys)
Stored Vegetable Areal Density 2.000E +00 kg/m2 (ysv) yv Vegetation Areal Density 2.000E +00 kg/m2 6w) mtb-needs to be 4.716E+08 when calculating Ground Plane Dose Factors
- NRC Regulatory Guide l.109 deflt 0.7 RSP-0008 REV -12 PAGE 53 OF 103
ATTACHMENT 11 PAGE 1 OF 2 TABLE G-2: STABLE ELEMENT TRANSFER FACTORS Nuclide Milk Cow Milk Goat Meat Veg./Soil H-3 1.OOOE-02 1.700E-01 1.200E-02 4.800E+OO C-14 1.200E-02 1.OOOE-Ol 3.100E-02 5.500E+OO NA-24 4.OOOE-02 4.OOE-02 3.OOOE-02 5.200E-02 P-32 2.500E-02 2.500E-O1 4.600E-02 1.lOOE+OO CR-51 2.200E-03 2.200E-03 2.400E-03 2.500E-04 MN-54 2.500E-04 2.500E-04 8.OOOE-04 2.900E-02 MN-56 2.500E-04 2.500E-04 8.OOOE-04 2.900E-02 FE-55 1.200E-03 1.300E-04 4.O0OE-02 6.600E-04 FE-59 1.200E-03 1.300E-04 4.OOOE-02 6.600E-04 CO-57 1.OOOE-03 1.OOOE-03 1.300E-02 9.400E-03 CO-58 I.OOOE-03 1.OOOE-03 1.300E-02 9.400E-03 CO-60 1.OOOE-03 1.OOOE-03 1.300E-02 9.400E-03 NI-63 6.700E-03 6.700E-03 5.300E-02 1.900E-02 NI-65 6.700E-03 6.700E-03 5.300E-02 1.900E-02 CU-64 1.400E-02 1.300E-02 8.000E-03 1.200E-O I ZN-65 3.900E-02 3.900E-02 3.000E-02 4.OOOE-Ol ZN-69 3.900E-02 3.900E-02 3.000E-02 4.OOOE-O 1 ZN-69M 3.900E-02 3.900E-02 3 .000E-02 4.000E-01 BR-82 5.OOOE-02 5.000E-02 2.600E-02 7.600E-Ol BR-83 5.000-02 5.000E-02 2.600E-02 7.600E-Ol BR-84 5.OOOE-02 5.OOOE-02 2.600E-02 7.600E-01 BR-85 5.OOOE-02 5.OOOE-02 2.600E-02 7.600E-O I RB-86 3,OOOE-02 3.OOOE-02 3.100E-02 1.300E-O1 RB-88 3.OOOE-02 3.OOOE-02 3.IOOE-02 1.300E-O1 RB-89 3.OOOE-02 3.000E-02 3.lOOE-02 1.300E-O1 SR-89 8.OOOE-04 1.400E-02 6.OOOE-04 1.700E-02 SR-90 8.OOOE-04 1.400E-02 6.OOOE-04 1.700E-02 SR-91 8.000E-04 1.400E-02 6.OOOE-04 1.700E-02 SR-92 8.OOOE-04 1.400E-02 6.OOOE-04 1.700E-02 Y-90 .OOOE-05 1.OOOE-05 4.600E-03 2.600E-03 Y-9lM 1.OOOE-05 I.OOOE-05 4.600E-03 2.600E-03 Y-91 l.OOOE-05 1.OOOE-05 4.600E-03 2.600E-03 Y-92 1.OOOE-05 1.OOOE-05 4.600E-03 2.600E-03 Y-93 1.OOOE-05 l.OOOE-05 4.600E-03 2.600E-03 ZR-95 5.OOOE-06 5.OOOE-06 3.400E-02 1.700E-04 ZR-97 5.000E-06 5.OOOE-06 3.400E-02 1.700E-04 NB-95 2.500E-03 2.500E-03 2.800E-OI 9.400E-03 NB-97 2.500E-03 2.500E-03 2.800E-O1 9.400E-03 MO-99 7.500E-03 7.500E-03 8.OOOE-03 1.200E-O1 TC-99M 2.500E-02 2.500E-02 4.000E-01 2.500E-O1 TC-101 2.500E-02 2.500E-02 4.OOOE-O1 2.500E-O1 RU-103 1.OOOE-06 1.OOOE-06 4.OOOE-O1 5.000E-02 RU-105 1.OOOE-06 I.OOOE-06 4.000E-O1 5.OOOE-02 RU-106 1.OOOE-06 I.OOOE-06 4.OOOE-O1 5.000E-02 AG-llOM 5.OOOE-02 5.OOOE-02 1.700E-02 1.500E-O1 RSP-0008 REV - 12 PAGE 54 OF 103 RSP-0008 REV-12 PAGE54OF1O3
ATTACHMENT 11 PAGE 2 OF 2 TABLE G-2: STABLE ELEMENT TRANSFER FACTORS Nuclide Milk Cow Milk Goat Meat Veg.ISoil SB-124 1.500E-03 1.500E-03 O.OOOE+00 0.OOOE+00 SB-125 1.500E-03 1.500E-03 O.OOOE+OO O.OOOE+00 TE-125M l.OOOE-03 l.OOOE-03 7.700E-02 1.300E+00 TE-127M 1.OOOE-03 1.OOOE-03 7.700E-02 1.300E+00 TE-127 1.OOOE-03 1.OOOE-03 7.700E-02 1.300E+00 TE-129M 1.OOOE-03 l.OOOE-03 7.700E-02 1.300E+00 TE-129 1.00E-03 I.OOOE-03 7.700E-02 1.300E+-00 TE-131M 1.OOOE-03 1.OOOE-03 7.700E-02 1.300E+00 TE-131 I.OOOE-03 I.OOOE-03 7.700E-02 1.300E+00 TE-132 I.OOOE-03 1.OOOE-03 7.700E-02 1.300E+O0 I-130 6.OOOE-03 6.0OOE-02 2.900E-03 2.OOOE-02 I-131 6.OOOE-03 6.OOOE-02 2.900E-03 2.000E-02 1-132 6.00OE-03 6.000E-02 2.900E-03 2.OO0E-02 1-133 6.000E-03 6.OOOE-02 2.900E-03 2.OOOE-02 1-134 6.OOOE-03 6.OOOE-02 2.900E-03 2.OOOE-02 I-135 6.OOOE-03 6.OOOE-02 2.900E-03 2.00OE-02 CS-134 1E200E-02 3.000E-01 4,000E-03 1.OOOE-02 CS-136 1.200E-02 3.OOOE-01 4.OOOE-03 I .OOE-02 CS-137 1,200E-02 3.OOOE-01 4.OOOE-03 1 .OOOE-02 CS-138 1.200E-02 3.OOOE-O1 4.OOOE-03 1.OOOE-02 BA-139 4.000E-04 4.OOOE-04 3 .200E-03 5.OOOE-03 BA-140 4.OOOE-04 4.000E-04 3.200E-03 5.000E-03 BA-141 4.OOOE-04 4.O0OE-04 3 .200E-03 5.OOOE-03 LA-140 5.000E-06 5.OOOE-06 2.O0OE-04 2.500E-03 LA-142 5.000E-06 5.OOOE-06 2.OOOE-04 2.500E-03 CE-141 I.OOOE-04 1.OOOE-04 1.200E-03 2.500E-03 CE-143 l.000E-04 1.OOOE-04 1.200E-03 2.500E-03 CE-144 l.OOOE-04 1.OOOE-04 1.200E-03 2.500E-03 PR-143 5.OOOE-06 5.OOOE-06 4.700E-03 2.500E-03 PR-144 5.000E-06 5.OOOE-06 4.700E-03 2.500E-03 ND-147 5.OOOE-06 5.OOOE-06 3.300E-03 2.400E-03 W-187 5.000E-04 5.OOOE-04 1.300E-03 1.800E-02 NP-239 5.000E-06 5.OOOE-06 2.OOOE-04 2.500E-03 Units: Milk - days/liter Meat - days/kg Soil - unitless RSP-0008 REV- 12 PAGE 55 OF 103
ATTACHMENT 12 PAGE 1 OF 2 TABLE G-3: BIOACCUMIJLATION FACTORS TABLE G-3 BIOACCUMILATION FACTORS Freshwater Freshwater Saltwater Saltwater Nuclide Fish Non-Fish Fish Non-Fish H-3 9.OOOE-O1 9.OOOE-O I 9.000E-O I 9.300E-OI C-14 4.600E+03 9. 100E+03 1.800E+03 1.400E+03 NA-24 1.OOOE+02 2.OOOE+02 6.700E-02 1.900E-01 P-32 I.OOOE+05 2.OOOE+04 2.900E+04 3.OOOE+04 CR-51 2.OOOE+02 2.OOOE+03 4.OOOE+02 2.OOOE+03 MN-54 4.OOOE+02 9.OOOE+04 5.500E+02 4.OOOE+02 MN-56 4.OOOE+02 9.OOOE+04 5.500E+02 4.OOOE+02 FE-55 I.OOOE+03 3.200E+03 3.OOOE+03 2.OOOE+04 FE-59 1.000E+02 3.200E+03 3.OOOE+03 2.OOOE+04 CO-57 5.OOOE+O1 2.OOOE+02 1.OOOE+02 1l.OOOF+03 CO-58 5.OOOE+01 2.OOOE+02 1.OOOE+02 1.OOOE+03 CO-60 5.000E+O1 2.OOOE+02 1.OOOE+02 1.OOOE+03 Nl-63 1.OOOE+02 1.OOOE+02 1.OOOE+02 2.500E+02 NI-65 1.OOOE+02 1.OOOE+02 1.OOOE+02 2.500E+02 CU-64 5.OOOE+01 4.OOOE+02 6.700E+02 1.700E+03 ZN-65 2.OOOE+03 1.OOOE+04 2.OOOE+03 5.OOOE+04 ZN-69 2.000E+03 1.OOOE+04 2.000E+03 5.OOOE+04 ZN-69M 2.OOOE+03 1.OOOE+04 2.00OE+-03 5.OOOE+04 BR-82 4.200E+02 3.300E+02 1.500E-02 3.100E+0O BR-83 4.200E+02 3.300E+02 1.500E-02 3.100E+O0 BR-84 4.200E+02 3.300E+02 1.500E-02 3.100E+O0 BR-85 4.200E+02 3.300E+02 1.500E-02 3.100lE+00 RB-86 2.OOOE+03 1.OOOE+03 8.300E+4O 1.700E+0 1 RIB-88 2.OOOE+03 1.OOOE+03 8.300E+O0 1.700E+01 RB-89 2.OOOE+03 1.OOOE+03 8.300E+00 1.700E+01 SR-89 3.OOOE+01 1.OOOE+02 2.000E+O0 2.000E+01 SR-90 3.OOOE+01 1.OOOE+02 2.000E+O0 2.OOOE+O1 SR-91 3.OOOE+O1 1.OOOE+02 2.000E+OO 2.OOOE+01 SR-92 3.000E+01 1.OOOE+02 2.000E+OO 2.OOOE+O1 Y-90 2.500E+O1 1.OOOE+03 2.500E+Ol 1.OOOE+03 Y-91M 2.500E+O 1 1.OOOE+03 2.500E+OlI 1.OOOE+03 Y-91 2.500E+01 1.OOOE+03 2.500E+OI 1.OOOE+03 Y-92 2.500E+O 1 1.OOOE+03 2.500E+OI 1.OOOE+03 Y-93 2.500E+O1 1.OOOE+03 2.5001E+0l 1.OOOE+03 ZR-95 3.300E+OO 6.700E+O0 2.000E+02 8.000E+01 ZR-97 3.300E+O0 6.700E+OO 2.000E+02 8.OOOE+01 NB-95 3.000E+04 1.OOOE+02 3.000E+04 1.000+02 NB-97 3.OOOE+04 1.OOOE+02 3.000E+04 1.OOOE+02 MO-99 1.OOOE+01 1.OOOE+01 1.OOOE+O1 1.OOOE+O I TC-99M 1.500E+O1 5.OOOE+00 1.OOOE+01 5.000E+O 1 TC-101 1.500E+O1 5.000E+OO 1.OOOE+01 5.000E+01 RU-103 1.OOOE+O I 3.000E+02 3.OOOE+0O 1.000E+03 RU-105 1.OOOE+O1 3.000E+02 3.OOOE+0O 1.OOOE+03 RU-106 1.OOOE+I01 3.OOOE+02 3.000E+O0 1.0003E+03 AG-I lOM O.OOOE+O0 O.OOOE+OO O.OOOE+OO 0.OOOE+00 RSP-0008 REV - 12 PAGE 56 OF 103
ATTACHMENT 12 PAGE 2 OF 2 TABLE G-3: BIOACCUMULATION FACTORS Freshwater Freshwater Saltwater Saltwater Nuclide, Fish Non-Fish Fish -
Non-Fish SB-124 O.OOOE+00 O.OOOE+00 O.OOOE+00 O.OOOE+OO SB-125 O.OOOE+00 O.OOOE+OO O.OOOE+00 O.OOOE+O0 TE-125M 4.OOOE+02 6.100E+03 1.OOOE+03 l.OOOE+02 TE-127M 4.000E+02 6.100E+03 1.OOOE+O1 1.OOOE+02 TE-127 4.000E+02 6. 100E+03 1.OOOE+O1 1.OOOE+02 TE-129M 4.000E+02 6.100E+03 1.OOOE+01 I.OOOE+02 TE-129 4.OOOE+02 6.100E+03 1.OOOE+01 1.OOOE+02 TE-13 IM 4.OOOE+02 6.100E+03 1.OOOE+O1 1.OOOE+02 TE-131 4.OOOE+02 6. IOE+03 1.OOOE+O1 1.OOOE+02 TE-132 4.000E+02 6.100E+03 l .OOOE+0l 1.OOOE+02 I-130 1.500E+O1 5.OOOE+OO 1.OOOE+01 5.000E+O1 1-131 1,500E+O1 5.OOOE+OO 1.OOOE+O1 5.OOOE+O1 1-132 1.500E+O1 5.OOE+00 1.OOOE+O1 5.OOOE+O1 1-133 1.500E+O1 5.000E+OO 1.OOOE+O1 5.OOOE+O 1 I-134 1.500E+O 1 5.OOOE+OO 1.OOOE+01 5.OOOE+01 1-135 1.500E+01 5.000E+OO 1.OOOE+01 5.OOOE+O I CS-134 2.000E+03 1.OOOE+03 4.OOOE+0 1 2.500E+O1 CS-136 2.OOOE+03 1.OOOE+03 4.OOOE+OI 2.500E+O I CS-137 2.OOOE+03 l.OOOE+03 4.OOOE+Ol 2.500E+O1 CS-138 2.000E+03 1.OOOE+03 4.000E+01 2.500E+O1 BA-139 4.OOOE+OO 2.OOOE+02 l .OOOE+01 1.OOOE+02 BA-140 4.OOOE+OO 2.000E+02 l .OOOE+O1 1.OOOE+02 BA-141 4.000E+OO 2.000E+02 1.OOOE+01 1.OOOE+02 BA-142 4.OOOE+OO 2.OOOE+02 1.OOOE+O I 1.OOOE+02 LA-140 2.500E+01 1.000E+03 2.500E+01 1.OOOE+03 LA-142 2.500E+OI 1.OOOE+03 2.500E+O1 1.OOOE+03 CE-141 l.OOOE+OO 1.OOOE+03 1.OOOE+01 6.OOOE+02 CE-143 1.OOOE+OO 1.OOOE+03 I.OOOE+O1 6.OOOE+02 CE-144 1.OOOE+O0 1.OOOE+03 1.OOOE+O1 6.OOOE+02 PR-143 2.500E+01 1.OOOE+03 2.500E+01 l.OOOE+03 PR-144 2.500E+01 1.OOOE+03 2.500E+O1 1.OOOE+03 ND-147 2.500E+O1 I .OOOE+03 2.500E+O1 1.OOOE+03 W-187 1.200E+03 1.OOOE+O1 3.OOOE+O1 3.OOOE+O1 NP-239 1.OOOE+O1 4.OOOE+02 1.OOOE+iO1 l .OOOE+01 RH-105 1.OOOE+01 3.OOOB+02 1.OOOE+O1 2.OOOE+03 Units --> pCi/kg per pCi/liter RSP-0008 RE -1 :PG 57O10 PAGE57OFIO3 RSP-0008 REV-12
ATTACHMENT 13 PAGE I OF I TABLE GC4: INDIVIDUAL USAGE FACTORS TABLE G4 INDIVTDUAL USAGE FACTORS Descripton Infant Child Teenager Adult Units Fresh Non-fish O.OOOE+00 1.700E+OO 3.800E+OO 5.OOOE+OO kg/year Drinking Water 3.300E+02 5.100E+02 5.100E+02 7.300E+02 liters/year Milk 3.300E+02 3.300E+02 4.OOOE+02 3. 100E+02 liters/year Shoreline Rec. O.OOOE+OO I .400E+01 6.700E+O1 1.200E+O1 hours/year Fresh Fish O.OOOE+OO 6.900E+OO 1.600E+O1 2. 100E+O1 kg/year Fresh Leafy Veg. O.OOOE+OO 2.600E+O1 4.200E+O1 6.400E+O1 kg/year Stored Veg. O.OOOE+OO 5.200E+02 6.300E+02 5.200E+02 kg/year hrrigated Veg. O.OOOE+OO 2.600E+01 4.200E+O1 6.400E+O1 kg/year Breathing 1.400E+03 3.700E+03 8.OOOE+03 8.OOOE+03 m3/year Meat O.OOOE+OO 4.100E+O1 6.500E+O1 1.IOOE+02 kg/year RSP-0008 REV -12 PAGE 58 OF 103
ATTACHMENT 14 PAGE 1 OF I TABLE H-i: ASSUMPTIONS/PARAMETERS FOR DOSES TO A MEMBER OF THE PUBLIC INSIDE SITE BOUNDARY TABLE H-1 NOTE This table contains default location, distance, sector and duration information. Other locations and variables could be used if they are more limiting and will be documented in the Annual RadiologicalEffluent Reportfor the applicableyear if needed.
ASSUMPTIONS/PARAMETERS FOR DOSES TO A MEMBER OF THE PUBLIC INSIDE SITE BOUNDARY MEMBER OF LOCATION DISTANCE (1) SECTOR DURATION THE PUBLIC METERS .HR/YEAR)
Private Driver North Parking Lot 275 N 125(3)
Employee Service Building 115(2) ENE 5 People Entering Alligator Bayou 2500 SW 40 Site Without Consent .
Casual Drivers Main Admin. 500 WNW 76(4)
_ _Building .
(1) The approximate distance from main plant vent exhaust to location.
(2) Midpoint of building.
(3)An individual is assumed to be on site 0.25/hr in the morning and 0.25/br in the evening, 5 days per week, 50 weeks per year (0.5 hr/day *5 days/week
- 50 weeks/year = 125 hours0.00145 days <br />0.0347 hours <br />2.066799e-4 weeks <br />4.75625e-5 months <br />).
(4)An individual is assumed to be on site .5 hr/day.
(5) Liquid pathways dose is not considered due to nature of activities that individuals are engaged in.
(6) Evaluate the dose, if applicable, to the National Guard/State Police while stationed on site as a member of the public. Ij3/
RSP-0008 RSP-0008 -- REV;-
REV-12 12 PAGE 59 OF 103 PAGE59OFIO3
ATTACHMENT 15 PAGE 1 OF2 TABLE I-1: DOSE FACTOR TABLE: P (1) - ADULT, INHALATION TABLE I-1 DOSE FACTOR TABLE: P (1)- Adult, Inhalation Units are mrem/yr per jCi/cu.m.
Nuclide Bone Liver Tbody Thyroid Kidney Lung GI Tract Skin H-3 O.OOE+00 1.26E+03 1.26E+03 1.26E+03 1.26E+03 1.26E+03 1.26E+03 O.OOE+00 C-14 1.82E+04 3.41E+03 3.41B+03 3.41E+03 3.418E+03 3.41 E+03 3.41E+03 0.00E+00 NA-24 1.02E+04 1.02E+04 1.02E+04 1.02E+04 1.02E+04 1.02E+04 1.02E+04 O.OOE+00 P-32 1.32E+06 7.71E+04 5.01B+04 O.OOE+00 O.OO+00 O.OOE+00 8.64E+04 O.OOE+00 CR-51 O.OO+00 O.OOE+800 1.00+02 5.95E+01 2.28E+01 1.44E+04 3.32E+03 O.OOE+00 MN-54 O.OOE+00 3'96E+04 6.30E+03 0.00E+00 9.84E+03 1.40E+06 7.74E+04 0.OOE+00 MN-56 O.OOE+00 1.24E+00 1.83E-01 O.OOE+00 1.30E+00 9.44B+03- 2.02E+04 0.00E+00 FE-55 2.46E+04 1.70E+04 3.94E+03 O.OOE+00 O.OOE+00 7.21E+04 6.03E+03 O.OOE+00 FE-59 1.18E+04 2.78E+04 1.06E+04 O.OOE+00 0.00+00 1.02E+06 1.88E+05 O.OOE+00 CO-57 0.00+00 0.00E+00 O.OOE+00 0.00+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 CO-S8 O.OOE+00 1.58E+03 2.07E+03 O.OOE+0O O.OOE+00 9.28E+05 1.06E+05 O.OOE+00 CO-60 O.OOE+00 1.15E+04 1.48E+04 O.OOE+00 O.OOE+00 5.97E+06 2.85E+05 O.OOE+00 NI-63 4.32E+05 3.14E+04 1.45E+04 O.OOE+OO O.OOE+0O 1.78E+05 1.34E+04 O.OOE+00 NI-65 1.54E+00 2.108-01 9.12E-02 0.00+00 0.OOE+00 5.60E+03 1.23E+04 O.OOE+00 CU-64 0.00+00 1.46E+00 6.15E-01 O.OOE+00 4.62E+O0 6.78E+03 4.90E+04 O.OOE+00 ZN-65 3.24E+04 1.03E+05 4.66E+04 O.OOE+00 6.90E+04 8.64E+05 5.34E+04 O.OOE+00 ZN-69 3.38E-02 6.51E-02 4.52E-03 O.OO+00 4.22E-02 9.208+02 1.63E+01 O.OOE+00 ZN-69M O.OOE+00 0.00+00 O.OOE+800 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 BR-82 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 BR-83 O.OOE+00 O.OOB+00 2.41E+02 O.OOE+00 O.OOE+00 0.00+00 2.32E+02 O.OOE+00 BR-84 O.OOE+00 O.OOE+00 3.13E+02 O.OOE+00 0.00E+00 O.OOE+00 1.64E-03 O.OOE+00 BR-85 O.OOB+00 O.OOE+00 1.28E+01 O.OOE+00 O.OOE+00 0.00+00 8.00E-15 O.OOB+00 RB-86 O.OOE+00 1.35E+05 5.90E+04 O.OOE+00 O.OOE+00 O.OOE+00 1.66E+04 O.OOB+00 RB-88 O.OOE+00 3.87E+02 1.93E+02 O.OOE+00 O.OOE+00 O.OOE+00 3.34E-09 0.00E+00 RB-89 0.0OE8+O 2.56E+02 1.70E+02 O.OOE+00 0.00E+OO O.OOE+00 9.28E-12 O.OOE+00 SR-89 3.04E+05 0.00E+00 8.72E+03 O.OOE+00 O.OOBE+O 1.40B+06 3.50E+05 O.OOE+00 SR-90 9.92E4-07 0.00E+00 6.10E+06 O.OOE+00 O.OOE+00 9.60E+06 7.22E+05 O.OOE+00 SR-91 6.19E+01 O.OOE+00 2.50E+OO 0.OOE+00 000E+00 3.65E+04 1.91E+05 O.OOE+00 SR-92 64E+EOO 0.00E+00 2.91E-01 O.OOE+00 0.00E+00 1.65B+04 4.30E+04 o.ooe+0o Y-90 2.09E+03 0.00E+00 5.61E+OI 0.00E+00 O.OOE+00 1.70E+05 5.06E+05 O.OOE+00 Y-91M 2.61E-0I O.OOE+00 1.02E-02 O.OOE+00 O.OO+00 1.92E+03 1.33E+00 O.OOE+00 Y-91 4.62E+05 O.OOE+00 1.24E+04 O.OOE+00 O.OOE+00 1.70E+06 3.85E+05 O.OOE+00 Y-92 1.03E+01 O.OOE+OO 3.02B-01 O.OOE+00 O.OOE+00 1.57E+04 7.35E+04 O.OOE+00 Y-93 9.44E+01 O.OOB+00 2.61E+00 0.00E+00 O.OOE+00 4.85B+04 4.22E+05 O.OOE+OO ZR-95 1.07E+05 3.44E+04 2.33E+04 0.008+00 5.42E+04 1.77E+06 1.50E+05 0.00E+00 ZR-97 9.68B+01 1.96E+01 9.04E+00 O.OOE+00 2.97E+01 7.87B+04 5.23E+05 O.OOE+00 NB-95 1.41E+04 7.82E+03 4.2 1E+03 0.00+00 7.74E+03 5.05E+05 1.04E+05 O.OOE+OO NB-97 O.OOE+00 O.OOE+00 O.OOE+00 0.00+00 O.OOE+00 O.OOE+00 O.OOB+00 O.OOE+00 MO-99 O.OOE+00 1.21E+02 2.30E+01 O.OOE+00 2.91E+02 9:12E+04 2.48E+05 O.OOE+00 TC-99M 1E03E-03 2.91E-03 3.70E-02 O.OOE+00 4.42E-02 7.64E+02 4.16E+03 O.OOE+00 TC-101 4.18E-05 6.02E-05 5.90E-04 O.OOE+00 1.08E-03 3.99E+02 1.09E-I I O.OOE+00 RU-103 1.53E+03 O.OOE+00 6.58E+02 O.OOE+00 5.83E+03 5.05E+05 1.10E+05 O.OOE+00 RU-105 7.90E-01 O.OOE+00 3.11E-01 O.OOE+00 1.02E+00 1.IOE+04 4.82E+04 O.OOE+00 RU-106 6.91E+04 O.OOE+00 8.72E+03 O.OOE+00 1.34E+05 9.36E+06 9.12E+05 O.OOE+00 AG-IIOM 1.08E+04 1.00E+04 5.94E+03 O.OOE+00 1.97E+04 4;63E+06 3.02E+05 O.OOE+00 SB-124 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OO+00 0.00E+00 SB-125, 0.00E+00 O.OO+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 TE-125M 3.42E+03 1.58E+03 4.67E+02 1.05E+03 1.24E+,04 3.14E+05 7.06E+04 0.00E+00 TE-127M 1.26E+04 5.77E+03 1.57E+03 3.29E+03 4.58E+04 9.60E+05 1.50B+05 0.00E+00 TE-127 1.40E+00 6.42E-01 3.10E-01 1.06E+00 5.10E+00 6.15E+03 5.74E+04 0.00E+00 TE-129M 9.76E+03 4.67E+03 1.58E+03 3.44E+03 3.66E+04 1.16E+06 3.83B+05 O.OOE+00 TE-129 4.98E-02 2.39E-02 1.24E-02 3.90E-02 1.87E-01 1.94E+03 1.57E+02 O.OOE+00 RSP-0008 000 -
RSP .REV E --112 PAGE P. G. 60 6 OF 0F.. 103
ATTACHMENT 15 PAGE 2 OF 2 TABLE I-1: DOSE FACTOR TABLE: P_) - ADULT, INHALATION Nuclide Bone Liver Tbody Thyroid Kidney Lung GI Tract Sin TE-131M 6.99E+01- 4.36E+01 2.90E+01 5.50O+01 3.09E+02 1.46E+05 5.56E+05 0.00E+00 TE-131 1.11E-02 5.95E-03 3.59E-03 9.36E-03 4.37E-02 1.39E+03 1.84E+01 0.00E+00 TE-132 2.60E+02 2.15E+02 1.628+02 1.90E+02 1.46E+03 2.88E+05 5.10E+05 0.00E+00 1-130 4.58E+03 1.34E+04 5.28E+03 1.14E+06 2.09E+04 0.OOE+00 7.69E+03 0.00E+00 1-131 2.52E+04 3.58E+04 2.05E+04 .19E+07 6.13E+04 0.00E+00 6.28E+03 0.00E+00 1-132 1.16E+03 3.26E+03 1.16B+03 1.14B+05 5.18E+03 0.00E+00 4.06E+02 0.OOE+'00 1-133 8.64E+03 1.48E+04 4.52E+03 2.15E+06 2.58E+04 0.00E+00 8.88E+03 0.00E+00 1-134 6.44E+02 1.73E+03 6.15E+02 2.98E+04 2.75E+03 0.00E+00 1.01E+00 0.00E+00 1-135 2.68E+03 6.98E+03 2.57E+03 4.48E+05 1.1 IE+04 0.00E+00 5.25E+03 0.00E+00 CS-134 3.73E+05 8.48E+05 7.28E+05 0.00E+00 2.87E+05 9.76E+04 1.04E+04 0.00E+00 CS-136 3.90E+04 1.46E+05 1.10E+05 0.008+00 8.56E+04 1.20E+04 1.17E+04 0.00E+00 CS-137 4.78E+05 6.21E+05 4.28E+05 0.00E+00 2.22E+05 7.52E+04 8.40E+03 0.00E+00 CS-138 3.31E+02 6.21E+02 3.24E+02 0.008+00 4.80E+02 4.86E+01 1.86E-03 0.00E+00 BA-139 9.36E-01 6.66E-04 2.74E-02 0.00E+00 6.22E-04 3.76E+03 8.96B+02 0.00B+00 BA-140 3.90E+04 4.90E+01 2.57E+03 0.008+00 1.67E+01 1.27E+06 2.18E+05 0.00E+00 BA-141 1.00-E01 7.53E-05 3.36E-03 0.00E+00 7.00E-05 1.94E+03 1.16E-07 0.00E+00 BA-142 2.63E-02 2.708-05 1.66E-03 0.00E+00 2.29E-05 1.19E+03 1.57E-16 0.00E+00 LA-140 3.44E+02 1.74E+02 4.58E+01 0.00E+00 0.00E+00 1.36E+05 4.58E+05 0.00E+00 LA-142 6.83E-01 3.10E-01 7.72E-02 0.00E+00 0.00E+00 6.338+03 2.11E+03 0.00E+00 CE-141 1.99E+04 1.35E+04 1.53E+03 0.OOE+00 6.26E+03 3.62E+05 1.20E+05 0.008+00 CE-143 1.86E+02 1.38E+02 1.53E+01 0.00E+00 6.08E+01 7.98E+04 2.26E+05 0.00E+00 CE-144 3.43E+06 1.43E+06 1.84E+05 0.00E+00 8.48E+05 7.788+06 8.16E+05 0.00E+00 PR-143 9.36E+03 3.75E+03 4.64E+02 0.00E+00 2.16E+03 2.81E+05 2.00E+05 0.00E+00 PR-144 3.01E-02 1.25E-02 1.53E-03 0.00E+00 7.05E-03 1.028+03 2.15E-08 0.00E+00 ND-147 5.27E+03 6.10E+03 3.65E+02 0.00E+00 3.56E+03 2.21E+05 1.73E+05 0.00E+00 W-187 8.488+00 7.08E+00 2.48E+00 0.008+00 0.00E+00 2.90E+04 1.50E+05 0.008+00 NP-239 2.308+02 2.26E+01 1.24E+01 0.008+00 7.00E+01 3.76E+04 1.19E+05 0.00E+00 RSP-0008- REIV - 12 PAGE 61 OF 103 PAGE61OF1O3 RSP-0008 REV-12
ATTACHMENT 16 PAGE I OF 2 TABLE 1-2: DOSE FACTOR TABLE: P (1) - TEEN, INHALATION TABLE 1-2 DOSE FACTOR TABLE: P (i) - Teen, inhalation, Units are mrem/yr per j!Ci/cu.m Nuclide Bone Liver Tbody Thyroid Kidney Lung GI Tract Skin H-3 O.OOE+OO 1.27E+03 1.27E+03 1.27E+03 1.27E+03 1.27E+03 1.27E+03 O.OOE+OO C-14 2.60E+04 4.87E+03 4.87E+03 4.87E+03 4.87E+03 4.87E+03 4.87E+03 O.OOE+OO NA-24 1.38E+04 1.38E+04 1.38E+04 1.38E+04 1.38E+04 1.38Et04 1.38E+04 O.OOE+OO P-32 1.89E+06 1I.IOE+05 7.16E+04 O.OOE+ O.ooE+OO OE O.OOE+OO 9.28E-+04 O.OOE+OO CR-SI O.OOE+OO O.OOE4-OO 1.35E+02 7.50E+01 3.07E+01 2.10E+04 3.O0E+03 O.OOE+OO MN-54 O.OOE+OO S. 1 lE+04 8.40E+03 O.OOE+OO 1.27E*04 1.98E+06 6.68E+04 O.OOE+OO MN-56 O.OOE+OO 1.70E+00 2.52E-OI O.OOE--OO 1.79B+00 1.52E+04 5.74E+04 O.OOE+OO FE-55 3.34E+04 2.38E+04 5.54E+03 O.OOE+OO O.OOE+OO 1.24E+05 6.39E+03 O.OOE+OO PE-59 1.59E+04 3.70E+-04 1.43E+04 O.OOE+OO O.OOE+OO 1.53E+06 1.78E+05 - O.OOE+OO C0-57 O.OOE+OO O.QO+OO O.OOE+OO O.OO+00 O.OOE+OO O.OOE+OO O.OOEOO O.OOE+OO .O CO-58 O.OOE+OO 2.07E+03 2.78E+03 O.OOE+OO O.OOE+OO 1.34E+06 9.52E+04 O.OOE+OO C0-60 O.OOE+00 1.51 E+04 1.98E+04 0.OOE+0O O.OOE+O0 8.72E+06 2.59E+05 O.OOE+O0 NI-63 5.80E+05 4.34E+04 1.98E+04 O.OOE+0O O.OOE+OO 3.07B+05 1.42E+04 0.OOE0+O NI-65 2.18E+00 2.93E-01 1.27E-O1 O.OOE+OO 0.OOE+OO 9.36E+03 3.67E+03 O.OOE+OO CU-64 O.OOE+00 2.03E+00 8.483301 O.OOE+O0 6.41E+0O 1. llE+04 6.14E+04 O.OOE+OO ZN-65 3.86E+04 1.34E+05 6.24E+04 O.OOE+O0 8.64E+04 1.24E+06 4.66E+04 Q.OOE+OO ZN-69 4.83E-02 9.20E-02 6.46E-03 O.OOE+OO 6.02E-02 1.58E+03 2.85E+02 0.OOE+OO ZN-69M O.OOE+OO O.OOE+O0 O.OOE+OO O.OOE+OO O.OOE+IOO Q.OOE+O0 0.OOE+OO O.OOE+OO BR-82 O.OOE+OO 0.OOE+O0 0.00E+00 O.OOE+O0 O.OOE+00 O.0OE+O0 0OE-O0 0.OOE+00 BR-83 O.OOE+OO O.OOE+OO 3.44E+02 O.OOE+OO O.OOE+O0 O.OOE+OO O.OOE+0O O.OOE+OO BR-84 0.OOt+OO O.OOE+O0 4.33E+02 0.OOE+0t O.OOEtOO O.OOE+OO O.OOE+OO O.OOE+OO BR-85 O.OOE+O0 O:OOE+O0 1.83E+O1 0.OOE+00 0.OOE+OO O.OOE+00 O.OOE+O0 0.OOB+00 RB-86 O.OOE+OO 1.90E+05 8.40E+04 O.OOE+OO 0.OOE+0O O.OOE+0O 1.77E+04 O.OOE+OO RB-88 O.OOE+O0 5.46E+02 2.72E+02 O.OOE+OO O.OOE+OO O.OOE+OO 2.92E-05 O.OOE+0O RB-89 O.OOE+O0 3.52E+02 2.33E+02 O.OOE+O0 O.OOE+O0 O.OOE+O0 3.38E-07 O.OOE+00 SR-89 4.34E+05 O.OOE+OO 1.25E+04 0.OOE+0 O.OO+O0O 2.42E+06 3.71B+05 O.OOE+00 SR-90 1.08E+08 0.OOE+OO 6.68E+06 O.OOB+OO O.OOE+OO 1.65E+07 7.65E+05 O.OOE+OO SR-91 8.80E+O1 0.OOE+OO 3.51E+O0 O.OOE+OO O.OOE+OO 6.07E+04 2.59E+05 O.OOE+OO SR-92 9.52E+OO O.OOB+00 4.06E-O1 0.OOE+0O O.OOE+O0 2.74E+04 1.19E+05 O.OOE+O0 Y-90 2.98E+03 O.OOE+00 8.00E+01 O.OOE+OO O.OOE+OO 2.93E+05 5.59E+05 O.OOE+OO Y-91M 3.70E-Ot O.OOE+0O 1.42E-02 O.OOE+O0 O.OOE+O0 3.20E+03 3.02E+0I 0.OOE+O0 Y-91 6.61 E+05 O.OOE+O0 1.77E3+04 O.OOE+00 O.OOE+O0 2.94E+06 4.09E+0S O.OOE+O0 Y-92 1.47E+O1 0.OOE+0O 4.29E-01 O.OOE+O0 O.OOE+OO 2.68E+04 1.65E+05 0.OOE+OO Y-93 1.35E+02 O.OOE+OO 3.72E+00 O.OOE+O0 O.OOE+O0 8.32E+04 5.79E+O5 O.OOE+OO ZR-95 1.46E+05 4.58E+04 3.15E+04 O.OOE+O0 6.74E+-04 2.69E+06 1.49E+05 O.OOE+OO ZR-97 1.38E+02 2.72E+01 1.26E+O1 O.OOB+OO 4.12E+01 1.30E+05 6.30E+05 0.OOE+00 NB-95 1.86E+04 1.03E+04 5.66E+03 O.OOE+OO l;OOE+04 7.51E+O5 9.68E+04 O.OOE+-0O NB-97 0.OOE+0O 0.OOE+O0 O.OOE+O0 O.OOE+OO O.OO O.OOE+OO O.OOE+O0 O.OOE+OO MO-99 0.OOE+O0 1.69E4-02 3.22E+01 0.OOE+00 4.1 1E+02 1.54E+05 2.69E+05 O.OOE+00 TC-99M 1.38E-03 3.86E-03 4.99E-02 0.OOE+O0 5.76E-02 I.I5E+03 6.13E+03 0.OOE+OO TC1-01 5.92E-05 8.40E-OS 8.24E-04 O.OOE+OO 1.52E-03 6.67E+02 8.72E-07 O.OOE+OO RU-103 2. 1OE+03 O.OOE+OO 8.96E,+02 O.OOE4-00 7.43E+03 7.83E+05 1.09E+O5 0.OOE+OO RU-IOS 1.12E+OO O.OOE+OO 4.34E-O1 O.OOE+OO 1.41E+OO 1.82E4-04 9.04E+04 O.OOE+OO RU-106 9.84E+04 O.OOE+OO 1.248+O4 O.OOE+OO I.90E+05 1.61E+07 9.60E+05 O.OOE+OO AG-1 1OM 1.38E+04 1.31E+04 7.99E+03 0.OOE+OO 2.50E+04 6.75E+06 2.73E+05 O.OOE+OO SB-124 O.OOE+OO O.OOE+ OO O.OOB+OO O.OOB+OO O.OOE+0O O.OOE+-O0 SB-125, O.OOE+ O.OOE+OO O.OOE+OO O.OOB+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO TE-125M 4.88B+03 2.24E+03 6.67E+Q2 1.40E+03 O.OOE+0O 5.36E+O5 7.50E+-04 O.OOE+QO TE-127M 1.80E+04 8.16E+03 2.1.8E+03 4.38E+03 6.54E+04 1.66E+06 1.59E+05 QO00E+00 TE-127. 2.01B4O0 9.12E-01 .4.42E-01 1.42E+OO 7.28E+00 1.12E+04 8.08E+04 O.OOE+OO TE-129M 1.39E+04 6.58E+03 2.25E+03.! . 4,58E+03 5.19E+04 1.98B+06 4.05E+05 O.OOE+OO TE-129 7.1OB-02 3.38E-02 1.76EA2 5.18E-02 2.66E-01 3.30E+03 1.62E+03 O.OOE+00 RSP-0008 REV -12 PAGE 62 OF 103
ATTACHMENT 16 PAGE 2 OF 2 TABLE 1-2: DOSE FACTOR TABLE: P (1)- TEEN, INHALATION Nuclide Bone Liver Tbody Thyroid Kidney Lung GI Tract Skin TE-131M 9.84E+01 6.01E+01 4.02E+01 7.25E+01 4.39E+02 2.38E+05 6.21E+05 O.OOE+00 TE-131 1.58E-02 8.32E-03 5.04E-03 1.24E-02 6.18E-02 2.34E+03 1.51E+01 O.OOE+00 TE-132 3.60E+02 2.90E+02 2.19E+02 2.466+02 1.956+03 4.49B+05 4.63E+05 O.OOE+OO 1-130 6.24E+03 1.79E+04 7.17E+03 1.49E+06 2.75E+04 O.OOE+00 9.12E+03 O.OOE+00 1-131 3.54E+04 4.91E+04 2.64E+04 1.466+07 8.40E+04 O.OOE+00 6.49E+03 O.OOE+00 1-132 1.59E+03 4.38E+03 1.58E+03 1.51E+05 6.92E+03 O.OOE+OO 1.27E+03 O.OOE+00 1-133 1.22E+04 2.05E+04 6.22E+03 2.92E+06 3.59E+04 0.00E+00 1.03E+04 0.00E+00 1-134 8.88E+02 2.32E+03 8.40E+02 3.95E+04 3.66E+03 O.OO+00 2.04E+01 0.00E+00 1-135 3.70E+03 9.44E+03 3.49E+03 6.2 1E+05 1.49E+04 O.OOE+00 6.95E+03 O.OOE+00 CS-134 5.02E+05 1.13E+06 5.496+05 O.OOE+00 3.75E+05 1.46E+05 9.76E+03 O.OOE+00 CS-136 5.15E+04 1.94E+05 1.37E+05 O.OOE+00 1.10E+05 1.78E+04 1.09E+04 O.OOE+00 CS-137 6.70E+05 8.48E+05 3.11E+05 O.OOE+00 3.04E+05 1.21E+05 8.48E+03 O.OOE+00 CS-138 4.66E+02 8.56E+02 4.46E+02 0.00E+00 6.62E+02 7.87E+01 2.70E-01 0.00E+00 BA-139 1.34E+00 9.44E-04 3.90E-02. O.OOE+00 8.88E-04 6.46E+03 6.45E+03 0.006+00 BA-140 5.47E+04 6.70E+01 3.52E+03 O.OOE+00 2.28E+01 2.036+06 2.29E+05 0.00E+00 BA-141 1.42E-01 1.06E-04 4.74E-03 0.00E+00 9.84E-05 3.29E+03 7.46E-04 O.OOE+00 BA-142 3.70E-02 3.70E-05 2.27E-03 0.006+00 3.14E-05 1.91E+03 4.79E-10 0.00E+00 LA-140 4.79E+02 2.36E+02 6.26E+01 O.OOE+00 O.OOE+00 2.14E+05 4.87E+05 O.OOE+00 LA-142 9.60E-01 4.25E-01 1.06E-01 O.OOE+00 O.OOE+00 1.02E+04 1.20E+04 0.00E+00 CE-141 2.84E+04 1.906+04 2.17E+03 O.OOE+00 8.88E+03 6.14B+05 1.26E+05 O.OOE+00 CE-143 2.66E+02 1.94E+02 2.16E+01 O.OOE+00 8.64E+01 1.30E+05 2.55E+05 O.OOE+00 CB-144 4.89E+06 2.02E+06 2.62E+05 0.00E+00 1.21E+06 1.346+07 8.64E+05 0.00+00 PR-143 1.34E+04 5.3 1E+03 6.62E+02 O.OOE+00 3.09E+03 4.83E+05 2.14E+05 O.OOE+00 PR-144 4.30E-02 1.766-02 2.18E-03 0.00E+00 1.01E-02 1.75E+03 2.35E-04 O.OOE+00 ND-147 .7.86E+03 8.566+03 5.136+02 0.00E+00 5.02E+03 3.72E+05 1.82B+05 0.00E+00 W-187 1.20E+01 9.76E+00 3.43E+00 0.0OE+00 O.OO+00 4.74E+04 1.77E+05 O.OOE+00 NP-239 3.38E+02 3.19E+01 1.77E+01 O.OOE+00 1.00E+02 6.49E+04 1.32E+05 0.00E+00 RSP-0008 REV - 12 PAGE 63 OF 103 RSP-0008 REV-fl PAGE63OFIO3
ATTACHMENT 17 PAGE 1 OF 2 TABLE 1-3: DOSE FACTOR TABLE: P (1) - CHILD, INHALATION TABLE 1-3 DOSE FACTOR TABLE: P (i) - CHILD, inhalation, Units are mrenilyr per pCilcu.m Nuclide Bone . Liver Tbody Thyroid Kiduey Lung GI Tract Skin H-3 O.OOE+00 E12E+03 1.12E+03 1.12E+03 1.12E+03 1. 12E+03 1.12E+03 0.00+00 C-14 3.592+04 6.73E+03 6.73E+03 6.73E+03 6.73E+03 6.73E+03 6-73E+03 O.OOB+00 NA-24 1.61E+04 1.61E+04 1.61E+04 1.61E+04 1.61E+04 1.61E+04 1.61E+04 O.OOE+00 P-32 2.60E+06 1.14E+05 9.88E+04 0,00E+00 O.OOE+00 O.OOE+00 4.22E+04 O.OOE+00 CR-51 0.002+00 O.OOE+00 1.54E+02 8.55E+01 2.43E+01 1.70E+04 1.08E+03 0.002+00 MN-54 O.OO+00 4.29E+04 9.51E+03 0.00E+00 1.00E+04 1.58E+06 2.29E+04 O.OOE+00 MN-56 O.OOE+00 1.66B+00 3.12E-01 O.OOE+00 1.672+00 1.31E+04 1.23E+05 O.OOE+00 FE-55 4.74E+04 2.52E+04 7.77E+03 0.00E+00 0.0OE+O0 1.11E+05 2.87E+03 O.OOE+00 FE-59 2.07E+04 3.34E+04 1.67E+04 O.OOE+00 0.00E+00 1.27E+06 7.07E+04 O.OOE+00 CO-57 O.OOE+00 O.OOE+00 O.OOE+O0 0.00E+00 O.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 CO-58 0.00E+00 1.77E+03 3.16E+03 O.OOE+00 O.OOB+00 1.1 1E+06 3.44E+04 O.OOE+00 CO-60 O.OOE+00 1.31E+04 2.26E+04 0.00E+00 O.OOE+00 7.07E+06 9.62E+04 O.OOE+00 NI-63 8.21E+05 4.63E+04 2.80E+04 0.00E+00 0.00E+00 2.75E+05 6.33E+03 O.OOE+00 NI-65 2.99E+00 2.96E-01 1.64E-01 O.OOE+00 0.00E+00 8.18E+03 8.40E+04 O.OOE+00 CU-64 O.OOE+00 1.99E+00 1.07E+OO O.OOE+00 6.032+00 9.58E+03 3.67E+04 O.0E+00 ZN-65 4.26E+04 1.13E+05 7.03E+04 O.OOE+00 7.14E+04 9.95E+05 1.63E+04 0.00E+00 ZN-69 6.70E-02 9.66E-02 8.92E-03 O.OOE+00 5.85E-02 1.42E+03 1.02E-04 O.OOE+00 ZN-69M O.OOE+00O O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 0.00E+00 O.OOE+00 BR-82 O.OOE+00O O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.OOE+00 O.OOE+00 BR-83 0.00E+00 O.OOE+00 4.74E+02 O.OOE+00 O.OOE+00 O.OOE+O0 O.OOE+00 0.OOE+00 BR-84 O.OOE+00 O.OOE+00 5.48E+02 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 BR-85 0.00E+00 O.OOE+00 2.53E+01 O.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 RB-86 O.OOE+00 1.98E+05 1.14E+05 O.OOE+00 O.OOE+00 O.OOE+00 7.992+03 O.OOE+00 RB-88 0.00E+00 5.62E+02 3.66E+02 O.OOE+00 O.OOE+00 0.002+00 1.72E+01 O.OOE+00 RB-89 O.OOE+00 3.45E+02 2.90E+02 O.OOE+00 O.OOE+00 O.OOE+00OO 1.89E+00 0-.00E+00 SR-89 5.99E+05 0.00E+00 1.72E+04 O.OOE+00 O.OOE+00 2.16E+06 1.67E+05 O.OOE+00 SR-90 I.01E+08 0.00E+00 6.44E+06 O.OOE+00 O.OOE+00 1.48E+07 3.43E+05 O.OOE+00 SR-91 1.21E+02 0.00E+00 4.59E+00 O.OOE+00 O.OOE+00 5.33E+04 1.74E+05 O.OOE200 SR-92 1.3 1E+01 O.OOE+00 5.25E-01 O.OOE+00 O.OOE+00 2.40E+04 2.42E+05 O.OOE+00 Y-90 4.1tE+03 O.OOE+O 1.11E+02 O.OOE+00 O.OOE+00 2.62E+05 2.68E+05 O.OOE+00 Y-91M 5.07E-01 O.OO+00 1.84B-02 O.OOE+00 O.OOE+00 2.81E+03 1.72E+03 0.002+00 Y-91 9.14E+05 O.OOE+00 2.44E+04 O.OOE+00 O.OOB+00 2.63E+06 1.84E+05 O.OOE+00 Y-92 2.04E+01 O.OOE+00 5.81E-01 O.OOE+00 O.OOE+00 2.39E+04 2.39E+05 0.00E+00 Y-93 1.86E+02 O.OOE+00 5.1 1E+00 O.OOE+00 O.OO+00 7.44E+04 3.89E+05 O.OOE+00 ZR-95 1.90E+05 4.18E+04 3.70E+04 O.OOE+00 5.96E+04 2.23E+06 6.11 E+04 0.00E+00 ZR-97 1.88E+02 2.72E+01 1.60E+01 O.OOE+00 3.88EtOl 1.13E+05 3.51E+05 O.OOE+00 NB-95 2.35B+04 9.18B+03 6.55E+03 O.OOE+00 8.62E+03 6.14E+05 3.70E+04 0.002+00 NB-97 0.00E+00 O.OOE+00 O.OOE+0O O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 MO-99 0.002+00 1.72E+02 4.25E+01 O.OOE+00 3.92E+02 1.35E+05 1.27E+05 0.00E+00 TC-99M 1.78E-03 3.48E-03 5.77E-02 O.OOE+00 5.07E-02 9.51E+02 4.812+03 O.OO+00 TC-101 8.10E-05 8.51E-05 1.08E-03 O.OOE+00 1.45E-03 5.85E+02 1.63E+01 O.OOE+00 RU-103 2.79E+03 O.OOE+00 1.07E+03 O.OOE+00 7.03E+03 6.62E+05 4.48E+04 O.OOE+00 RU-105 1.532+00 O.OO+00 5.55E-01 O.OOE+00 1.34E+00 1.59E+04 9.95E+04 O.OOE+00 RU-106 1.36E+05 0.O02+0O 1.69E+04 O.OOE+00 1.84E+05 1.43E+07 4.29E+05 O.OOE+00 AG-1IOM 1.69E+04 1.14E+04 9.14E+03 O.OOE+00 2.12E+04 5.48E+06 1.00E+05 O.OOE+00 SB-124' O.0OE+00 0.OOE+O0 0.00E+00 0.OOE+O0 0.002+00 O.OOE+00 O.OOE+00 O.OOE+00 SB-125 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+000 0.002+0 O.OOE+00 O.OOE+00 O.OOE+00 TE-125M 6.73E+03 2.332+03 9.14E+02 1.922+03 0.00E+00 4.77E+05 3.38E+04 O.OOE+00 TE-127M 2.49E+04 8.552+03 3.02E+03 6.07E+03 6.36E+04 1.48E+06 7.14E+04 O.OOE+00 TE-127 2.77E+00 9.51B-01 6.10B-01 1.96E+00 7.07E+00 1.00E+04 5.62E+04 O.OOE+00 TE-129M 1.92B+04 6.85E+03 3.04E+03 6.33E+03 5.03E+04 1.76E+06 1.82E+05 O.OOE+00 TE-129 9.77E-02 3.50E-02 2.38E-02 7.14E-02 2.57E-01. 2.93E+03 2.55E+04 O.OOB+00 RSP-0008 REV- 12 PAGE 64 OF 103
ATTACHMENT 17 PAGE 2 OF 2 TABLE I-3: DOSE FACTOR TABLE: P (I - CHILD, INHALATION Nuclide Bone Liver Tbody Thyroid Kidney . Long GI Tract Skin TE-131M 1.34E+02 5.92E+01 5.07B+01 9.77E+01 4.00E+02 2.06E+05 3.08E+05 0.00E+00 TE-131 2.17E-02 8.44E-03 6.59E-03 1.70E-02 5.88E-02 2.05E+03 1.33E+03 O.OOE+00 TE-132 4.818+02 2.72E+02 2.63E+02 3.17E+02 1.77E+03 3.77E+05 1.38E+05 O.OOE+00 1-130 8.18E+03 1.64E+04 8.44E+03 1.85E+06 2.45E+04 O.OOE+00 S. I1B+03 0.00+00 1-131 4.81E+04 4.81E+04 2.73E+04 1.62E+07 7.88E+04 O.OOE+00 2.84E+03 O.OOE+00 1-132 2.12E+03 4.07E+03 1.88E+03 1.94E+05 6.25E+03 0.00E+00 3.20E+03 O.OOE+00 1-133 1.66E+04 2.03E+04 7.70E+03 3.85E+06 3.38E+04 O.OOE+00 5.48E+03 O.OOE+00 1-134 1.17E+03 2.16E+03 9,95E+02 5.07E+04 3.30E+03 O.OOE+00 9.55E+02 O.OOE+OO 1-l35 4.92E+03 8.73E+03 4.14E+03 7.92E+05 1.34E+04 O.OOE+00 4.44E+03 O.OOE+00 CS-134 6.51E+05 1.0IE+06 2.25E+05 O.OOE+00 3.30E+05 1.2 1E+05 3.85E+03 O.OOE+00 CS-136 6.51E+04 1.71E+OS 1.16E+05 O.OOE+00 9.55E+04 1.45E+04 4.188+03 0.OOE+00 CS-137 9.07E+05 8.25E+OS 1.28+05 O.OOE+00 2.82E+05 1.04E+05 3.62E+03 O.OOE+00 CS-138 6.33E+02 8.40E+02 5.55E+02 0.00E+00 6.22E+02 6.81E+01 2,70E+02 O.OOE+OO BA-139 1.84E+00 9.84E-04 5.36E-02 O.OOE+00 8.62E-04 5.77E+03 5.77E+04 0.00+00 BA-140 7.40E+04 6.48E+01 4.33E+03 O.OOE+00 2.1 1E+OI 1.74E+06 1.028+05 O.OE+00 BA-141 1.96E-01 1.09E-04 6.36E-03 O.OOB+00 9.47E-05 2.92E+03 2.75E+02 O.OOE+OO BA-142 4.99E-02 3.60E-05 2.79E-03 O.OOE+00 2.91E-05 1.64E+03 2.74E+00 O.OOE+00 LA-140 6.448+/-02 2.25E+02 7.55E+01 O.OOE+00 O.OOE+00 1.83E+05 2.26E+05 O.OOB+OO LA-142 1.29E+00 4.11E-01 1.29E-01 0.008+O0 0.008+O0 8.70E+03 7.59E+04 O.OOE+00 CE-141 3.92E+04 1.95E+04 2.90E+03 O.OOE+00 8.55E+03 5.44E+05 5.66E+04 O.OOE+00 CE-143 3.66E+0Z 1.99E+02 2.87E+01 O.OOE+00 8.36B+01 1.15E+05 1.27E+05 O.OOE+00 CE-144 6.77E+06 2.128+06 3.618+05 O.OOE+00 1.17E+06 1.20E+07 3.89E+05 0.00+00 PR-143 1.85E+04 5.558+03 9.14E+02 O.OOE+00 3.00E+03 4.33E+05 9.73E+04 O.OOE+00 PR-144 5.96E-02 1.85E-02 3.00E-03 0.00+00 9.77E-03 1.57E+03 1.97E+02 O.OOE+00 ND-147 1.08E+04 8.73E+03 6.81E+02 O.OOE+00 4.81E+03 3.28E+05 8.21E+04 0.00+00 W-187 1.63E+01 9.66E+00 4.33E+00 O.OOE+00 O.OOE+00 4.11E+04 9.10E+04 O.OOE+00 NP-239 4.66E+02 3.34E+01 2.35E+01 0.008+00 9.73E+01 5.81E+04 6.40E+04 0.00o+00 RSP-0008 REV - 12 PAGE 65 OF 103.
ATTACHMENT 18 PAGE 1 0F2 TABLE 1-4: DOSE FACTOR TABLE: P (1)- INFANT, INHALATION TABLE 1-4 DOSE FACTOR TABLE: P (i) - Infant, Inhalation, Units are mrem/yr per CiL/cu.m Nuclide Bone Liver Thody Tbyroid Kidney Lung GI Tract Skdn H-3 O.OOE+00 6.47E+02 6.47E+02 6.47E+02 6.47E+02 6.47E+02 6.473+02 O.OOE+00 C-14 2.65E+04 5.31E+03 5.31E+03 5.31E+03 5.31E+03 5.31E+03 5.31E+03 O.OOE+00 NA-24 1.06E+04 1.06E+04 1.06E+04 1.06E+04 1.06E+04 1.06E+04 1.06E+04 O.OOE+00 P-32 2.03E+06 1.12E+05 7.74B+04 O.OOE+00 0.00E+00 O.OOE+00 1.61E+04 O.OOE+00 CR-51 O.OOE+00 O.OOE+00 8.95E+01 5.75E+01 1.32B+01 1.28E+04 3.57E+02 O.OOE+00 MN-54 O.OOE+00 2.53E+04 4.98E+03 0.00E+00 4.98E+03 1.00E+06 7.06E+03 0.OOE+00 MN-56 0.00E+00 1.54B+00 2.21E-01 0.00E+00 1.10E+00 1.25E+04 7.17E+04 O.OOE+00 FB-55 1.97E+04 1.17B+04 3.33E+03 O.OOE+00 0.00B+00 8.69E+04 I.09E+03 O.OOE+00 FP-59 1.36E+04 2.35E+04 9.48E+03 0.00E+00 O.OOE+00 1.02E+06 2.48E+04 0.00E+00 CO-57 O.OE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+OO O.OOE+00 0.00E+00 O.OOE+00 CO-58 O.OOE+00 1.22E+03 1.82E+03 O.OOB+00 0.008+00 7.77E+05 1.11+04 O.OOE+00 CO-60 O.OOE+00 8.02E+03 1.18E+04 O.OOE+0O 0.00E+00 4.51E+06 3.19E+04 O.OOE+00 NI-63 3.39E+05 2.04E+04 1.16E+04 O.OOE+00 0.00+00 2.09E+05 2.42E+03 O.OOE+00 NI-65 2.39E+00 2.84E-01 1.23E-01 O.OOE+00 O.OOE+00 8. 12E+03 5.01E+04 O.OOE+00 CU-64 O.OOE+00 1.88E+00 7.74E-01 O.OOE+CO 3.98E+00 9.30E+03 1.50E+04 O.OOE+00 ZN-65 1.93E+04 6.26E+04 3.11E+04 O.OOE+00 3.25E+04 6.47E+05 5.14E+04 0.00E+00 ZN-69 5.39E-02 9.67E-02 7.18E-03 O.OOE+00 4.02E-02 1.47E+03 1.32E+04 0.00E+00 ZN-69M 0.00+00 O.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 0.00E+00 O.OOE+00 BR-82 0.00+00 O.OOE+00 0.OOB+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OO.+00 0.00+00 BR-83 O.OOE+00 O.OOE+00 3.81E+02 O.OOE+00 O.OOE+00 O.OOE+00 0.008+00 O.OOE+00 BR-84 O.OOE+00 0.00E+00 4.00E+02 0.0OE+00 0.008+OO O.OOE+00 O.OOE+00 O.OOB+00 BR-85 O.OOE+00 0.00E+00 2.04E+01 O.OOE+00 0.008+00 O.OOE+00 0.00E+00 O.OOE+00 RB-86 O.OOE+00 1.90E+05 8.82E+04 O.OOE+00 O.OOE+00 O.OOE+00 3.04E+03 0.00+00 RB-88 O.OOE+00 5.57E+02 2.87E+02 O.OOE+00 0.00E+00 0.OOE+00 3.39E+02 0.008+00 RB-89 0.OOE+00 3.21E+02 2.06E+02 O.OOE+00 O.OOE+00 O.OOE+00 6.82E+01 O.OOE+00 SR-89 3.98E+05 O.OOE+00 1.14E+04 O.OOE+00 0.00E+00 2.03E+06 6.40E+04 0.OOE+00 SR-90 4.09E+07 0.00E+00 2.59E+06 0.00E+00 O.OOE+00 1.12E+07 1.31E+05 0.00E+00 SR-91 9.56B+01 O.OOE+00 3A6E+00 O.OOE+00 . O.OOE+00 5.26E+04 7.34E+04 O.OOE+00 SR-92 1.05B+01 O.OOB+00 3.91E-01 O.OOE+00 O.OOE+00 2.38E+04 1.40E+05 0.00E+00 Y-90 3.29E+03 O.OOE+00 8.82E+01 O.OOE+00 O.OOE+00 2.69E+05 1.04E+05 O.OOE+00 Y-91M 4.07E-01 O.OOE+00 1.39E-02 O.OOE+00 0.00E+00 2.79E+03 2.35E+03 O.OOE+00 Y-91 5.88E+05 O.OOE+00 1.57E+04 O.OOE+00 O.OOE+00 2.45E+06 7.03E+04 0.00E+00 Y-92 1.64B+01 O.OOE+00 4.61E-01 O.OOE+00 0.00+00 2.45E+04 1.27E+05 0.0OE+00 Y-93 1.50E+02 O.OOE+00 ,4.07E+00 0.00+00 O.OOE+00 7.64E+04 1.67E+05 O.OOE+00 ZR-95 1.15E+05 2.?9E+04 2.03E+04 0.00E+00 3.11E+04 - 1.75E+06 2.17E+04 O.OOE+00 ZR-97 1.50+02 2.56E+01 1.17E+01 0.OOE+00 2.59E+oi 1.10E+05 1.40E+05 O.OOE+00 NB-95 1.57E+04 6.43E+03 3.78E+03 O.OOE+00 4.72E+03 4.79E+05 1.27E+04 0.00E+00 NB-97 O.OOE00 0:00-+00 O.OOE+00 O.OOE+00 O.OOE00 0.00+00 0.00+OO O.OOE+00 MO-99 O.OOE+OO 1.65E+02 3.23E+01 O.OOE+00 2.65E+02 1.35E+05 4.87B+04 0.00+00 TC-99M 1.40E-03 2.88E-03 3.72E-02 0.00E+OO 3.11E-02 8.11-+02 2.03E+03 O.OOE+00 TC-lOI 6.51E-05 8.23E-05 8.12E-04 0.OOE+00 9.79E-04 5.84E+02 8.44E+02 0.00E+00 RU-103 2.02E+03 O.OOE+00 6.79E+02 0.00E+00 4.24E+03 5.52E+05 1.61E+04 0.00E+00 RU-I05 1.22E*00 O.OOE+00 4.10E-01 O.OOE+00 8.998-01 1.57E+04 4.84E+04 O.OOE+00 RU-106 8.68E+04 O.OOE+00 1.09B+04 O.OOE+00 1.07E+05 1.16E+07 1.64E+05 0.0OE+00 AG-I IOM 9.98E+03 7.22E+03 5.00E+03 O.OOE+00 1.09E+04 3.67E+06 3.30E+04 0.00E+00 SB-124, O.OOE+00 O.OOE+00 0.00+00 O.OOE+00 O.OOE*+00 0.00+O0 0.00E+00 O.OOE+00 SB-125 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 TE-125M 4.76E+03 1.99E+03 6.58E+02 1.62E+03 0.00E+00 4A7E+05 1.29E+04 O.OOE+00 TE-127M 1.67E+04 6.908+03 2.07E+03 '4.87E+03 3.75E+04 1.31E+06 2.73E+04 O.OOE+00 TE-127 2.23E+00 9.53E-01 4.89E-01, 1;85E+00 4.86B+00 1.03E+04 2.44E+04 O.OE*+00 TI-129M 1.41E+04 6.09E+03 2.23E+03 5.47E+03 3.18E+04 1.68E+06 6.90E+04 0.00E+00 TE-129 7.88E-02 3.47E-02 1.88E-OZ 6.75E-02 1.75E-01 3.00E+03 2.63E+04 0.00E+00 RSP-0008 REV- 12 PAGE 66 OF 103
ATTACHIMENT 18 PAGE 2 OF 2 TABLE 14: DOSE FACTOR TABLE: P (1)- INFANT, INRALATION Nuclide Bone Liver Thody Thyroid Kidney Lung GI Tract Sldn TE-131M 1.07E+02 5.50B+01 3.63E+01 8.936+01 2.65E+02 1.99E+05 1.19E+05 0.00E+00 TE-131 1.74E-02 8.22E-03 5.00E-03 1.58E-02 3.99E-02 2.06E+03 8.22E+03 0.00+/-+00 TE- 132 3.72B+02 2.37E+02 1.76E+02 2.79E+02 1.03E+03 3.40E+OS 4.41E+04 0.00E+00 1-130 6.36E+03 1.39E+04 5.576+03 1.60E+06 1.53E+04 O.OOE+00 1.99E+03 0.00+00 1-131 3.79E+04 4.44E+04 1.96E+04 1.48E+07 5.18E+04 O.OOE+00 1.06E+03 O.OOE+00 1-132 1.69E+03 3.54E+03 1.26E+03 1.69E+05 3.95E+03 O.OOE+00 1.90E+03 O.OOB+00 1-133 1.32E+04 1.92E+04 5.60E+03 3.56E+06 2.24E+04 O.OOE+00 2.166+03 O.OOE+00 1-134 9.21E+02 1.88E+03 6.65E+02 4.45E+04 2.90E+03 O.OOE+00 1.29E+03 O.OOE+00 1-135 3.86E+03 7.60E+03 2.77E+03 6.96E+05 8.47E+03 O.OOE+00 1.83E+03 O.OOE+00 CS-I134 3.96E+05 7.03E+05 7.45E+04 O.OOE+00 1.906+05 7.97E+04 1.33E+03 O.OOE+00 CS-136 4.83E+04 1.35E+05 5.29E+04 O.OOE+00 5.64E+04 1.18E+04 1.43E+03 0.00+00 CS-137 5.49E+05 6.12E+05 4.55E+04 0.OOE+00 1.72E+05 7.13E+04 1.33E+03 O.OOE+00 CS-138 5.05E+02 7.81E+02 3.98E+02 0.OO+00 4.10E+02 6.54E+01 8.76E+02 0.00+00 BA-139 1.48E+00 9.84E-04 4.30E-02 0.OOE+00 5.92E-04 5.95E+03 5. 1OE+04 0.00+00 BA-140 5.60E+04 5.60E+01 2.90E+03 0.00E+00 1.34E+01 1.60E+06 3.84E+04 O.OOE+00 BA-141 1.57}-01 1.08E-04 4.97E-03 O.OOE+00 6.50B-05 2.97E+03 4.75E+03 O.OOE+00 BA-142 3.98E-02 3.30E-05 1.96E-03 O.OOE+00 1.90E-05 1.55E+03 6.93E+02 O.OOE+00 LA-140 5.05E+02 2.OOE+02 5.15E+01 O.OOE+00 O.OOE+00 1.68E+05 8.48E+04 O.OOE+00 LA- 142 1.03E+00 3.77B-01 9.04E-02 0.00E+00 0.00+00 8.22E+03 5.95E+04 O.OOE+00 CE-141 2.77E+04 1.67E+04 1.99E+03 O.OOE+00 5.25E+03 5.17E+05 2.16E+04 O.OOE+00 CE-143 2.93E+02 1.93B+02 2.21E+O1 0.00E+00 5.64E+01 1.16E+05 4.97E+04 O.OOE+00 CE-144 3.19E+06 1.216+06 1.76E+05 0.00E+00 5.38E+05 9.84E+06 IA8E+05 O.OOE+00 PR-I 43 1.40E+04 5.24E+03 6.99E+02 O.OOE+00 1.97E+03 4.33E+05 3.72E+04 O.OOE+00 PR-144 4.796-02 1.856-02 2.41E-03 O.OOE+00 6.72E-02 1.61E+03 4.28E+03 0.00E+00 ND-147 7.94E+04 8.13E+03 5.00E+02 O.OOE+00 3.15E+03 3.22E+05 3.12E+04 O.OOE+00 W-187 1.30E+01 9.02E+00 3.12E+00 O.OOE+00 0.00E+00 3.96E+04 3.56E+04 0.00+00 NP-239 3.71E+02 3.32E+01 1.88B+01 0.00+00 6.62E+01 5.95B+04 2.49E+04 O.OOE+00 IRSP-0008 REV- 12 PAGE 67 OF 103
ATTACHMENT 19 PAGE I OF 2 TABLE 1-5: DOSE FACTOR TABLE: R (I) - ALL, GR. PLANE TABLE I-5 DOSE FACTOR TABLE: R (i) -All, gr. plane, Units are ml*mremlyr per pxCilsec Naclide Bone Liver Tbody Thyroid Kidne . Lung GI Tract Skin H-3 O.OOE+00 0.008E+O00 0.008+00 .OOE+OO 0.00+00 0.00+00 0.OE+OO O.OOE+00 C-14 O.OOE+00 0.008+00 0.00+00 0.008+00 0.OOE+00 0.00+00 0.008+00 0.00E+00 NA-24 1.198+07 1.19E+07 1.19E+07 1.19t+07 1.19E+07 1.198+07 1.19E+07 I.39E+07 P-32 O.OOE+00 0.008+00 0.OOE+OO 0.008+00 0.008+00 0.00+00 0.00E+00. O.OOE+00 CR-51 4.66E+06 4.66E+06 4.66E+06 4.668+06 4.66E+06 4.668+06 4.668+06 5.518+06 MN-54 1.39E+09 1.398+09 1.39t+09 1.398+09 1.398+09 1.398+09 1.39E+09 1.628+09 MN-56 9.03E+05 9.038+05 9.038+05 9.038+05 9.03E8+05 9.038+05 9.038+05 1.07E+06 FE-55 .OOE+00 0.008+00 0.006+00 0.00+00 0.008E+00 O.OOE+OO 0.008+00 O.OOE+O0 FE-59 2.73E+08 2.738+08 2.736+08 2.738+08 2.73E+08 2.732+08 2.73E+08 3.21E+08 CO-57 O.OOE+00 0.0OE+00 0.006+00 O.OOE+00 0.006+00 0.006+00 0.008+00 O.OOE+00 CO-58 3.79B+08 3.79E+08 3.79E+08 3.79E+08 3.79E+08 3.79E+08 3.798+08 4.44E+08 CO-60 2.15E+10 2.15E+10 2.156+10 2.158+10 2.158+10 2.156+10 2.158+10 2.53E+10 NI-63 0.00+00 O.OOE+00 0.006+O00 O.OOE+00 0.008+00 O.OOE+00 0.008+00 O.OE+00 NI-65 2.976+05 2.97E+05 2.97t+05 2.978+05 2.97E+05 2.976+05 2.97E+05 3.458+05 CU-64 6.078+05 6.07E+05 6.07E+05 6.07t+05 6.07E+05 6.076+05 6.078+05 6.88E+05 ZN-65 7.47E+08 7.47E+08 7.47E+08 7.476+08 7.47E+08 7.47E+08 7.48E+08 8.59E+08 ZN-69 0.008+00 O.OO+00 O.OOE+00 O.OOE+00 0.008+00 O.OOE+00 O.OO+00 0.008+00 ZN-69M O.OOE+00 0.0OE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+000 0.008+00 O.OE+00 BR-82 0.008+00 0.00E+00 0.006+00 0.006+00 0.008+00 0.00+00 O.OOE+00 0.00+00.
BR-83 4.87E+03 4.87E+03 4.878+03 4.878+03 4.876+03 4.878+03 4.87E+03 7.08E+03 BR-84 2.038+05 2.03E+05 2.03E+05 2.038+05 2.03E+05 2.03E+05 2.038+05 2.36E+05 BR-85 0.008+00 O.OOE+00 0.006+00 0.00+00 0.008+00 0.006+00 0.008+00 0.00+00 RB-86 8.998+06 8.998+06 8.996+06 8.998+06 8.99E+06 8.998+06 8.998+06 1.03E+07 RB-88 3.318+04 3.31E+04 3318+04 3.31t+04 3.31E+04 3.316+04 3.31E+04 3.78E+04 RB-89 1.23E+05 1.23E+05 1.236+05 1.23t+05 1.23E+05 1.23E+05 1.238+05 1.48E+05 SR-89 2.162+04 2.168+04 2.16E+04 2.168+04 2.16E+04 2.16E+04 2.168+04 2.51E+04 SR-91 2.158+06 2.158+06 2.156+06 2.15E+06 2.158+06 2.15E+06 2.15E+06 2.51E+06 SR-92 7.778+05 7.77E+05 7.77E+05 7.776t+05 7.77E+05 7.77E+05 7.778+05 8.638+05 Y-90 4.49E+03 449E+03 4.49E+03 4.498+03 4.49E+03 4.498+03 4.498+03 5.316+03 Y-91M 1.00E+05 1.008+05 1.008+05 1006+05 1.008+05 1.008+05 1.00E+05 1.16E+05 Y-91 1.07E+06 1.07E+06 1.07E+06 1.078+06 1.07E+06 1.078+06 1.07E+06 1.21E+06 Y-92 1.808+05 1.808+05 1.80E+05 1.80E+05 1.80E+05 1.80E+05 .1.80E+05 2.148+05 Y-93 1.83E+05 1.83E+05 1.838+05 1.83E+05 1.83E+05 1.83E+05 1.838+05 2.518+05 ZR-95 2.45E+08 2.458+08 2.45E+08 2.45E+08 2.45E+08 2.45E+08 2.458+08 2.84E+08 ZR-97 2.968+06 2.968+06 2.96E+06 2.96E+06 2.96E+06 2.968+06 2.968+06 3.448+06 NB-95 1.37E+08 1.378+08 1.378+08 1.376+08 1.37E+08 1.378+08 1.37E+08 1.61E+08 NB-97 O.OOE+00 0.0OE+00 0.008+00 O.OOE+00 0.008+00 O.OOE+00 0.00E+00 O.OOE+00 MO-99 3.998+06 3.996+06 3.998+06 3.99E+06 3.99E+06 3.99E+06 3.998+06 4.63E+06 TC-99M 1.848+05 1.84B+05 1.84E+05 1.846+05 1.846+05 1.84E+05 1.84E+05 2.11E+05 TC-101 2.048+04 2.048+04 2.048+04 2.04E+04 2.04E+04 2.04E+04 2.048+04 2.268+04 RU-103 1.086+08 1.08E+08 1.088+08 1.088+08 1.08E+08 1.086+08 1.088+08- 1.268+08 RU-105 6.368+05 6.36E+05 6.366+05 6.368+05 6.368+05 6.36E+05 6.368+05 7.21E+05 RU-106 4.228+08 4.228+08 4.226+08 4.228+08 4.228+08 4.228+08 4.228+08 5.078+08 AG-11OM 0.006+00 0.008+00 0.00E+00 0.0063+00 0.008+00 0.008+00 O.OOE+00 4.016+09 SB-124 0.00E+00 0.008+00 O.OOE6+00 0.008E+00 0.00+00 O.OOE+00 0.00E+00 0.008+00 S1-125' 0.008+00 O.OOE600 O.OOE+00 O.OOE+00 0.008+00 0.00E+00 O.OOE+00 O.OOE+00 TE-125M 1.558+06 1.556+06 1.558+06 1.5SE+06 1.558+06 1.55E+06 1.55E+06 2.13E+06 TB-12iM 9.16E+04 9.166+04 9.166+04 9.16E+04 9.16E+04 9.162+04 9.16E+04 1.08E+05 TE-127 2.98E+03 2.98E+03 2.988+03 2.98E+03 2.98E+03 2.98E+03 2.986+03 3.288+03 TE-129M 1.98E+07 1-.986+07 1.982+07 1.98E+07 1.988+07 1.98E+07 1.98E+07 2.31E+07 TE-129 2.628+04 2.628+04 2.628+04 2.628+04 2.62E+04 2.62E+04 2.62E+04 . 3.10E+04 RSP-0008 REV- 12 PAGE 68 OF 103
ATTACHMENT 19 PAGE 2 OF 2 TABLE 1-5: DOSE FACTOR TABLE: R (1) - ALL, GR. PLANE Nuclide Bone Liver Tbody Thyroid Kidney Lung GI Tract Sldn TE-lilM 8.03E+06 8.03E+06 8.03E+06 8.03E+06 8.03E+06 8.03E+06 8.03E+06 9.46E+06 TE-131 2.92E+04 2.92E+04 2.92E+04 2.92E+04 2.92E+04 2.92E+04 2.92E+04 3.45E+07 TE-132 4.23E+06 4.23E+06 4.23E+06 4.23E+06 4.23E+06 4.23E+06 4.23E+06 4.98E+06 1-130 5.SIE+06 5.51E+06 5.51E+06 5.5 1E+06 5.5 IE+06 5.5 1E+06 5.51 E+06 6.69E+06 1-131 1.72E+07 1.72E+07 1.72E+07 1.72E+07 1.72E+07 1.72E+07 1.72E+07 2.09E+07 1-132 1.25E+06 1.25E+06 1.25E+06 1.25E+06 1.25E+06 1.25E+06 1.25E+06 1.46E+06 1-133 2.45E+06 2.45E+06 2.45E+06 2.45E+06 2.45E+06 2.45E+06 2.45E+06 2.98E+06 1-134 4.47E+05 4.47E+05 4.47E+05 4.47E+05 4.47E+05 4.478+05 4.47E+05 5.30E+05 1-135 2.53E+06 2.53E+06 2.53E+06 2.53E+06 2.53E+06 2.53E+06 2.53E+06 2.95E+06 CS-134 6.86E+09 6.86B+09 6.86E+09 6.86E+09 6.86E+09 6.86E+09 6.86E+09 8.00E+09 CS-136 1.51E+08 1.51E+08 1.51E+08 1.51E+08 1.51E+08 1.5 1E+08 1.51E+08 1.71 E+08 CS-137 1.03E+10 1.03E+10 1.03E+10 1.03E+10 1.03E+10 1.03E+10 1.03E+10 1.20E+10 CS-138 3.59E+05 3.59E+05 3.59E+05 3.59E+05 3.59E+05 3.59E+05 3.59E+05 4. 1OE+05 BA-139 1.06B+05 1.06E+05 1.06E+05 1.06E+05 1.06E+05 1.068+05 1.068+05 1.19E+05 BA-140 2.05E+07 2.05E+07 2.05E+07 2.05E+07 2.05E+07 2.05E+07 2.05E+07 2.35E+07 BA-141 '4.17E+04 4.17E+04 4.17E+04 4.17E+04 4.17E+04 4.17E+04 4.17E+04 4.75E+04 BA- 142 4.49B+04 4.49E+04 4.49E+04 4.49E+04 4.49E+04 4.49E+04 4.49E+04 5.11 E+04 LA-140 1.92E+07 1.92E+07 1.92E+07 1.92E+07 1.92E+07 1.92E+07 1.92E+07 2.18E+07 LA-142 7.60E+05 7.60E+05 7.60E+05 7.60E+05 7.60E+05 7.60E+05 7.60E+05 9.1 IE+05 CE-141 1.37E+07 1.37E+07 1.37E+07 1.37E+07 1.37E+07 1.37E+07 1.37E+07 1.54E+07 CE-143 2.31E+06 2.3 IE+06 2.318+06 2.31E+06 2.31E+06 2.31E+06 2.31E+06 2.63E+06 CE-144 6.95E+07 6.95E+07 6.95E+07 6.95E+07 6.95E+07 6.95E+07 6.95E+07 8.04E+07 PR-143 O.OOE+00 O.OOE+00 O.OOE+00 0.0OE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 PR-144 1.83E+03 1.83E+03 1.83E+03 1.83E+03 1.83E+03 1.83E+03 1.83E+03 2.1 IE+03 ND-147 8.39E+06 8.39E+06 8.39E+06 8.39E+06 8.39E+06 8.39E+06 8.39E+06 1.01E+07 W-187 2.35E+06 2.35E+06 2.35E+06 2.35E+06 2.35E+06 2.35E+06 2.35E+06 2.73E+06 NP-239 1.71E+06 1.71E+06 1.71E+06 1.71E+06 1.71E+06 1.718+06 1.71 E+06 1.98E+06 RSP-OOD8 RSP-0008 Rv RUNV - 12
- I? PAGE 69 OF 103
ATTACHMENT 20 PAGE 1 OF2 TABLE 1-6: DOSE FACTOR TABLE: R (1)- ADULT, COWS MILK TABLE 1-6 DOSE FACTOR TABLE: R (i) -Adult, cows' milk Units are m2 *mrem/yr per MCl/sec Nuclide Bone Liver Tbody Thyroid Kidney Lung GI Tract Skin H-3 O.OOE+00 4.73E+02 4.73E+02 4.73E+02 4.73E+02 4.73E+02 4.73E+02 O.OOE+00 C-14 3.63E+05 7.26E+04 7.26E+04 7.26E+04 7.26E+04 7.26E+04 7.26E+04 O.OOB+00 NA-24 2.44E+06 2.44E+06 2.44E+06 2.44E+06 2.44E+06 2.44E+06 2.44E+06 O.OOE+00 P-32 1.62E+10 1.OIE+O9 6.26E+08 0.00E+00 O.OOE+00 0.00+00 1.82E+09 O.OOE+00 CR-51 O.OOE+00 0.OOE+00 2.55E+04 1.53E+04 5.62E+03 3.39E+04 6.42E+06 O.OOE+OO MN-54 0.00E+00 6.63E+06 1.27E+06 O.OO2+00 1.97E+06 0.00+00 2.032+07 O.OOE+00 0.002+00 MN-56 0.O02+00 4.21E-03 7.47E-04 0.002+00 5.342-03 0.00+00 1.34E-01 O.OOE+00 FE-55 1.95E+07 1.35E+07 3.15E+06 0.00+00 O.OOE+00 7.53E+06 7.75E+06 O.OOE+00 FE-59 2.55E+07 5.99E+07 2.30E+07 O.OOE+00 O.OOE+00 1.67E+07 2.00E+08 CO-57 0.00+00 O.OO+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.OOE+00 O.OOE+00 CO-58 O.OOE+00 3.92E+06 8.78B+06 O.OOE+00 O.OOE+00 0.002+00 7.94E+07 O.OOE+00 CO-60 O.OOE+00 1.27E+07 2.81E+07 O.OOE+00 0.00E+00 O.OOB+00 2.39E+08 0.00E+00 NI-63 5.21E+09 3.61E+08 1.75E+08 O.OOE+00 O.OOE+00 O.OOE+00 7.53E207 O.OOE+00 0.00E2+00 NI-65 3.76E-01 4.88E-02 2.23202 0.00E+00 . O.OOE+00 0.00+00 1.24E+00 O.OOE+00 CU-64 O.OOE+00 2.39B+04 1.12E+04 0.OOE+00 6.03E+04 O.OOE+OO 2.04E+06 0.00E+00 ZN-65 1.09E+09 3.46E+09 1.56E+09 0.002+00 2.31E+09 0.00+00 2.18E+09 OOOE+00 ZN-69 2.1 SE-12 4.17E-12 2.90E-13 O.OOB+00 2.71E-12 O.OOE+00 6.26E-13 O.OOB+00 ZN-69M 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 0.00+00 O.OOE+00 0.00E+00 O.OOE+00 BR-82 O.OOE+00 O.OOE+00 0.00+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.002+00 BR-83 O.OOE+00 O.OOE+00 9.87E-02 0.00E+00 O.OOE+00 O.OOE+00 1.42E-01 O.OOE+00 BR-84 0.OOE+00 O.OOE+00 1.73E-23 O.OOE+00 0.00+00 0.OOE+00 1.36E-28 O.OOE+00 BR-85 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.001+00 0.00+00 0.00E+00 RB-86 O.OOE+00 2.40E+09 1.12E+09 O.OOE+00 O.OOE+00 0.OOE+00 4.74E+08 O.OOE+00 RB-88 O.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 0.00E+00O 0.00E+00 O.OOE+OO RB-89 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OO+00 0.00+00 O.OOE+00 O.OOE+00 SR-89 1.232+09 O.OOE+00 3.54E+07 O.OOE+00 0.00+00 0.002+00 1.98E+08 O.OOE+00 SR.-90 3.62E+10 O.OOE+00 8.89E+09 O.OOE+00 O.OOE+00 O.OOE+00 1.05E+09 O.OOE+~O SR-91 2.90E+04 O.OOE+00 1.17E+03 0.00E+00 O.OO2+00 O.OOE+00 1.38E+05 0.(002+00 SR-92 4.95E-01 O.OOE+00 2.14E-02 0.002E+00 0.02+OO O.OOE+00 9.81E+00 O.OOE+00 Y-90 7.09E+01 O.OOE+OO 1.90E+00 0.002+00 0.00E+0O O.OOE+00 7.5 1E+05 0.00+00 Y-91M 6.27E-20 O.OOE+00 2.43E-21 O.OOE+00 O.OOE+00 O.OOE+00 1.84B-19 O.OOE+00 Y-91 7.22E+03 0.00+00 1.932+02 0.002+00 O.OOE+00 O.OOE+00 3.98E+06 Y-92 5.64E-05 0.00E+00 1.65E-06 0.002+00 O.OOE+00 O.OOE+00 9.88E-01 O.OOE+00 0.0012+/-00 Y-93 2.24E-01 O.OOE+00 6.19E-03 0.00E+00 O.OOE+00 O.OOE+00 7.11 E+03 O.OOE+00 ZR-95 7.89E+02 2.53E+02 1.71E+02 0.00E+00 3.972+02 O.OOE+00 8.02B+05 O.OOE+00 ZR-97 4.34E-01 8.76E-02 4.01E-02 O.OOE+00 1.32E-01 0.00E+00 2.71E+04 NB-95 7.22E+04 4.02B+04 2.16E+04 0.00E+00 3.97E+04 0.0OE+OO 2.44E+08 O.OOE+00 0.002+/-,00 NB-97 0.002+00 0.00E+00 O.OO+00 0.00E+00 O.OO+00 0.OOE+00 0.00E+00 O.OOE+00 MO-99 O.OOE+00 2.48E+07 4.712+06 O.OOE200 5.61E+07 O.OOE+00 5.74E+07 0.002+00
.TC-99M 3.34E+00 9.44E+00 1.202+02 0.00E+00 1.43E+02 4.63E+00 5.59E+03 TC-10L O.0OE+00 O.OOE+00 O.OOE+00 0.002+00 0.002+00 O.OOE+00 O.OOE+00 0.002+/-00 O.OOE200 RU-103 8.82E+02 O.OOE+00 3.80E+02 0.00E+00 3.37E+03 O.OOE+00 1.03E+05 O.OOE+00 RU-105 8.64E-04 O.OOE+00 3.41E-04 0.00E+00 1,12E-02 O.OOE+00 5.29E-01 O.OOB+00 RU-106 1.60E+04 0.00E+00 2.03E+03 O.OOE+00 3.10E+04 0.0OE+00 1.04E+06 O.OOE+00 AG-I OM 4.61E+07 4.26E+07 2:53E+07 O.OO+200 8.38E+07 O.OOE+00 1.74E+10 O.OOE+00 SB-124 0.00E+00 O.OOE+00 0.002+00 O.OOE+00 O.OO+00 O.OOE+00 O.OOE+00 SB-125 0.00E+00 O.OOE+00 0.00E+00 O.OOE+O O.OOE+00 0.00+00 O.OOE+00 O.OOE+00 TE-125M 1.37E+07 4.97E+06 1.84E+06 4.122+06 5.582+07 O.OOE+00 5.48E+07 O.OOE+00 TE-127M 3.72E+07 1.33E+07 4.53E+06 9.512+06 1.51E+08 0.00E+00 1.25E+08 O.OOE+00 0.00E+OO 1P-127 6.56E+02 2.35E+02 1.42E+02 4.86E+02. 2.672+03 O.OOE+00 5.17E+04 O.OOE+00 0.00E+OO TE-129M 5.29E+07 1.97E+07 8.37E+06' 1.82E+07 2.21E+08 O.OOE+00 2.66E+08 TB-129 2.922-10 1.1OE-10 7.112-Il. 2.24E-10 1.23E-09 O.OOE+00 2.20E-10 RSP-0008 REV -12 PAGE 70 OF 103
ATTACHMENT 20 PAGE 2OF2 TABLE 1-6: DOSE FACTOR TABLE: R (I) - ADULT, COWS MILK Nuclide Bone Liver Tbody Thyroid Kidney Lung GI Tract Skin TE-131M 3.62E+OS 1.77E+05 1.47E+05 2.80E+05 1.79E+06 0.00E+00 1.76E+07 0.00E+00 TE-131 3.95E-33 1.65E-33 1.25E-33 3.25E-33 1.73E-32 0.00E+O0 5.60E-34 0.OOE+00 TE-132 2.40E+06 1.55E+06 1.46E+06 1.72E+06 1.50E+07 O.OOE+00 7.35B+07 0.00E+00 1-130 4.21E+05 1.24E+06 4.90E+05 1.95B+08 1.94E+06 O.OOE+00 1.07E+06 0.00E+00 1-131 2.91E+08 4.16E+08 2.38E+08 1.36E+11 7.13E+08 O.OOE+00 1.10E+08 0.00E+00 1-132 1.67E-01 4.47E-01 1.56E-01 1.56E+01 7.12E-01 0.OOE+00 8.39E-02 0.00E+00
[-133 3.88E+06 6.74E+02 2.06E+06 9.91E+08 1.18+07 0.00E+00 6.06E+06 0.00E+00 1-134 2.11B-12 5.72E-12 2.056-12 9.92E-11 9.10E-12 O.OO+00 4.99E-15 0.00E+00 1-135 1.29E+04 3.38E+04 1.256+04 2.23E+06 5.42E+04 0.00E+00 3.82E+04 0.00E+00 CS-134 4.41E+09 1.05E+10 8.57E+09 0.006+00 3.39E+09 1.13E+09 1.84E+08 0.00E+00 CS-136 2.51E+08 9.91E+08 7.13E+08 0.00E+00 5.51E+08 7.56E+07 1.13E+08 0.00E+00 CS-137 5.71E+09 7.81E+09 5.12E+09 0.006+00 2.65E+09 8.82E+08 1.51E+08 0.00E+00 CS-138 9.72E-24 1.92E-23 9.506-24 0.00E+00 1.41E-23 1.39E-24 8.18E-29 0.006+00 BA-139 4.54E-08 3.24E-11 1.33E-09 O.OOE+00 3.03E-11 1.84E-11 8.06E-08 0.00E+00 BA-140 2.57E+07 3.23E+04 1.686+06 O.06E+00 1.10E+04 1.85E+04 5.29E+07 0.00E+00 BA-141 0.00E+00 O.O0E+00 0.006+00 0.00E+00 0.00E+00. 0.00E+00 0.00E+00 0.00E+00 BA-142 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 LA-140 4.52E+00 2.28E+00 6.01E-01 0.00E+00 0.00E+00 0.00E+00 1.67E+05 0.00E+00 LA-142 1.90E-11 8.66E-12 2.16E-12 0.00E+00 0.00E+00 0.00E+00 6.32E-08 O.OOE+00 CE-141 4.27E+03 2.89E+03 3.27E+02 0.00E+00 1.34E+03 0.00+00 1.10E+07 O.O0E+00 CE-143 4.16E+01 3.08E+04 3.40E+00 0.00E+00 1.35E+00 O.00E+00 1.15E+06 0.00E+00 CE-144 2.82E+05 1.18E+05 1.52E+04 0.00E+00 7.00E+04 O.OOE+00 9.55E+07 0.00E+00 PR-143 1.50E+02 6.02E+01 7.44E+00 0.00E+00 3.48E+01 0.00E+00 6.58E+05 0.00E+00 PR-144 0.00E+00 0.006+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ND-147 9.106+01 1.05E+02 6.29E+00 O.00E+00 6.15E+01 0.00E+00 5.05E+05 0.00E+00 W-187 6.52E+03 5.45E+03 1.90E+03 0.00E+00 0.00E+00 0.00E+00 1.786+06 0.006E+O NP-239 3.67E+00 3.61E-01 1.99E-01 0.00E+00 1.13E+00 0.00E+00 7.41E+04 0.00E+00 RSP-0008 REV - 12 PAGE 71 OF 103
ATTACHMENT 21 PAGE I OF 2 TABLE 1-7: DOSE FACTOR TABLE: R (1) - TEEN, COWS MILK TABLE 1-7 DOSE FACTOR TABLE: R (i) - Teen, cows'milk Units are m2 *nremlyr per xCilsec Nucllde Bone Liver Tbodv - Thyroid Kidney Lung GI Tract Skin H-3 0.00E+OO 6.16E+02 6.16E+02 6.16E+02 6.16E+02 6.16E+02 6.16E+02 0.00+00 C-14 6.70E+05 1.34E+05 1.34E+05 1.34E+05 1.34E+05 1.34E+05 1.34E+05 0.OOB+00 NA-24 4.27E+06 4.27B+06 4.27E+06 4.27E+06 4.27E+06 4.27E+06 4.27E+06 O.OOE+00 P-32 2.99E+10 1.856s+09 1.16E+09 O.OOE+00 O.OOE+00 O.OOE+00 2.51 E+09 0.00E+00 CR-51 0.00+00 0.00+00 4.46E+04 2.48E+04 9.77E+03 6.366+04 7.49E+06 O.OOE+00 MN-54 0.00+00 1.10E+07 2.19E+06 0.0063+00 3.30E+06 0.00+00 2.27E+07 O.OOE+00 MN-56 0.00E+OO 7.46E-03 1.336-03 0.0016+00 9.45E-03 0.00E+00 4.91E-01 0.006+OO FE-55 3.47E+07 2.46E+07 5.73E+06 0.0016+00 0.00+O0 1.56E+07 1.06E+07 O.OOE+00 FE-59 4.45E+07 1.04E+08 4.01 E+07 0.0063+00 O.OOE+00 3.27E+07 2.456+08 0.006+00 CO-57 0.00+00 O.pOE+00 0.00+00 0.0016+00 O.OO+00 0.OOE+00 0.00E+00 0.006+00 CO-58 0.OOE+00 6.60E+06 1.52E+07 0.0061+00 0.00E+OO 0.00+00 9.096+07 0.006+00 CO-60 0.OOE+OO 2.16E+07 4.86E+07 0.0013+/-00 0.00+00 0.00E+00 2.81E+08 0.006+00 NI-63 9.15E+09 6.46E+08 3.1OE+08 O.OOE+00 0.00+00 0.00E+00 1.03E+08 0.006+00 NI-65 6.876-01 8.78E-02 4.00E-02 0.00+00 0.00+00 0.00+00 4.766+00 0.00+00 CU-64 0.006+00 4.26E+04 2.00E+04 O.OOE+00 1.08E+05 O.OOE+00 3.30E+06 0.00E+OO ZN-65 1.67E+09 5.796+09 2.70E+09 0.00+00 3.71E+09 0.006+00 2.45E+09 0.006+00 ZN-69 4.01E-12 7.65E-12 5.35E-13 0.00E+00 5.00E-12 0.006+00 1.411E-ll 0.00E+OO ZN-69M 0.00+00 O.OOE+00 0.00+00 0.00+00 O.OOE+00 0.006+00 0.00E+OO 0.00+00 BR-82 0.00+00 0.00+OO 0.00+00 0.00+00 O.OOE+00 0.00E+OO 0.006+00 0.00+00 BR-83 0.OOE+00 0.00+00 1.82E-01 0.00E+00 0.00E+OO 0.006+00 0.006+00 O.OOE+00 BR-84 0.006+00 0.006+00 3.09B-23 0.00Q+00 0.0OE+OO 0.001+00 0.006+00 0.006+00 BR-85 0.006+00 0.00+00 0.00+00 O.OOE+00 0.006+00 O.0OE+00 O.OOE+00 0.006+00 RB-86 0.00+00 4.38E+09 2.066+09 O.OOE+00 0.006+00 0.006+OO 6.48E+08 O.OOE+00 RB-88 0.001+00 0.006+00 0.00+00 0.00+00 O.OOE+O0 0.006+00 0.00E+O0 0.OOE+00 RB-89 0.0OE+00 0.00+00 0.00+00 0.00E+OO O.OOE+O0 0.00E+00 0.006+00 O.OOE+00 SR-89 2.27E+09 0.00+00 6.51E+07 O.OOE+00 0.00++00 0.0063+00 2.71 E+08 0.00+00 SR-90 5.12E+10 O.OOE+00 1.26E+10 O.OOE+00 O.OOE+00 0.00E+OO 1.44E+09 O.OOE+00 SR-91 5.33E+04 0.00+00 2.12E+03 O.OOE+00 0.0OE+00 0.006+00 2.42E+05 0.00E+OO SR-92 9.07E-01 O.OOE+00 3.86B-02 0.00+00 0.006+00 O.OOE+00 2.31 E+O 1 O.OOE+00 y-go 1.30E3+02 0.00+00 3.51E+00 O.OOE+00 O.OOE+00 0.006+0O 1.07E+06 0.00+00 Y-91M 1.15E-19 0.00+00 4.39E-21 0.00p+00 O.OOE+OO 0.006+00 0.006+00 5.42E-18 0.006+00 Y-91 1.33E+04 0.00E+OO 3.56E+02 O.OOE+00 0.006+00 O.OOE+00 5.45E+06 0.006+00 Y-92 1.04E-04 O.OOE+00 3.016-06 0.001+00 0.006+00 0.006+00 2.86E+00 0.00+00 Y-93 4.13E-01 0.00+00 1.13E-02 0.00E+OO O.OOE+00 1.266+04 0.00+00 ZR-95 1.38E+03 4.35E+02 2.99E+02 0.00+00 6.406+02 0.006+00 1.00+06 0.00E+OO ZR-97 7.90E-01 1.56E-01 7.206-02 0.0OE+0O 2.376-01 0.00E+00 4.23E+04 0.006+00 NB-95 1.23E+05 6.83E+04 3.76E+04 0.00E+OO 6.62E+04 0.00E+OO 2.926+08 0.00+00 NB-97 0.006+00 0.p0E+0O O.OOE+00 O.OOE+00 O.OOE+00 0.006+00 O.OOE+00 0.OOE+00 MO-99 O.OOE+00 4.47E+07 8.536+06 O.OOE+00 1.026+08 0.006+00 8.01E+07 0.00+00 TC-99M 5.80E+00 1.62E+01 2.1 OE+02 0.00E+OO 2.416+02 8.97E+00 I .06E+04 0.006+00 TC-101 0.006+00 O.OOE+00 0.006+00 O.OOE+00 0.006+00 0.006+00 0.006+00 0.006+00 RU-103 1.57E+03 0.00E+OO 6.71E6+02 0.00E+OO 5.53E+03 0.00E+00 1.316+05 O.OOE+00 RU-105 1.58E-03 0;OOE+OO 6.13E-04 0.006+00 1.99E-02 0.00E+00 1.27B+00 0.006+00 RU-106 2.95E+04 0.OOE+OO 3.72E+03 O.OOE+00 5.69E+04 O.OOE+00 1.41E+06 O.OOB+00 AG-llOM 7.62E+07 7.21E+07 4.396+07 0.006+00 1.386+08 0.006+O0 2.036+10 0.00E+OO SB-124, O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.006+00 0.0011+00 0.00+00 0.00+00 SB-125 0.00+/-+00 0.00+00 0.006+00 O.OOE+00 0.006+00 0.00+00 0.006+00 0.006+00 TE-125M 2.53E+07 9.1 1E+06 3.386+06 7.066+06 O.OOE+00 0-006+00 7.46E+07 0.00E+OO TE-127M 6.86E+07 2.43E+07 8.16E+06 1.63E+07 2.78E+08 O.OO+OO 1.71E+08 0.006+00 TE-127 1.22E+03 4.316+02 2.61E+02 8.386+02 4.926+03 0.00E+OO 9;38E+04 0.00+OO TE-129M 9.671E+07 3.59B+07 1[53E+07 3.12E+07 4.046+08 0.006+OO 3.63E+08 O.OO+00 TE-129 5.37E-10 2.00E-10 1.31E-10 3.84E-10 2.25E-09 0.006+00 2.94B-09 0.006+00 RSP-0008 REV -12 PAGE 72 OF 103
ATTACHMENT 21 PAGE 2 OF 2 TABLE 1-7: DOSE FACTOR TABLE: R O - TEEN, COWS MILK Nudide Bone Liver Thody Thyroid Kidney Lung GI Tract Skin TB-131M 6.58E+05 3.15E+05 2.63E+05 4.75E+05 3.29B+06 0.00E+00 2.53E+07 O.OOE+00 TE-131 7.22E-33 2.98E-33 2.26E-33 5.57E-33 3.16E-32 0.00+00 5.93E-34 0.00E+OO TE-132 4.29E+06 2.726+06 2.56B+06 2.876+06 2.616+07 O.OOE+00 8.61E+07 0.00E+00 1-130 7.41E+05 2.14E606 8.56E+05 1.75E608 3.30E+06 0.00E+OO 1.65E+06 O.OOE+00 1-131 5.28E+08 739E+08 3.97E+08 2.16E+11 1.27E+09 0.00E+OO 1.46E+08 0.OOE+00 1-132 2.96E-01 7.75E-01 2.78E-01 2.61E+01 1.22E+00 O.OOE+00 3.38E-01 0.00E+OO 1-133 7.08E+06 1.20E+07 3.66E+06 1.68E+09 2.11E+07 O.OOE+00 9.09E+06 O.OOE+00 1-134 3.74E-12 9.92E-12 3.56E-12 1.65E-10 1.566-11 0.00E+OO 1.31E-13 O.OOE+00 1-135 2.29E+04 5.90E+04 2.19E+04 3.80E+06 9.33E+04 0.00E+00 6.54E+04 O.OOE+00 CS-134 7.65E+09 1.80E+10 8.36B+09 O.OO+00 5.72E+09 2.19E+09 2.24E+08 O.OOE+00 CS-136 4.27E+08 1.68E+09 1.13B+09 O.OOE+00 9.15E+08 1.44E+08 1.35E+08 0.00E+OO CS-137 1.04E+10 1.38E+10 4.80E+09 O.OOE+00 4.69E+09 1.82E+09 1.96E+08 O.OOE+00 CS-138 1.76E-23 3.38E-23 1.69E-23 0.OOE+00 2.50E-23 2.916-24 1.54E-26 O.OOE+00 BA-139 8.40E-08 5.91E-11 2.45E-09 O.OOE+00 5.576-11 4.07E-11 7.50E-07 O.OOE+00 BA-140 4.64E+07 5.68B+04 2.996+06 O.OOE+00 1.93E+04 3.82E+04 7.15E+07 0.00E+00 BA-141 0.00E+0O 0.00E+00 0.00E+OO 0.00E+0O O.OOE+00 O.OOE+O0 O.OO+00 O.OOE+00 BA-142 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.0OE+00 O.OOE+00 0.00E+00 LA-140 8.118+00 3.98E+00 1.06E+00 O.OOE+00 O.OOE+00 0.00E+OO 2.29E+05 0.00E+00 LA-142 3.43E-11 1.53E-11 3.80E-12 O.OOE+00 O.OOE+00 O.OOE+00 4.64E-07 0.00E+OO CE- 141 7.82E+03 5.22E+03 6.00E+02 O.OOE+00 2.46E+03 O.OO+00 1.49E+07 0.0OE+00 CE-143 7.65E+01 5.56E+04 6.21E+00 O.OO6+00 2.50E+01 0.008+00 1.676+06 0.;OE+00 CB-144 5.20E+05 2.15E+05 2.79E+04 O.OOE+00 1.28E+05 0.00E+00 1.31E+08 0.00E+OO PR-143 2.76E+02 1.10E+02 1.37E+01 O.OOE+00 6.40E+01 0.00+00 9.086+05 0.006+00 PR-144 O.OOE+00 O.OOE++00 0.OE+00 O.OOE+00. 0.00E+00 O.OOE+00 O.OOE+00 0.OOE+00 ND-147 1.75E+02 1.90E+02 1.14E+01 O.OOE+00 1.12E+02 O.OOE+00 6.87E+05 0.008+00 W-187 1.19E+04 9.71E+03 3.408+03 0.00E+00 O.OOE+00 O.OOE+00 2.63E+06 0.00E+00 NP-239 7.01E+00 6.61E-01 3.67E-01 O.OO+00 2.08E+00 O.OOE+00 1.06E+05 O.OOE+00 A-.
RSP-0008 . . REV- 12 PAGE 73 OF 103
ATTACMENT 22 PAGE 1 OF 2 TABLE I-8: DOSE FACTOR TABLE R (1) - CmI LD, COWS MILK TABLE I-8 DOSE FACTOR TABLE: R (i) - Child, cows' milk Units are mt *mrem/yr per uCi/sec Nuclide Bone Liver Tbody Thyroid Kidney Lung GI Tract Skin H-3 0.008+00 9.73E+02 9.73E+02 9.73E+02 9.73E+02 9.73E+02 9.73E+02 0.OOE+0O C-14 1.65E+06 3.29E+05 3.29E+05 3.29E+05 3.29E+05 3.29E+05 3.29E+05 O.OOE+00 NA-24 8.88E+06 8.88E+06 8.88E+06 8.88E+06 8.88E+06 8.88E+06 8.88E+06 O.OOE+00 P-32 7.37E+10 3.45E+09 2.84E+09 0.OOE+00 0.00+00 O.OO+0O 2.04E+09 O.OOE+00 CR-51 O.OOE+00 0.008+00 9.09E+04 5.05E+04 1.38E+04 9.21E+04 4.82E+06 O.00E+00 MN-54 O.OOE+00 1.65E+07 4.40E+06 0.00E+00 4.63E+00 O.OOE+00 1.39E+07 0.OOE+OO MN-56 0.008+00 1.30E-02 2.94E-03 O.OOE+00 1.57E-02 0.OOE+00 1.89E+00 O.OOE+00 FP855 8.708+07 4.61E+07 1.43E+07 0.008+00 O.OOE+00 2.61E+07 8.55E+06 O.OOE+00 FE-59 1.03E+08 1.678+08 8.31E+07 O.OOE+00 0.008+00 4.84E+07 1.74E+08 O.OOE+00 C0-57 O.OOE+OO O.OO+00 0.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 C0-58 0.008+00 1.01E+07 3.08E+07 0.008+00 O.OOE+00 O.OOE+00 5.88E+07 O.OOE+00 C0-60 0.00E+00 3.35E+07 9.88E+07 0.00E+00 0.008+00 O.OOE+00 1.86E+08 O.OOE+00 NI-63 2.29E+10 1.238+09 7.80E+08 0.00E+00 O.OOE+00 O.OOE+O0 8.27E+07 O.OOE+00 NI-65 1.68E+00 1.88E-01 9.24E-02 0.8OE+00 O.OOE+0O O.OOE800 1.94E+01 O.OOE+00 CU-64 O.OOE+00 7.48E+04 4.52E+04 O.OOE+00 1.818+05 O.OOE+00 3.51E+06 0.OOE+00 ZN-65 3.27E+09 8.72E+09 5.43E+09 O.OOE+0O 5.50E+09 O.OOE+00 1.53E+09 O.OOE+00 ZN-69 9.87E-12 1.43E-11 1.32E-12 0.00E+00 8.65E-12 O.OOE+00 8.99E-10 O.OOE+00 ZN-69M 0.008+00 O.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 BR-82 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OO+00 0.00E+00 0.00E+00 O.OOE+00 BR-83 O.OOE+00 0.005+00 4.47E-01 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 0.OOE+00 BR-84 O.OOE+00 0.00E+OO 7.00E-23 O.OOE+00 0.008+00 O.OOE+00 OOOE+00 O.OOE+00 BR-85 O.OO+0O 0.005+00 O.OE+OO 0.008+00 0.00+00 0.00E+00 O.OOE+00 0.008+0O RB-86 O.OOE+00 8.128+09 4.99E+09 O.OOE+00 O.OOE+00 O.OOE+00 5.22E+08 O.OOE+00 RB-88 0.OOE+O O.OOE+00 0.0O0,+0O O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 RB-89 O.OOE+00 O.OOE+00 0.008+00 0.00E+O0 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+0O SR-89 5.63E+09 O.OOE+O 1.61E+08 O.OO+00 0.00E+00 O.OOE+00 2.18E+08 O.OOE+00 SR-90 8.65E+10 O.OOE+00 2.19E+10 O.OOE+00 O.OOE+00 O.OOf+00 1.16E+09 O.OOE+00 SR-91 1.31E+05 O.OOE+00 4.948+03 0.00E+00 O.OOE+00 0.008+00 2.89E+05 0.00E+00 SR-92 2.21E+00 O.OOE+00 8.888-02 O.OOE+00 O.OOE+00 0.00E+00 4.195+01 O.OOE+00 Y-90 3.22E+02 0.00E+00 8.635+00 O.OOE+00 O.OO+00 O.OOE+00 9.18E+05 O.OOE+00 Y-91M 2.80E-19 O.OOE+00 1.02E-20 0.00E+00 O.OOE+00 O.OO+00 5.49E-16 0.00E+00 Y-91 3.28E+04 O.OOE+00 8.78E+02 O.OOE+00 O.OOE+00 0.00E+00 4.37E+06 O.OOE+00 Y-92 2.56E-04 O.OOE+00 7.32E-06. O.OO+00 O.OO+00 0.00E+00 7.39E+00 O.OOE+00 Y-93 1.028+0O O.OOE+00 2.79E-02 O.OOE+O 0.00E+00 O.OOE5+00 1.51E+04 0.08E+00 ZR-95 3.20E+03 7.04E+02 6.27E+02 O.OOE+00 1.01E+03 O.OOE+00 7.35E+05 O.OOE+00 ZR-97 1.925+00 2.788-01 1.64E-01 0.005+00 3.995-01 O.OOE+00 4.21E+04 0.005+00 NB-95 2.78E+05 1.08E+05 7.74E+04 0.00E+00 1.02E+05 O.OOE+00 2.008+08 O.OOf+00 NB-97 O.OOE+00 O.OO+00 O.OOE+00 O.OOE+800 O.OOE++00 0.00+00 .0080 0.00+00 MO-99 0.00+00 8.14E+07 2.01E+07 0.00E+00 1.748+08 O.OOE+0O 6.73E+07 O.OOE+00 TC-99M 1.33E+01 2.61E+01 4.32E+02 O.OOE+00 3.79E+02 1.32E+01 1.488+04 O.OOE+00 TC-IOl O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+0O 0.0OE+00 O.OOE+00 RU-103 3.71E+03 0.00E+00 1.43E+03 .000E++00 9.348+03 O.OOE+00 9.59E+04 0.0OE+00 RU-I05 3.85E-03 0.00E+00 1.40E-03 0.005+00 3.39E-02 O.OOE+00 2.51E+00 O.OOE+00 RU-106 7.26E+04 0.00E+00 9.06E+03 O.OOE+00 9.81E+04 0.00E+00 1.13E+06 O.OOE+00 AG-I 10M 1.65E+08 1.12E+08 8.92E+07 O.OOE+00 2.08E+08 O.OOE+00 1.33E+10 O.OOE+00 SB-124 0:00E+00 O.OOE+00 O.OOE+00 O.OOE800 O.OOE+00 0.0OE+00 O.OOE+00 O.OOE+00 SB-125 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 TE-125M 6.21E+07 1.68E+07 8.28E+06 1.74E+07 O.OOE+00 0.008+00 5.998+07 O.OOE+00 TE-127M 1.69E+08 4.55E+07 2.01E+07 4.04E+07 4.82E+08 O.OOE+00 1.37E+08 O.OOE+00 TE-127 2.99E+03 8.06E+02 6.41E+02, 2.07E+03 8.50E+03 O.OO+00 1.17E+05 O.OOE+00 TE-129M 2.38E+08 6.65E+07 3.70E+07' 7.68E+07 7.00E+08 0.08E+00 2.91E+08 O.OOE+00 TE-129 1.33E-09 3.705-16 3.15.E-10 9.46E-10 3.88E-09 0.008+00 8.25E-08 O.OOE+O RSP-0008 REV -12 PAGE 74 OF 103
ATTACHMENT 22 PAGE 2 OF 2 TABLE 1-8: DOSE FACTOR TABLE R M - CHILD, COWS MILK Nuclide Bone- _ Liver Tbody Thyroid Kidney -Lun GI Tract Skin TE-131M 1.60E+06 5.54E+05 5.89E+05 1.14E+06 5.36E+06 0.00E+00 2.25E+07 0.00E+00 TE-131 1.77E-32 5.40E-33 5.27E-33 1.36E-32 5.36E-32 0.00E+00 9.31E-32 0.00E+00 TB-132 1.02E+07 4.54E+06 5.48E+06 6.61E2+06 4.21E+07 0.00E+00 4.57E+07 0.00E+00 1-130 1.73E+06 3.50E+06 1.80B+06 3.86E+08 5.23E+06 0.00E+00 1.64E+06 0.00E+00 1-131 1.28E+09 1.29E+09 7.32E+08 4.26E+11 2.1 1E+09 0.00E+00 1.15E+08 O.OOE+00 1-132 7.01E-01 1.29E+00 5.92E-01 5.97E+01 1.97E+00 O.OOE+00 1.52E+00 O.OOE+00 I-133 1.72B+07 2.13E+07 8.05E+06 3.95E+09 3.55E+07 0.00E+00 8.57E+06 0.00E+00 I-134 8.87E-12 1.65B-11 7.57E-12 3.79E-10 2.52E-11 0.00B+00 1.092-11 0.00E+00 1-135 5.43E+04 9.77E+04 4.62E+04 8.66E+06 1.50E+05 0.00E+00 7.45E+04 0.00E+00 CS-134 1.77E+10 2.90E+1I-0 6.1 1E+09 0.00E+00 8.98E+09 3.22E+09 1.56E+08 0.00E+00 CS-136 9.65E+08 2.65E+09 1.72E+09 0.00E+00 1.41E+09 2.1 E+08 9.32E+07 0.00E+00 CS-137 2.50E+10 2.39B+10 3.53E+09 0.00E+00 7.78E+09 2.80E+09 1.50E+08 0.00E+00 CS-138 4.27E-23 5.94E-23 3.77E-23 0.00E+00 4.18E-23 4.502-24 2.74E-23 0.00E+00 BA-139 2.06E-07 1.10B-10 5.98E-09 0.00E+00 .9.62E-11 6.48E-1 1 1.19E-05 0.00E+00 BA-140 1.12E+08 9.80E+04 6.53E+06 0.00B+00 3.19E+04 5.84E+04 5.67E+07 0.00E+00 BA-141 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 BA-142 O.O0E+00 0.00E+00 O.OE0.00+00 0.002+00 0.002+00 0.00E+00 0.00E+00 0.00E+00 LA-140 1.94E+01 6.79E+00 2.29E+00 0.002+00 0.002E+00 .00£+00 1.89E+05 0.00E+00 LA-142 8.30E-II 2.64E-11 8.282-12 0.00E+00 0.00E+00 0.00E+00 5.24E-06 0.00E+00 CE-141 1.93E+04 9.61E+03 1.43E+03 0.00E+00 4.21E+03 0.002+O0 1.20E+07 0.00E+00 CE-143 1.88E+02 1.02E+05 1.47E+01 0.00E+00 4.27E+01 0.00E+00 1.49E+06 0.00E+00 CE-144 .28E+06 4.02E+05 6.84E+04 0.002+00 2.22E+05 O.OOE+00 1.05E+08 0.00E+00 PR-143 6.83E+02 2.05E+02 3.39E+01 O.OOE+00 1.11E+02 0.00E+00 7.37E+05 0.00E+00 PR-144 0.002+00 o.OOE+00 0.00E+00 0.002+00 0.002+00 O.OOE+00 0.00E+00 0.00E+00 ND-147 4.29E+02 3.4SE+02 2.69E+01 0.002+00 1.912+02 0.00E+00 5.51E+05 0.00E+00 W-187 2.89E+04 1.71B+04 7.68E+03 0.00E+00 0.00E+00 O.OOE+00 2.40E+06 0.00E+00 NP-239 1.732+01 1.24E+00 8.71E-01 0.00E+00 3.58E+00 0.00E+00 9.17E+04 0.00E+00 WW-4008
-0 0 -
R - -RV-_ 12
.1 PA G 75 OF n5O PG 10 0
ATTACHMENT 23 PAGE 1 OF 2 TABLE 1-9: DOSE FACTOR TABLE: R (1) - INFANT, COWS MILK TABLE 1-9 DOSE FACTOR TABLE: R (i) - Infant, cows' milk Units are mZ*mrem/yr per 1CI/sec Nuclide Bone Liver Tbody Thyroid Kidney Lung GI Tract Sldn H-3 0.00E+00 1.48E+03 1.48E+03 1.48E+03 1.48E+03 1.48E+03 1.48E+03 0.00E+00 C-14 3.23E+06 6.89E+05 6.89E+05 6.89E+05 6.89E+05 6.89E+05 6.89E4+05 0.00E+00 NA-24 1.55E+07 1.55E+07 1.55E+07 1.55E+07 1.55E+07 1.55E+07 1.55E+07 0.00E+00 P-32 1.52E+11 8.93E+09 5.886+09 0.00E+00 0.00E+00 0.00E+00 2.05E+09 0.00E+00 CR-51 0.00E+00 0.00E+00 1.44E+05 9.40E+04 2.05E+04 1.83E+05 4.20E+06 0.00E+00 MN-54 0.00E+00 3.07B+07 6.976+06 0.00E+00 6.81E+06 0.00E+00 1.13E+07 0.006+00 MN-56 O.00E+00 3.19E-02. 5.49E-03 0.00E+00 2.74E-02 0.00E+00 2.90E+00 0.00E+00 FE-55 1.05E+08 6.79E+07 1.82B+07 0.006+00 O.OOE+00 3.32E+07 8.62E+06 0.00E+00 FE-59 1.92E+08 3.36E+08 1.32E+08 0.00E+00 0.006+00 9.94E+07 1.61E+08 0.00E+00 CO-57 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 CO-58 O.O0E+00 2.02E+07 5.03E+07 0.00E+00 0.00E+00 0.00E+00 5.026+07 O.00E+00 CO-60 0.00E+00 6.84E+07 1.62E+08 0.00E+00 0.00E+00 0.00E+00 1.63E+08 0.00B+00 NI-63 2.70E+10 1.67E+09 9.38E+08 0.006+00 0.006+00 0.00E+00 8.31E+07 0.00E+00 NI-65 3.56E+00 4.03B-01 1.83E-01 0.00E+00 0.00E+00 0.00E+00 3.076+01 0.006+00 CU-64 0.006E*O 1.86E+05 8.61E+04 0.00E+00 3.15E+05 0.00E+00 3.82E+06 0.006+00 ZN-65 4.40E+09 1.51t6+10 6.95E+09 0.00E+00 7.31E+09 0.00E+00 1.27E+10 O.OOE+00 ZN-69 2.106-11 3.79E-11 2.82E-12 0.006E+O 1.57B-lI 0.00E+00 3.096-09 0.00E+00 ZN-69M 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 BR-82 0.00E+00 0.00E+00 O.00E+00 0.00E+00 0.00E+00 0.006+00 0.006+00 0.006+00 BR-83 0.00E+00 0.00E+00 9.496-01 0.006+00 O.00E+00 0.006E+O 0.00E+00 0.006+00 BR-84 0.00E+00 0.00E+00 1.35E-22 O.OO+00 O.00E+000 0.00E+00 0.00E+00 0.006+00 BR-85 0.00E+00 0.00E+00 .0.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 RB-86 0.00E+00 2.06E+10 1.02E+10 0.006+00 0.00E+00 O.00E+00 5.27E+08 0.006+00 RB-8 8 0.00E+00 0.00E+00 0.00E+00 O.00E+00 0.00E+00 0.00E+00 0.006+00 O.OOE+00 RB-89 0.00E+00 0.00E+00 0.006+00 0.00E+00 0.006+00 0.00E+00 0.00E+00 O.OOE+00 SR-89 1.07B+10 0.00E+00 3.07E+08 O.OOE+00 O.00E+00 0.006+00 2.20E+08 0.00E+00 SR-90 9.41E+10 0.006+00 2.40E+10 0.00E+00 0.00E+00 0.00E+00 1.18E+09 0.006+00 SR-91 2.73B+05 0.00E+00 9.87E+03 0.00E+00 0.00E+00 0.00E+00 3.23E+05 0.006+00 SR-92 4.71E+00 0.00E+00 1.75E-01 0.00E+00 0.00E+00 0.00E+00 5.08E+01 0.006+00 Y-90 6.82E+02 0.006+00 1.83E+01 0.00E+00 0.00E+00 O.00E+00 9.41E+05 0.00E+00 Y-91M 5.94E-19 0.00E+00 2.03E-20 0.00E+00 0.00E+00 0.006+00- 1.986-15 0.00E+00 Y-91 6.16E+04 0.00E+00 1.64E+03 0.006+00 0.00E+00 O.OOE+00 4.42E+06 0.00E+00 Y-92 5.44E-04 0.00E+00 1.53E-05 0.00E+00 O.00E+00 0.00E+00 1.04E+01 0.00E+00 Y-93 2.16E+00 0.00E+00 5.90E-02 0.00E+00 0.00E+00 O.OOE+00 1.71E+04 0.00E+00 ZR-95 5.69E+03 1.396+03 9.83E+02 0.00E+00 1.496+03 0.00E+00 6.91B+05 0.006+00 ZR-97 4.07E+00 6.99E-01 3.19E-01 0.00E+00 7.04E-01 0.00E+00 4.46E+04 0.00E+00 NB-95 5.19E+05 2.14E+05 1.24E+05 0.006+00 1.53E+05 O.00E+00 1.80E+08 0.00E+00 NB-97 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 MO-99 0.00E+00 2.08E+08 4.06E+07 0.006+00 3.11E+08 O.OOE+00 6.85E+07 O.OOE+00 TC-99M 2.77E+01 5.706+01 7.35E+02 O.O0E+00 6.14E+02 2.9SE+01 1.66E+04 0.00E+00 TC-IOI 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 RU-103 7.51E+03 O.OOE+00 2.516+03 0.00E+00 1.56E+04 0.00E+00 9.14E+04 0.006+00 RU-105 8.12E-03 0.00E+00 2.74E-03 0.00E+O0 5.97E-02 0.00E+00 3.23E+00 0.00E+00 RU-106 1.50E+05 0.00E+00 1.87E+04 0.006+00 1.77E+05 0.00E+00 1.14E+06 0.00E+00 AG-1OM 3.05E+08 2.23E+08 1.48E+08 0.006+00 3.196+08 0.00E+00 1.16E+10 0.00E+00 SB-124 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 SB-125 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 0.0OE+00 0.006+00 0.00E+00 TE-125M 1.27E+08 4.24E+07 1.72B+07 4.27E+07 0.00E+00 0.00E+00 6.05E+07 0.00E+00 TE-127M 3.42E+08 1.14E+08 4.14E+07 9.896+07 8.43E+08 0.00E+00 1.386+08 0.00E+00 TE-127 6.34E+03 2.13E+03 1.36E+03, 5.16B+03 1.55E+04 0.00E+00 1.33E+05 0.00E+00 TE-129M 4.89E+08 1.686+08 7.54E+07' 1.88E+08 1.226+09 0.00+O00 2.92E+08 O.OOE+00 TE-129 2.81E-09 9.69E-10' 6.56E-10, 2.36E-09 7.00E-09 0.00E+00 2.25E-07 O.OOE+00 RSP-0008 REV -12 PAGE 76 OF 103
ATTACHMENT 23 PAGE 2 OF 2 TABLE 1-9: DOSE FACTOR TABLE: R U - FMANT, COWS MILK Nuclide Bone Liver Tbody Thyroid Kidney LURE GI Tract Skin TE-131M 3.38E+06 1.36E+06 1.12E+06 2.76E+06 9.31E+06 O.OOE+00 2.29E+07 O.OOE+00 TE-131 3.76E-32 1.39E-32 1.05E-32 3.35E-32 9.61E-32 0.OOE+00 1.52E-30 0.00E+00 TE-132 2.11 E+07 1.05E+07 9.756+06 1.54E+07 6.53E+07 O.OOE+00 3.87E+07 O.OOE+00 1-130 3.56E+06 7.83E+06 3.14E+06 8.78B+08 8.60B+06 O.OO+00 1.68E+06 O.OOE+00 1-131 2.67E+09 3.1SE+09 1.38E+09 1.03E+12 3.68E+09 O.OOE+00 1.12E+08 0.OOE+00 1-132 1.45E+00 2.95E+00 1.05E+00 1.38E+02 3.29E+00 O.OOE+OO 2.39E+00 0.00+OO 1-133 3.63B+07 5.29E+07. 1.55E+07 9.62E+09 6.226+07 0.006+00 8.95E+06 O.OOE+00 1-134 1.84E-11 3.77E-II 1.34B-11 8.78E-10 4.21E-I I O.OOE+00 3.89E-I i O.OOE+00 1-135 1.13E+05 2.25E+05 8.19E+04 2.01E+07 2.50E+05 O.OOE+00 8.13E+04 O.OOE+00 CS-134 2.84E+10 5.30E+10 5.36E+09 O.OOE+00 1.37E+10 5.60E+09 1.44E+08 O.OOE+00 CS-136 1.88E+09 5.54E+09 2.07E+09 O:OOE+00 2.21E+09 4.51E+08 8.41E+07 O.oOE+00 CS-137 3.986+10 4.66E+10 3.30E+09 O.OOE+00 1.25E+10 5.07E+09 1.46E+08 0.00+00 CS-138 9.01E-23 1.47E-22 7.10E-23 O.OOE+00 7.31E-23 1.14E-23 2.34E-22 O.OOE+00 BA-139 4.39E-07 2.916-10 1.27E-08 O.OOE+00 1.75E-10 1.77E-10 2.78E-05 O.OO+OO BA-140 2.30E+08 2.30E+05 1.19E+07 O.OOE+00 5.47E+04 1.41E+05 5.66E+07 O.OOE+00 BA-141 O.OOE+00 0.OOE+00 O.OOB+OO O.OOE+00 O.OOE+00 O.OOE+00 0.00+00 O.OOE+00 BA-142 O.OO+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 LA-140 . 4.06E+01 1.60E+01 4.1 1E+00 O.OOE+00 O.OOE+00 O.OOE+00 1.88E+05 O.OOE+00 LA-142 1.74B-10 6.40& I I 1.53E-11 O.OOE+00 O.OOE+00 O.OOE+00 1.09E-05 O.OOE+00 CE-141 3.82E+04 2.33E+04 2.746+03 O.OOE+00 7.18E+03 0.00E+00 1.20E+07 O.OOE+00 CE-143 3.97E+02 2.64E+05 3.01E+01 O.OOE+O0 7.68E+01 O.OOE+00 1.54E+06 O.OOE+00 CE-144 1.84E+06 7.52B+05 1.03E+05 O.OOE+00 3.04E+05 0.OOE+00 1.05E+08 O.OOE+00 PR-143 1.41B+03 2.28E+02 7.00E+01 O.OOE+00 1.96E+02 O.OOE+00 7.45E+05 0.00+00 PR-144 O.OOE+00 0.006+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 ND-147 8.51E+02 8.74E+02 5.36E+01 O.OOE+00 3.37E+02 O.OOE+00 5.54E+05 O.OOE+00 W-1 87 6.08E+04 4.2363+04 1.46E+04 O.OOE+00 O.OOE+00 O.OOE+00 2.49E+06 O.OOE+00 NP-239 3.65E+01 3.26E+00 1.S4E+00 O.OOE+00 6.51E+00 O.0OE+00 9.43E+04 0.OOE+OO RSP-0008 REV -12 PAGE 77 OF 103
ATTACHMENT 24 PAGE I OF 2 TABLE 1-10: DOSE FACTOR TABLE: R (I) - ADULT, GOATS MILK TABLE1I-10 DOSE FACTOR TABLE: R (i) - Adult goats' milk Units are mn*mrem/yr per xCi/sec Nuclide Bone Liver Thody Thyroid Kidney Lung GI Tract Skin H-3 O.OOE+00 9.65E+02 9.65E+02 9.65E+02 9.65E+02 9.65E+02 9.65E+02 O.OOE+00 C-14 3.63B+05 7.268+04 7.26E+04 7.26E+04 7.26E+04 7.26E+04 7.268+04 0.00+00 NA-24 2.93E+05 2.93E+05 2.93E+05 2.93E+05 2.93E+05 2.938+05 2.93E+05 O.OOE+00 P-32 1.94E+10 1.21E8-09 7.518+08 0.008+00 O.OOE+00 O.OOE+00 2.18E+09 O.OOE+00 CR-51 O.OO800 0.008E+00 3.06E+03 1.83E+03 6.75E+02 4.06E+03 7.70E+05 O.OO+00 MN-54 O.OOE+00 7.96E+05 1.52E+05 0.008+00 2.37E+05 0.00E+00 2.44E+06 O.OOE+00 MN-56 0.008+00 5.05E-04 g.96E-05 0.00E+00 6.41E-04 O.OOE+00 1.61E-02 0.00+00 FE-55 .2.54E+05 1.76E+05 4.09E+04 0.008+00 0.OOE+00 9.79E+04 1.01+05 O.OOE+00 FE-59 3.31E+05 7.79E+05 2.98E+05 0.0E++00 0.008+00 2.18E+05 2.60E+06 0.008+00 CO-57 0.00E+OO 0.00E+OO O.OOE+800 0.008+00 0.00+00 0.008+00 O.OOE+00 O.OOE+00 CO-58 0.00E+OO 4.70E+05 1.05E+06 0.00+00 O.OOE+800 0.008+00 9.538+06 0.00E+OO CO-60 0.001+00 1.53E+06 3.37E+06 0.00E+0O 08OE+00 0.0011+00 2.87E+07 O.OOE+OO NI-63 6.25E+08 4.33E+07 2.10B+07 O.OOE+00 0.008+00 0.00E+00 9.03E+06 O.OOE+00 NI-65 4.51E-02 5.86E-03 2.67E-03 0.00E+00 0.00E+0O 0.00+00 1.498-01 O.OOE+00 CU-64 O.OOE+00 2.66E+03 1.25E+03 O.OOE+00 6.7 1E+03 0.008+00 2.27E+05 0.008+00 ZN-65 1.30E+08 4.15E+08 I.88E+08 O.OOE+00 2.788+08 0.00E+OO 2.61E+08 0.008+00 ZN-69 2.62E-13 5.00E-13 3.48E-14 O.OOE+00 3.25E 13 O.OOE+00 7.52E-14 O.OOE+00 ZN-69M 0.00E+00 0.008+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.008+OO 0.00E+00 BR-82 0.00E+00 O.OOE+00 O.OOE+00 0.008+00 0.008+00 O.OOE+00 O.OOE+00 O.OOE+00 BR-83 O.OOE+00 0.00Q+0O 1.18E-02 O.OOE+00 0.0OE+00 O.OOE+00 1.718-02 O.OOE+00 BR-84 0.001+00 O.OOE+O 2.08E-24 O.OOE+00 0.008+00 0.0011+00 1.63E-29 0.008+00 BR-85 O.OOE800 0.008+00 0.00+00 0.008E+O0 O.OOE+00 0.00E+00 0.008+00 0.00E+00 RB-86 0.008+00 2.88E+08 1.34E+08 0.008+00 0.OOE+00 O:OOE800 5.68E+07 O.OOE+00 RB-88 0.008+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+OO 0.00E+00 O.OOE+00 0.008+00 RB-89 0.008+00 0.008+00 0.008+OO 0.008+00 O.OOE+00 0.008+00 0.00E+OO 0.008+00 SR-89 2.59E+09 0.00E+O0 7.43E+07 0.00E+00 O.OOE+00 0.00E+00 4.15E+08 0.00E+00 SR-90 7.61E+10 0.00E+OO 1.87E+10 O.OOE+00 0.008+00 0.00E+OO 2.208+09 O.OOE+00 SR-91 6.10E+04 O.OOE+00 2.46E+03 O.OOE+00 O.OOE+00 0.00E+00 2,90E+05 0.00E+00 SR-92 1.04E+00 0.008+00 4.508-02 O.OOE+00 0.008+00 0.008+00 2.06E+01 O.OOE+00 Y-90 8.508+00 0.00E+OO 2.28E-01 0.008+00 O.OOE+00 0.008+00 9.02E+04 0.0011+00 Y-91M 7.52E-21 0.00E+OO 2.91E-22 0.OOE+00 O.OOE+00 0.00E+00 2.21E-20 O.OE+00 Y-91 8.678+02 0.008+00 2.32E+01 O.OOE+00 O.OOE+00 0.00E+OO 4.77E+05 0.008+00 Y-92 6.77E-06 0.001+00 1.98E-07 0.001+00 O.OOE+00 0.00E+00 1.19E-01 0.0OE+00 Y-93 2.69E-02 O.OO+00 7.43E-04 O.OOE+00 O.OOE+00 0.00E+00 8.53E+02 O.OOE+00 ZR-95 9.47E+01 3.04E+01 2.06E+01 0.008+00 4.76E+01 0.00E+00 9.628+04 0.00E+OO ZR-97 5.21E-02 1.05E-02 4.818-03 0.00E+OO 1.59E-02: O.OOE+00 3.268+03 0.8OE+00 NB-95 8.678+03 4.82E+03 2.59E+03 0.008+00 4.77E+03 O.OOE+00 .2.93E+07 0.00+00 NB-97 0.008+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 MO-99 O.OOE+00 2.97E+06 5.66E+05 0.00+00 6.738+06 0.00E+OO 6.89E+06 O.OOE+00 TC-99M 4.01E-01 1.13E+00 1.44E+01 O.OOE+00 1.72E+01 5.55E-01 6.71E+02 O.OOE+00 TC-IOI O.OOE+00 0.008+00 O.OOE+00 0.60E+00 O.OOE+00 0.00E+00 0.008+00 O.OOE+00 RU-103 1.068+02 0.00E+OO 4.568+01 0.008+00 4.04E+02 O.OOE+00 1.248+04 0.0OB+00 RU-105 1.04E-04 O.OOE+00 4.09E-05 0.00E+OO 1.34E-03 O.OOE+00 6.34E-02 0.008+00 RU-106 1.92E+03 0.008+00 2.43B+02 0.008+00 3.718+03 0.008+00 1.258+05 O.OO+00 AG-I10M 5.53E+06 5.128+06 3.04E+06 O.OOE+00 1.01E+07 O.OOE+00 2.09E+09 O.OOE+00 SB-124 O.OE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 0.001+00 0.008+00 0.00E+OO SB-125 O.OOE+00 O.OE+00 O.OOE+00 O.OOE+00 0.00E+0O 0.0011+00 O.OE+00 0.0E+00 TE-125M 1.65E+06 5.96E+05 2.20E+05 4.95E+05 6.69E+06 0.008+00 6.57E4+06 O.OOE+00 TE-127M 4.47E+06 1.608+06 5.448+05 1.14B+06 1.81E+07 O.OOE100 1.50E+07 O.OO+00 TE-127 7.87E+01 2.82E+01 1.70E+01. 5.83E+01 3.20E+02 0.008+00 6.21E+03 O.OOE+O0 TE-129M 6.34E+06 2.378+06 1.008+06 2.188+06 2.6511+07 0.00E+00 3.198+07 0.00E+00
- TE-129 3.50-1I 1.328-11 8.53B-12; 2.698-11 .1.478-10 O.OOE+00 2.64E-II 0.00E+0O RSP-0008 REV -12 PAGE 78 OF 103
ATTACHMENT 24 PAGE 2 OF 2 TABLE 1-10: DOSE FACTOR TABLE: R (I - ADULT, GOATS MILK Nuclide Bone Liver Tbody Thyroid Kidney . Lune GI Tract Skin TB-131M 4.34E+04 2.12E+04 1.77E+04 3.36E+04 2.15E+05 O.OOE+00 2.11E+06 O.OOE+00 TE-131 4.74E-34 1.98E-34 1.50E-34 3.90E-34 2.08E-33 O.OOE+00 6.72E-35 0.00E+00 TE-132 2.88E+05 1.86E+05 1.75E+05 2.06E+05 1.80E+06 O.OOE+00 8.82E+06 O.OOE+00 I-130 5.06E+05 1.49E+06 5.89E+05 1.26E+08 2.33E+06 0.00E+00 1.28E+06 0.00+00 1-131 3.49E+08 4.99E+08 2.86E+08 1.64E+11 8.S6E+08 O.OOE+00 1.32E+08 O.OOE+00 1-132 2.00E-01 5.36E-01 1.88E-01 1.88E+01 8.54E-01 O.OOE+00 1.01E-01 0.00+00 1-133 4.65E+06 8.09E+06 2.47E+06 1.19E+09 1.41E+07 O.OOE+00 7.27E+06 O.OOE+OO I-134 2.53E-12 6.87E-12 2.46E-12 1.19-10 1.09E-l I O.OOE+00 5.99E-15 O.OOE+00 1-135 1.556+04 4.06B+04 1.50E+04 2.68E+06 6.51E+04 O.OOE+00 4.58E+04 O.OOE+00 C5-134 1.32E+10 3.15E+10 2.57E+10 O.OOE+00 L02E+10 3.38E+09 5.51 E+08 O.OOE+00 CS-136 7.53E+08 2.97E+09 2.14E+09 0.00E+00 1.65E+09 2.27E+08 3.38E+08 O.OOE+00 CS-137 1.71E+10 2.34E+10 1.54E+10 O.OOE+00 7.96E+09 2.65E+09 4.54E+08 O.OOE+00 CS-138 2.91 E-23 5.76E-23 2.85E-23 O.OOE+00 4.23B-23 4.18E-24 2.46E-28 0.0OE+00 BA-139 5.45E-09 3.88E-12 1.60E-10 O.OOE+00 3.63E-12 2.20E-12 9.67E-09 O.OOE+00 BA-140 3.08E+06 3.87E+03 2.02E+05 O.OOE+00 i.32E+03 2.22E+03 6.35E+06 O.OOE+00 BA-141 0.00E+00 O.OOE+00 O.OO+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 BA-142 O.OOE+00 O.OOE+00 0.006+00 O.OOE+00 0.00E+00 O.OOE+00 0.00+00 O.OOE+00 LA-140 5.42E-01 2.73E-01 7.22E-02 O.OOE+00 0.00E+00 O.OOE+00 2.00E+04 O.OOE+OO LA-142 2.28E-12 1.04E-12 2.59E-13 O.OOE+00 0.006+00 O.OOE+00 7.58E-09 O.OOE+00 CE-141 5.12E+02 3.46E+02 3.93E+01 O.OOE+00 1.61E+02 O.OOE+00 1.32E+06 O.OOE+00 CE-143 4.99E+00 3.69E+03 4.09E-01 0.006+00 1.63E+00 O.OOB+00 1.38E+05 0.00E+00 CE-144 3.396+04 1.426+04 1.82E+03 O.OOE+00 8.40E+03 O.OOE+00 I. 15E+07 O.OOE+00 PR-143 1.80E+01 7.23E+00 8.93E-01 O.OOE+00 4.17E+00 O.OOE+00 7.89E+04 O.OOE+00 PR-144 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 ND-147 I.09E+01 1.26E+01 7.55E-01 O.OOE+00 7.37E+00 O.OOE+00 6.06E+04 0.00E+00 W-187 7.826+02 6.54E+02 2.29E+02 O.OOE+00 O.OOE+00 O.OOE+00 2.14E+05 O.OOE+00 NP-239 4.41E-01 4.34E-02 2.39E-02 O.OOE+00 1.35E-01 O.OOE+00 8.89E+03 O.OOE+00 RSP-0008 RSP-0008 REV-12 REV - 12 PAGE79OF1O3 PAGE 79 OF 103
ATTACHMENT 25 PAGE 1 OF 2 TABLE I-ll: DOSE FACTOR TABLE: R (I) - TEEN, GOATS MILK TABLE 1-11 DOSE FACIOR TABLE: R (i) - Teen, goats' milk Units are m2*mrem/yr per LCi/sec Nuclide Bone Liver Thody Thyroid Kidney Lung GI Tract Skin H-3 O.OOE+OO 1.26E+03 1.26E+03 1.26E+03 1.26E+03 1.26E+03 1.26E+03 O.OOE+00 C-14 6.70E+05 1.34E+OS 1.34E+05 1.34E+05 1.34B+05 1.34E+05 1.34E+05 O.OOE+OO NA-24 5.12E+05 5.12E+05 5.12E+05 5.12E+05 5.12E+05 5. 12E+05 5. 12E+05 O.OOE+OO P-32 3.58E+10 2.22E+09 1.39E+09 O.OOE+OO O.OOE+OO O.OOE+OO 3.0 I E+09 O.OOE+OO CR-SI O.OOE+OO O.OOE+OO 535E+03 2.97E+03 1.17E+03 7.64E+03 8.99E+05 O.OOE+OO MN-54 O.OOE+OO 1.33E+06 2.63E+05 O.OOE+OO 3.95E+05 O.OOE+OO 2.72E+06 O.OOE+OO MN-56 O.OOE+OO 8.95E-04 I.59E-04 O.OOE+OO 1.13E-03 O.OOE+OO 5.89E-02 O.OOE+OO FE-55 4.5IE+05 3.19E+05 7.45E+04 O.OOE+OO O.OOE+OO 2.03E+05 1.38E+05 O.OOE+OO FE-59 5.78E+05 1.35E+06 5.21E+05 O.OOB+OO O.OOE+OO -4.25E+05 3.19E+06 O.OOB+OO CO-57 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOB+OO O.OOE+00 O.OOE+OO CO-58 O.OOE+OO 7.92E+05 1.82E+06 O.OOE+OO O.OOE+OO O.OOE+OO 1.09E+07 O.OOE+OO CO-60 O.OOE+OO 2.59E+06 5.83E+06 O.OOE+OO O.OOE+OO O.OOE+OO 3.37E+07 O.OOE+OO NI-63 1.IOE+09 7.75E+07 3.72E+07 O.OOE+OO O.OOE+OO O.OOE+OO 1.23E+07 O.OOE+00 NI-65 8.25E-02 .I.05E-02 4.80E-03 O.OOE+OO O.OOE+OO O.OOE+OO 5.72E-OI O.OOE+OO CU-64 O.OOE+OQ 4.74E+03 2.23E+03 O.OOE+OO 1.20E+04 O.OOE+OO 3.68E+05 O.OOE+OO ZN-65 2.OOE+08 6.95E+08 3.24E+08 O.OOE+OO 4.45E+08 O.OOE+OO 2.94E+08 O.OOE+OO ZN-69 4.82E- 13 9,18E-13 6.42E-14 O.OOE+OO 6.OOE-13 O.OOE+OO 1.69E-12 O.OOE+00 ZN-69M O.OOB+OO O.OOE+OO O.QOE+OO O.OOE+OO O.0E+4OO O.OOE+OO O.OOE+OO O.OOE+OO BR-82 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO BR-83 O.OOE+OO O.OOE+OO 2.18E-02 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO BR-84 O.OOE+OO O.OOE+OO 3.71E-24 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO BR-85 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO R13-86 O.OOE+OO 5.25E+08 2.47B+08 O.OOE+OQ O.OOE+OO O.OOE+OO 7.77E+07 O.OOE+O0 RB-88 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO RBE89 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO SR-89 4.77E+09 O.OOE+OO 1.37E+08 O.OOE+OO O.OOE+OO O.OOE+OO 5.69E+08 O.OOE+OO SR-90 1.07E+lI O.OOE+OO 2.65E+10 O.OOE+OO O.OOE+OO O.OOE+OO 3.02E+09 O.OOE+OO SR-91 1.12E+05 O.OOE+OO 4.46E+03 O.OOE+OO O.OOE+OO O.OOE+OO 5.08E+05 O.OOE+OO SR-92 1.90E+OO O.OOE+OO 8.11 E-02 OOOE+OO O.OOE+OO O.OOE+OO 4.85E+ol O.OOE+OO Y-90 1.56E+O1 O.OOE+OO 4.21E-01 O.OOE+OO O.OOE+OO O.OOE+OO 1.29E+05 O.OOE+OO Y-91M 1.38E-20 O.OOE+OO 5.26E-22 O.OOE+OO O.OOE+OO O.OOE+OO 6.50E-19 O.OOB+OO Y-91 1.59E+03 O.OOE+OO 4.28E+O1 O.OOE+OO O.OOE+OO O,OOE+OO 6.54E-+05 O.OOE+OO Y-92 1.25E-05 O.OOE+OO 3.62E-07 O.OOE+OO O.OOE+OO O.OOE+OO 3.43E-O1 O.OOE+OO Y-93 4.96E-02 O.OOE+OO 1.36E-03 O.OOE+OO O.OOE+OO O.OOE+OO 1.52E+03 O.OOE+OO ZR-95 1.66E+02 5.22E+01 3.59E+O1 O.OQE+OO 7.67E+O1 O.OOE+OO 1.21E+05 O.OOE+OO ZR-97 9.48E-02 1.88E-02 8.64E-03 O.OOE+OO 2.84B-02 O.OOE+OO 5.08E+03 O.OOE+OO NB-95 1 .48E+04 8.20E+03 4.51E+03 O.OOE+OO 7.95E+03 O.OOE+OO 3.51E+07 0.00E+00 NB-97 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO MO-99 O.OOE+OO 5.37E+06 1.02E+06 O.OOE+OO 1.23E+07 O.OOE+OO 9.61E+06 O.OOE+00 TC-99M 6.96E-O1 1.94E+00 2.51E+O1 O.OOE+OO 2.89E+O1 1.08E+OO 1.27E+03 O.OOE+OO TC-1O1 O.OOE+WO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO RU- 103 1.88E+02 O.OOE+OO 8.05E+O1 O.OOE+OO 6.64E+02 O.OOE+OO 1.57E+04 O.OOE+OO RU-105 1.89E-04 O.OOB+OO 7.35E-05 O.OOE-OO 2.39E-03 O.OOE+OO 1.53E-O1 O.OOE+OO RU-106 3.54E+03 O.OOE+OO 4.46B+02 O.QOE+OO 6.82E+03 O.OOE+OO 1.70B+05 O.OOE+OO AG-IlOM 9.14E+06 8.65E+06 5.26BtO6 O.OOE+OO 1.65E+07 O.OOE+OO 2.43E+09 O.OOE+OO SB-124, O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O;OOE+00 O.OOE+00 O.OOE+OO SB- 125 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+00 O.OOE+OO TE-125M 3.03E+06 1.09E+06 4.06E+05 8.48E+05 O.OOE+OO O.OOE+OO 8.95E+06 O.OOE+OO TE-127M 8.23E+06 2.92E+06 9.79E+05 1.96E+06 3.34E+07 O.OOE+OO 2.05E+07 O.OOE+OO TE-127 1.46E+02 5.17B+O1 3.14E+OI I.O1E+02 5.91E+02 O.OOE+OO 1.13E+04 O.OOE+OO TE-129M 1.16E+07 4.31E+06 1.84E+06 3.74E+06 4.85E+07 O.OOE+00 4.36E+07 O.OOE+OO TE--129 6.45E1l1 2.40E-Il 1.57E-11 4.61B-II 2.71 B-10 O.OOE+00 3.53E-10 O.OOE+OO RSP-0008 REV - 12 PAGE 80 OF 103
ATTACHMENT 25 PAGE 2 OF 2 TABLE I-1i1: DOSE FACTOR TABLE: R () - TEEN, GOATS MILK Nuclide Bone Liver Tbody Thyroid Kidney Lune GI Tract Sidn TE-131M 7.89B+04 3.79E+04 3.16E+04 5.69E+04 3.95B+05 O.OOE+00 3.04E+06 O.OOE+00 TE-131 8.67E-34 3.57E-34 2.71E-34 6.68E-34 3.79E-33 O.OOE+OO 7.11E-35 0.00+00 TE-132 5.15E+05 3.26E+05 3.07E+05 3.44E+05 3.13E+-06 0.OOE+OO 1.03E+07 O.OOE+00 1-130 8.89E+05 2.57E+06 1.03E+06 2.10E+08 3.96E+06 O.OOE+00 1.98E+06 O.OOE+OO 1-131 6.33E+08 8.87E+08 4.76E+08 2.59E+11 1.53E+09 0.OOE+00 1.75E+08 O.OOE+00 1-132 3.55E-01 9.30E-01 3.34E-01 3.13E+01 1.47E+00 0.00+00 4.0SE-01 O.OOE+00 I-133 8.50E+06 1.44E+07 4.40E+06 2.01E+09 2.53E+07 O.OOE+00 1.09E+07 0.00E+OO 1-134 4.49E-12 1.19E-li 4.28E-12 1.98E-10 1.88E-l1 0.008+00 1.57E-13 O.0OE+00 I-135 2.75E+04 7.09E+04 2.63E+04 4.56E+06 1.12E+05 O.OOE+00 7.85E+04 O.OOE+00 CS-134 2.30E+10 5.408+10 2.51E+10 O.OOE+00 1.72E+10 6.56E+09 6.72E+08 O.OOE+00 CS-136 1.28E+09 5.04E+09 3.39E+09 O.OOE+00 2.75E+09 4.33E+08 4.06E+08 O.OOE+00 CS-137 3.11E+10 4.13E+10 1.44E+10 0.00E+00 1.41E+10 5.47E+09 5.88E+08 0.00E+00 CS-138 5.298-23 1.02E-22 5.08E-23 0.00+00 7.49E-23 8.72E-24 4.61E-26 O.OOE+00 BA-139 1.01E-08 7.09E-12 2.94E-10 0.008+00 6.698-12 4.89E-12 8.998-08 O.OOE+00 BA-140 5.56E+06 6.82E+03 3.58E+05 O.OOE+00 2.31E+03 4.58E+03 8.58E+06 0.008+OO BA-141 0.00E+00 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00B+0O O.OOE+00 O.OE+00 BA-142 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+OO 0.008+00 LA-140 9.73E-01 4.78E-01 1.27E-01 O.OOE+00 0.00E+OO O.OOE+00 2.75E+04 O.008+00 LA-142 4.128-12 1.83E-12 4.56E-13 O.OOE+00 O.OOE+00 0.OE+00 5.57E-08 O.OOE+00 CE-141 9.39E+02 6.27E+02 7.20E+01 O.OOE+00 2.958+02 0.00E+00 1.79E+06 O.OOE+00 CE-143 9.18E+00 6.68E+03 7.46E-01 0.008+00 2.99E+00 O.OOE+00 2.01E+05 O.OOE+00 CE-144 6.24E+04 2.58E+04 3.35E+03 O.OOE+00 i.54E+04 0.00E+00 1.57E+07 O.OOE+00 PR-143 3.31E+01 1.32E+01 1.65E+00 O.OOE+00 7.68B+00 0.OOE+OO 1.09E+05 O.OOE+00 -
PR-144 O.OOE+00 O.OOE+00 O.OOE+00 0.008+00 0.00E+O 0.00E+00 O.OOE+00 0-008+00 ND-147 2.10E+01 2.28E+01 1.37E+00 0.00E+0O 1.34E+01 O.OOE+00 8.24E+04 O.OO+00 W-187 1.43E+03 1.17E+03 4.08E+02 O.OOE+00 . O.OOE+00 O.OOE+00 3.15E+05 0.00E+OO NP-239 8.42E-01 7.94E-02 4.41E-02 O.OOE+00 2.498-O1 0.008+00 1.28B+04 O.OOE+00 RSP-0008 ____-REV - 12 PkGE. 81 OF 103 RSP-0008 _ REV-fl PAGE81OF1O3
ATTACHMENT 26 PAGE] 1OF2 TABLE 1-12: DOSE FACTOR TABLE: R (1) - CHILD, GOATS MILK TABLE 1-12 DOSE FACTOR TABLE: R (i) - Child, goats' milk Units are mZ*mrem/yr per MCi/sec Nuclide Bone Liver Thody Thyroid Kidney Lung GI Tract Skin H-3 0.OOE+00 1.99E+03 1.99E+03 1.99E+03 1.99E+03 1.99E+03 1.99E+03 O.OOE+00 C-14 1.65E+06 3.29E+05 3.29E+05 3.29E+05 3.29E+05 3.29E+05 3.29E+05 O.OOE+00 NA-24 1.07E+06 1.07E+06 1.07E+06 1.07E+06 1.07E+06 1.07E+06 1.07E+06 0.00E+00 P-32 8.84E+10 4.14E+09 3.412E+09 O.OOE+00 O.OOE+00 O.OOE+00 2.44E+09 O.OOE+00 CR-51 O.OOE+00 O.OOE+OO 1.09E+04 6.05E+03 1.65E+03 1.11 E+04 5.79E+05 O.OOE+00 MN-54 0.OOE+00 1.98E+06 5.28E+05 O.OOE+00 5.56E+05 0.00E+O0 1.66E+06 0.00E+00 MN-56 O.OOE+00 1 .56E-03 3.53E-04 O.OOE+00 1.89E-03 O.OOE+00 2.26E-01 O.OOE+00 FE-55 1.13E+06 6.OOE+05 1.86E+05 O.OOE+OO 0.00+00 3.39E+05 1.11 E+05 O.OOE+00 FE-59 1.34E+06 2.17E+06 1.08E+06 . O.OOE+00 O.OOE+00 6.29E+05 2.26E206 0.00+00 CO-57 O.OOE+00 0.OOE+00 0.00E+00 O.OOE+00 0.00+00 O.OOE+00 O.OOE+00 O.OOE+00 CO-58 0.OOE+00 1.21E+06 3.70E+06 0.00E+00 0.00E+00 O.OOE+00 7.05E+06 O.OOE+00 CO-60 O.OOE+OO 4.02E+06 1.19E+07 O.OOE+00 0.OOE+00 O.OOE+0O 2.23E+07 O.OOE+00 NI-63 2.75E+09 1.47E+08 9.36E+07 O.OOE+00 0.00E+00 0.00E+00 9.92E+06 0.00E+00 NI-65 2.02E-01 1.90E-02 1.11 E-02 O.OOE+00 0.00E+00 O.OOE+00 2.33E+00 0.00E+00 CU-64 O.OOE+O0 8.34E+03 5.04E+03 O.OOE+00 2.02E+04 O.OOE+00 3.91E+05 O.OOE+00 ZN-65 3.93E+08 1.05E+09 6.51E+08 O.OOE+00 6.60E+08 O.OOE+00 1.84E+08 O.OOE+00 ZN-69 I.ISE-12 1.71B-12 1.58E-13 0.OOE+00 1.042-12 O.0OE+00 1.08E-10 O.OOE+00 ZN-69M O.OOB+00 0.00E+00 O.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+O0 BR-82 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00+00 0.00E+00 0.OOE+00 0.00+00 BR-83 O.OOE+O0 O.OOE+00 5.36E-02 O.OOE+00 0.00E+00 O.OOE+00 0.0OE+00 O.OOE+00 BR-84 O.OOE+0O O.OOE+00 8.40E-24 O.OOE+00 0.00E+00 0.00E+00 0.OOE+00 O.OOE+00 BR-85 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+O0 0.00E+00 RB-86 0.OOE+00 9.74E+08 5.99E+08 O.OOE+00 0.00+00 0.00E+00 6.27E+07 O.OOE+00 RB-88 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OO+00 O.OOE+00 RB3-89 0.00+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.OOB+00 O.OO+00 O.OOE+00 SR-89 1.18E+10 0.00E+00 3.37B+08 O.OOE+00 O.00E+00 0.00+00 4.57E+08 O.OOE+00 SR-90 1.82E+1I 0.00E+00 4.60E+10 O.OOE+00 0.OOE+00 O.OOE+00 2.45E+09 O.OOE+00 SR-91 2.75E+05 O.OOE+00 1.04E+04 O.OOE+00 0.002+00 O.OOE+00 6.07E+05 0.002+00 SR-92 4.65E+00 O.OQE+00 1.86E-01 O.OO+00 O.OOE+00 O.OOE+00 8.81E+01 O.OOE+00 Y-90 3.87E+01 O.QOE+OO 1.042+00 O.OOE+00 0.00E+00 O.OO+00 1.I OE+05 0.002+00 Y-91M 3.36E-20 O.OQE+00 1.22E-21 0.00+00 0.00E+00 0.002+00 6.56E-17 O.OOE+00 Y-91 3.94E+03 O.OOB+00 l.05E+02 0.00E+00 0.00+00 0.00E+00 5.25E+05 O.OOE+00 Y-92 3.07E-05 O.OOB+00 8.78E-07 0.004E00 O.OOE+00 O.OOE+00 8.87E-01 O.OOE+00 Y-93 1.22B-01 O.OOE+00 3.35E-03 O.OOE+00 O.OOE+00 O.OOE+00 1.82E+03 O.OOE+00 ZR-95 3.85E+02 8.45E+01 7.53E+01 0.00+00 1.21E+02 O.OOE+0O 8;82E+04 O.OOE+00 ZR-97 2.3 IE-OI 3.33E-02 1.97E-02 O.OOE+00 4.79E-02 O.OOE+OO 5.05E+03 O.OOE+00 NB-95 3.34E+04 1.30E+04 9.29E+03 O.OOE+00 1.22E+04 O.OOE+00 2.40E+07 O.OOE+00 NB-97 0.00+00 O.OOE+00 O.O0E+00 O.O0E+00 0.00E+00 0.00+00 0.00+00 0.00E+00 MO-99 O.OOE+00 9.77E+06 2.42E+06 0.00+00 2.09E+07 O.OO+00 8.08E+06 O.OOE+00 TC-99M 1.60E+00 3.13E+00 5.19E+01 0.OOE+00 4.55E+01 1.59E+00 }.78E+03 0.00E+00 TC-101 0.00E+00 O.OOE+00 O.OOE+00 O.OE+00 0.00E+00 0.OOE+00 0.00+00 O.OOE+00 RU-103 4.45B+02 O.OOE+0O 1.71E+02 O.OOE+00 1.12E+03 O.OOE+00 1.15E+04 O.OOE+00 RU-105 4.62B-04 O.OOE+/-00 1.68E-04 0.OOE+00 4.06E-03 O.OOE+O0 3.02E-01 O.OO+00 RU-106 8.71E+03 O.OOE+00 1.09E+03 O.OOE+00 1.18E+04 O.OOE+00 1.36E+05 O.OOE+00 AG-I IOM 1.98E+07 1.34B+107 1.07E+07 0.00+00 2.50E+07 0.00E+00 1.59E+09 O.OOE+O0 SB-124, 0.00+00 0.00E+00 O:.OOE+00 .OOE+00 O.OOE+00 0.00+00 O.OOE+00 O.OOE+00 SB-125 0.00+00 O.OOE+00 0.00E+00 O.OOE+00 0.OOE+00 O.0OE+00 0.00E+00 O.OOE+00 TE-125M .7.45E+06 2.02E+06 9.94E+05 2.09E+06 O.OO+00 0.00E+00 7.19E+06 0.00E+00 TE-127M 2.03E+07 5.46E+06 2.41 E+06 4.85E+06 5.79E+07 O.OOE+00 1.64E+07 O.OOE+00 TE-127 3.59E+02 9.67E+01 7.69E+01 2.48E+02 1.02E+03 O.OOE+00 1.40E+04 O.OOE+00 TE-129M 2.86E+07 7.99E+06 4.44E+06 9.22E+06 8.40E+07 O.OOE+00 3.49E+07 0.00E+00O TE-129 1.59E-10 4.44E- I 3.78E-11, 1.14E-10 4.65B-10 O.OOE+00 9.90E-09 O.OOB+0O RSP-0008 REV -12 -PAGE 82 OF 103
ATTACHMENT 26 PAGE 2 OF 2 TABLE 1-12: DOSE FACTOR TABLE: R (I3 - CHILD, GOATS MILK Nu clide Rona Liver Tbodv Thvroid KidneY Lune GI Tract Skin TE-13IM I.92E+05 6.65E+04 7.07E+04 1.37E+05 6.432+05 O.OOE+00 2.70E+06 0.00+00 TE-131 2.13B-33 6.48E-34 6.33E-34 1.63E-33 6.43E-33 0.2OE+O0 1.12E-32 0.00+00 TE-132 1.23E+06 5.44E+05 6.57E+05 7.93E+05 5.05E+06 O.OOE+00 5.48E+06 O.OOE+00 1-130 2.08E+06 4.20E+06 2.16E+06 4.63E+08 6.28E+06 O.OOE+00 1 97E+06 0.00E+OO 1-131 1.54E+09 1.55E2+09 8.78E+08 5.iIE+li 2.54E+09 0.002+00 1.38E+08 0.OQE+00 1-132 8.41E-01 1.54E+00 7.10E-01 7.17E+01 2.36E+00 O.OOE+00 1.82E+00 O.OOE+00 I-133 2.06E+07 2.55E+07 9.66E+06 4.74E+09 4.25E+07 O.OOE+00 1.03E+07 0.00+00 I-134 1.06E- 11 1.98E-1I 9.09E-12 4.54E-10 3.02E-lI O.OOE+00 1.31B-II 0.00+00 I-135 6.52E+04 1.17E+05 5.55E+04 1.04E+07 1.80E+05 O.OOE+00 8.94E+04 0.00+00 CS-134 5.30E+10 8.69E+10 1.83E+10 0.00E+0O 2.69E+10 9.66E+09 4.682+08 O.OOE+00 CS-136 2.89E+09 7.59E+09 5.15E+09 O.OOE+00 4.24E+09 6.32E+08 2.80E+08 O.OOE+00 CS-137 7.492+10 7.17E+10 1.06E+10 0.002+00 2.33E+10 8.40E+09 4.49B+08 O.OOE+00 CS-138 1.28B-22 1.78E-22 I. 13E-22 O.OOE+00 1.25E-22 1.35E-23 8.21 E-23 O.OOE+00 BA-139 2.482-08 1.32E-11 7.18E-10 O.OOE+00 1.ISE-11 7.78E-12 1.43E-06 0.00E+OO BA-140 1.34E+07 1.18E+04 7.84E+05 O.OOE+00 3.83E+03 7.01E+03 6.80E+06 0.00Q+00 BA-141 0.00E+0O 0.002+00 0.OOE+OO O.OOE+00 0.00E+OO 0.00E+00 0.00+00 0.00E+00 BA-142 O.OOE+OO 0.002+OO O.OOE+00 O.OOE+00 0.00+00 O.OOE+00 O.OOE+00 0.00+00 LA-140 2.33E+00 8. 14E-01 2.75E-01 O.OQE+00 O.OOE+00 O.OOE+00 2.27E+04 0.00+OO LA-142 9.95E-12 .3.17E-12 9.94E-13 0.00+00 O.OOE+00 0.00E+00 6.29E-07 0.00+OO CE-141 2.31E+03 l.15E+03 1.7 1E+02 0.00+00 5.05E+02 O.QOE+00 1.44E+06 O.OOE+00 CE-143 2.25E+01 1.22E+04 1.77E+00 0.00E+00 5.12E+00 0.00+00 1.79E+05 0.00E+OO CE-144 1.54B+05 4.82E+04 8.21E+03 O.OOE+00 2.67E+04 0.00+00 1.26E+07 O.OOE+00 PR-143 8.19E+01 2.46E+01 4.07E+00 0.00E+OO 1.33E+01 O.OOE+00 8.84E+04 O.OOE+00 PR-144 0.002+00 0.002+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 ND-147 5.15E+01 4.17E+01 3.23E+00 O.OOE+00 2.29E+01 O.OOE+00 6.61E+04 O.OOE+00 W-187 3.472+03 2.05E+03 9.21E+02 0.00E+OO O.OOE+00 O.OOE+00 2.89E+05 0.00+00 NP-239 2.07B+00 1.49E-01 1.05E-01 O.OOE+00 4.30E-01 O.OOE+00 1.1OE+04 0.00E+OO
-r RSP-0008 REV- 12 PAGE 83 OF 103
ATTACHMENT 27 PAGE I OF 2 TABLE 1-13: DOSE FACTOR TABLE: R (I) - INFANT, GOATS MILK TABLE 1-13 DOSE FACTOR TABLE: R (i) - Infant, goats' milk Units are mZ*mrem/yr per gCi/sec Nuclide Bone Liver Thody T hyroid Kidney Lung GI Tract Skin H-3 O.OOE+00 3.01E+03 3.01E+03 3.01E+03 3.01E+03 3.01E+03 3.01E+03 O.OOE+00 C-14 3.23E+06 6.89E+05 6.89E+05 6.89E+05 6.89E+05 6.89E+05 6.89B+05 O.OOE+00 NA-24 1.85E+06 1.85E+06 1.85E+06 1.85E+06 1.85E+06 1.85E+06 1.858+06 O.OOE+00 P-32 1.82E+l I 1.07E+10 7.06E+09 O.OOE+00 O.OOE+00 O.OOE+00 2.46E+09 O.OOE+0O CR-51 O.OOE+00 O.OOE+00 1.71E+04 1.13E+04 2.46E+03 2.19E+04 5.04E+05 0.00E+00 MN-54 0.008+00 3.69E+06 8.36E+05 O.OOE+00 8.17E+05 0.00E+00 1.36E+06 O.OOE+00 MN-56 0.008+00 3.82E-03 6.59E-04 O.OOE+00 3.29E-03 0.00+00 3.47E-01 O.OOE+00 FE-55 1.37E+06 8.83E+05 2.36E+05 O.OOE+00 O.OOE+00 4.32E+05 1.12E+05 O.OOE+00 FE-59 2.50E+06 4.37E+06 1.72E+06 O.OOE+00 O.OOE+00 1.29E+06 2.09E+06 O.OOE+00 CO-57 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 CO-58 O.OOE+00 2.42E+06 6.03E+06 O.OOE+00 O.OOE+00 O.OOE+00 6.03B+06 O.OOE+00 CO-60 O.OOE+00 8.21E+06 1.94E+07 o.ooe+00 0.00E+00 O.OOE+00 L.95E+07 O.OOE+00 NI-63 3.24E+09 2.0 1E+08 1.13E+08 O.OOE+00 O.OOE+00 O.OOE+00 9.98E+06 0.008+00 NI-65 4.27E-01 4.83E-02 2.20E-02 0.00E+00 O.OOE+00 O.OO+00 3.68E+00 O.OOE+00 CU-64 0.00+00 2.07E+04 9.608+03 O.OOE+00 3.51E+04 0.00E+00 4.25E+05 O.OOE+00 ZN-65 5.28E+08 1.81E+09 8.35E+08 O.OOE+00 8.78E+08 0.00E+00 1.53E+09 O.OOE+00 ZN-69 2.52E-12 4.54E-12 3.38E-13 O.OOE+00 1.89E-12 0.00+OO 3.70E-10 O.OOE+00 ZN-69M O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.OOE+00 0.008+00 O.OOE+00 0.0OE+00 BR-82 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 BR-83 O.OOE+00 0.00+00 1.14E-01 0.00E+00 O.OOE+00 0.00+00 0.00E+00 0.0OE+00 BR-84 0.00E+00 O.OOE+00 1.62E-23 O.OOE+00 0.00E+00 0.008+00 O.OOE+00 0.008+00 BR-85 O.OOE+00 O.OOE+00 O.OO+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 RB-86 0.00E+00 2.47B+09 1.22E+09 O.OOE+00 O.OOE+00 O.OOE+00 6.33E+07 0.00E+00 RB-88 O.OOE+00 O.OO+00 O.OOE+00 O.OOE+00 O.OOE+OO O.OOE+00 0.00+00 O.OOE+00 RB-89 O.OOE+00 O.OO+00 O.OOE+00 0.OE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.001+00 SR-89 2.25E+10 O.OOE+00 6.44E+08 O.OOE+00 O.OOE+00 O.OOE+00 4.62E+08 0.008E00 SR-90 1.98E+11 O.OOE+00 5.03E+10 O.OOE+00 0.00E+00 O.OOE+00 2.47E+09 O.OOE+00 SR-91 5.73E+05 O.OOE+00 2.07E+04 O.OOE+00 O.OOE+00 O.OOE+00 6.78E+05 O.OOE+00 SR-92 9.89E+00 O.OOE+00 3.67E-01 0.00+00 0.00E+00 O.OOE+00 1.07E+02 O.OOE+00 Y-90 8.18E+OI O.OOB+00 2.19E+00 0.00E+00 0.00E+00 O.OOE+00 1.13E+05 0.00-+00 Y-91M 7.13E-20 O.OOE+00 2.43E-21 O.OOE+00 0.00E+00 0.00+00 2.38E-16 O.0OE+00 Y-91 7.40E+03 O.OOE+00 1.97E+02 0.00E+00 O.OOE+00 0.00E+00 5.30E+OS O.OOE400 Y-92 6.52E-05 O.OOE+00 1.83E-06 O.OOE+00 O.OOE+00 O.OO+00 1.24E+00 O.OOE00 Y-93 2.60E-01 O.OOE+00 7.08E-03 O.OOE+00 O.OOE+00 0.00E+ 2.05E+03 O.OOE800 ZR-95 6.83E+02 1.66E+02 1.18E+02 O.OOE+00 1.79E+02 O.OOE+00 8.29E+04 0.0E0+00 ZR-97 4.89E-01 8.38E-02 3.83E-02 O.OOE+00 8.45E-02 0.00+00 5.35E+03 0.00E+00 NB-95 6.23E+04 2.57E+04 1.48E+04 0.00E+00 1.84E+04 O.OOE+00 2.17E+07 O.OOE00 NB-97 O.OOB+OO O.OOE+00 0.OOE+00 0.00+00 0.00E+00 0.OOE+00 O.OOE+00 O.OOE400 MO-99 0.00+00 2.50E+07 4.87E+06 0.00+00 3.73E+07 0.00E+00 8.23E+06 0.00E+O0 TC-99M 3.32E+00 6.84E+00 8.82B+01 O.OOE+00 7.36E+01 3.58E+00 1.99B+03 0.008+00 TG-101 O.OOE+00 O.OOE+00. O.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.0OE+00 RU-103 9.02E+02 O.OOE+00 3.02E+02 O.OOE+00 1.88E+03 O.OOE+00 1. lOE+04 O.OOE+00 RU-IOS 9.75E-04 O.OOE+00 3.28E-04 O.OOE+00 7.178-03 O.OOE+00 3.S8E-01 0.00E+00 RU-106 1.79E+04 O.OOE.+00 224E+03 O.OOE+00 2.12E+04 O.OOE+00 1.36E+05 O.OOE+00 AG-11 OM. 3.67E+07 2.68E+07 1.77E+07 O.OO+00 3.83E+07 O.OOE+00 1.39E+09 O.OOE800 SB-124. O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.008+00 SB-125 0.00+00 0.00E+00 0.00E+00 O.OOE+000 0.00+00 O.OOE+00 0.00E+00 O.OOE+00 TE-125M 1.52E+07 5.09E+06 2.06E+06 5.12B+06 0.00B+00 O.OOE+00 7.26B+06 0.00E+00 TE-127M 4.11E+07 1.36E+07 4.97E+06 1.19E+07 1.01E+08 O.OOE+00 1.66E+07 O.OOE+00 TE-127 7.61E+02 2.55E+02 1.64E+02 . 6.20E+02 1.86E+03 0.00E+00 1.60E+04 O.OOE+00 TE-129M 5.87E+07 2.01E+07 9.04BE+0 2.25E+07 1.47E+08 O.OOE+00 3.51E+07 O.OOE+00
, E--
-129 3.37E-10 1.16E-10 7.87E-11 2.838-10 8.40E-10 O.OOE+00 2.70E-08 0.00E+00 RSP-0008 REV- 12 PAGE 84 OF 103
AITACIMENT 27 PAGE 2 OF 2 TABLE I-13: DOSE FACTOR TABLE: R ( - INFANT, GOATS MILK Nuclide Bone Liver Tbody Thyroid Kidney Lumn GI Tract SkIn TE-131M 4.06B+05 1.63E+05 1.35B+05 3.31-E+05 1.12B+06 0.003+00 2.75E+06 O.OOE+00 TE-131 4.51E-33 1.67E-33 1.27E-33 4.02E-33 1.15E-32 0.00+00 1.82B-31 O.OOE+00 TE-132 2.53E+06 1.25E+06 1.17E+06 1.85E+06 7.84E+06 0.00E+00 4.64E+06 0.008+00 1-130 4.27E+06 9.40E+06 3.77E+06 1.05E+09 1.03E+07 O.OOE+00 2.01E+06 0.008+00 1-131 3.21E+09 3.78E+09 1.66E+09 1.24E+12 4.41E+09 0.0E+00 1.35E+08 O.OOE+00 1-132 1.74E+00 3,54E+00 1.26B+00 1.66E+02 3.95E+00 0-00.+00 2.87E+00 O.OOE+00 1-133 4.36B+07 6,35E+07 1.86B+07 1.15E+10 7.46E+07 0.OOE+00 1.07E+07 O.OOE+0O 1-134 2.21E-11 4.52E-11 1.61B-11 1.05B-09 5.05E-11 0.OOE+00 4.67E-1II 0.00+OO 1-135 1.36E+05 2.70B+05 9.83E+04 2.42E+07 3.00E+05 O.OOE+00 9.76E+04 O.OOE+00 CS-134 8.53E+10 1.59E+11 1.61E+10 O.OOE+00 4.10E+10 1.68E+10 4.32E+08 0.OOE+00 CS-136 5.65E+09 1.66E+10 6.21E+09 0.008+00 6.628+09 1.35E+09 2.52E+08 O.OOE+00O CS-137 1.19E+11 1.40E+11 9.918+09 O.OOE+00 3.75E+10 1.528+10 4.37E+08 0.00-E00 CS-138 2.708-22 4.40E-22 2.138-22 O.OOE+0O 2.19E-22 3.428-23 7.03E-22 O.OOE+00 BA-139 5.27E-08 3.49E-11 1.53E-09 O.OOE+00 2.10E-11 2.12E-11 3.34E-06 0.00E+00 BA-140 2.76E+07 2.76E+04 1.42E+06 O.OOE+00 6.56E+03 1.70E+04 6.79E+06 0.00E+00 BA-141 O.OOE+00 0.008+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 0.00B+00 BA-142 0.00E+0O OOOE+OO 0.00++00 0.00E+00 0.00O+00 0.OOE+00 0.00E+00 0.008+00 LA-140 4.87E+00 1.92E+00 4.94E-01 0.00E+00 0.00+00 0.00E+00 2.258+04 0.0OE+00 LA-142 2.09E-11 7.67E-12 1.84E-12 0.008+00 O.OOE+OO 0.00+00 1.30E-06 O.OO+00 CE-141 4.58E+03 2.79E+03 3.29E+02 0.008+00 8.62E+02 0.00E+00 1.44E+06 0.00E+00 CB-143 4.77E+01 3.16E+04 3.61E+00 O.OOE+00 9.21E+00 0.001+00 1.85E+05 .OOE+OO CB-144 2.20E+05 9.02E+04 1.23E+04 0.008+00 3.64E+04 0.008+00 1.26E+07 0.008+00 PR-143 1.70E+02 6.34E+01 8.40E+OO 0.008+00 2.36E+01 0.00E+00 8.95E+04 0.008+00 PR-144 O.OOE+00 0.008+00 0.OOE+00 0.00E+00 0.00E+00 0.008+00 0.00E+00 0.00+00 ND-147 1.02E+02 1.05B+02 6.438+00 O.OOE+00 4.05E+01 O.OOE+00 6.65E+04 0.008+00 W-187 7.30E+03 5.08E+03 1.75E+03 0.008+00 0.00E+00 O.OOE+00 2.98E+05 0.00E+00 NP-239 4.38E+00 3.92E-01 2.21E-01 O.OOE+00 7.81E-01 O.OOE+00 1.138+04 0.00E+00 RSP-0008 REV - 112 .PAGE PA _E 85. OF 103
_ESOF1O_
RS-OO
ATTACHMENT 28 PAGE 1 OF 2 TABLE 1-14: DOSE FACTOR TABLE: R (I) - ADULT, MEAT TABLE 1-14 DOSE FACTOR TABLE: R (i) - Adult, meat Units are m2 *mremlnr per WClsec Nuclide Bone Liver Tbody Thyroid Kidney Lung GI Tract Skin H-3 O.OOE+OO 2.01E+02 2.01E+02 2.01E+02 2.01E+02 2.0IE+02 2.01E+02 O.OOE+00 C-14 3.33E+05 6.66E+04 6.66E+04 6.66E+04 6.66E+04 6.66E+04 6.66E+04 O.OOE+00 NA-24 1.39E-03 1.39E-03 1.39E-03 1.39E-03 1.39E-03 1.39E-03 1.39E-03 0.0OE+00 P-32 4.41E+09 2.74E+08 1.71E+08 O.OOE+OO O.OOE+OO O.OOE+OO 4.96E+08. 0.OOE+O0 CR-51 O.OOE+OO O.OOE+OO 6.30E+03 3.76E+03 1.39E+03 8.36E+03 1.58E+06 O.OOE+00 MN-54 O.OOE+OO 7.24E+06 1.38EF+06 Q.OOE+OO 2.15E+06 O.OOE+OO 2.22E+07 O.OOE+00 MN-56 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00+00 O.OOE+OO O.OOE+OO O.OOE+0 O FE-55 2.28E+08 1.58E+08 3.68E+07 O.OOE+OO O.OOE+OO 8.80E+07 9.05E+07 .0.E+00 FE-59 2.28E+08 5.36E+08 2.05E+08 O.OOE+OO O.OOE+OO 1.50E+08 1.79E+09 O.OOE+00 CO-57 O.OOE+OO O.OOE+OO O.OO+OO 0.OO+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+00 CO-58 O.OO-+00 1.52E+07 3.40E+07 O.OOE+OO O.OOE+OO O.OOE+OO 3.07E+08 O.OOE+00 CO-60 O.OOE+OO 5.84E+07 1.29E+08 O.OOE+OO O.OOE+OO O.OOE+OO I.IOE+09 O.OOE+00 NI-63 1.46E+10 I.OlE+09 4.90E+08 O.OOE+OO O.OOB+O O.OOE+OO 2.1 IE+08 O.OOE+00 NI-65 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.OOE+O0 CU-64 O.OOE+OO 2.79E-07 1.31 E-07 O.OOE+OO 7.03E-07 O.OOE+OO 2.38E-O5 O.OOE+00 ZN-65 2.82E+08 8.97E+08 4.05E+08 O.OOE+OO 6.OOE+08 O.OOE+OO 5.65E+08 O.OOE+00 ZN-69 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+O0 O.OOE+OO O.OOE+OO 0.00E+00 ZN-69M O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+ O.OOEf+OO O.OOE+OO O.OOE+00 BR-82 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOB+OO O.OOE+OO O.OOE+OO O.OOE+O0 BR-83 O.OOE+OO O.OOE+OO O O.OOE+OO O.OOE+OO O.OOE+OO .OOE+OO O.OOE+OO O.OOE+00 BR-84 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOB+OO O.OOE+OO 0.OOE+00 BR-85 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.00E+OO O.OOE+00 RB-86 O.OOE+OO 4.51 E+08 2.10E+08 O.OOE+OO O.OOE+OO O.OOE+OO 8.90E+07 O.OOE+00 RB-88 O.OOE+OO O.OOE+OQ O.OOE+OO O.OOE+OO O.OOE+OO O.0OE+OO O.OOE+OO 0.00E+00 RB-89 O.OOE+OO O.OOE+0 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+O0 SR-89 2.56E+08 O.OOE+OO 7.36E+06 O.OOE+OO O.OOE+OO O.OOE+O0 4.1 1E+07 O.OOE+00 SR-90 9.63E+09 O.OOE+OO 2.36E+09 O.OOE+OO O.OOE+OO O.OOE+OO 2.78E+08 O.OOE+00 SR-91 1.58E-10 O.OOE+OO 6.39E-12 O.OOE+OO O.OOE+O O.OOE+OO 7.53E-10 0.002+00 SR-92 O.OOE+OO O.OQE+OO O.OOE+OQ O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+00 Y-90 1.08E+02 O.OOE+OO 2.90E+OO O.OOE+OO O.OOE+OO 0.OO+OO I. 15E+06 O.OOE+00 Y-91M O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+00 Y-91 9.53E+05 O.OOE+OO 2.55E+04 OO.OOE+OO O.OOE+OO O.OOE+OO 5.24E+08 O.OOE+00 Y-92 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO OOOB+OO O.OOE+OO O.OOE+00 Y-93 4.87E-12 O.OOE+OO 1.35E-13 O.OOE+OO O.OOE+OO O.OOE+OO 1.55E-07 O.OOE+00 ZR-95 1.57E+-06 5.02E+05 3.40E+05 O.OOE+OO 7.88E+05 O.OOE+OO 1.59E+09 O.OOE+00 ZR-97 2.1 1E-05 4.27E-06 1.95E-06 O.OOE+OO 6.44E-06 O.OOE+OO 1.32E+-OO O.OOE+00 NB-95 2.01E+06 1.12BE06 6.01E+05 O.OOE+OO 1.IIE+06 O.OOE+OO 6.79E+09 0.002+00 NB-97 O.OOE+OO O..OOE+ O.OOE+00 O O O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+00 MO-99 O.OOE+OO 1.OIE+05 I.91E+04 O.OOB+0 2.28E+05 O.OOE+OO 2.33E+05 0.00E+00 TC-99M 4.74E-21 1.34E-20 1.71E-19 O.OOEE+00 2.04E-19 6.57E-21 7.93E-18 O.OOE+00 TC-101 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Q.OOE+OO O.OOE+OO O.OOE+00 RU-103 9.12E+07 O.OOE+OO 3.93E+07 O.OOE+OO 3.48E+08 O.OOE+OO 1.06E+10 0.OOE+00 RU-105 6.30E-28 O.OOE+OO 2.49E-28 O.OOE+OO 8.14E-27 O.OOE+OO 3.85E-25 0.OOE+06 RU-106 2.20E+09 O.OOE+OO 2.78E+08 O.OOE+OO 4.25E+09 O.OOE+OO 1.42E+I I 0.OOE+00 AG-I IOM 5.29E+06 4.89E+06 2.91E+06 0.00+00 9.62E+06 O.OOE+00 2.OOE+09 O.OOE+00 SB-124 O.OOE+OO O.OOE+00 O.OOE+00 O.OOE+OO O.OOB+00 O.OOE+00 O.OOE+00 O.OOE+00 SB-125 O.OOE+0 0.00+00 OOOE+
00+ 00 0.00E+OO O.OOB+OO 0.00E+00 O.OOE+00 0.00F+00 TE-125M 3.02B+08 1.09E+08 4.05E+07 9.09B+07 1.23E+09 O.OOE+00 1.21E+09 0.002+00 TE-127M 9.07E+08 3.24E+08 I.IOE+08 2.32E+08 3.68E+09 .00E+0O 3.04E+09 O.OOE+00 TE-127 2.21E-10 7.94E-11 4.78E-11 1.64B-10 9.01E-10 0.00E+00 1.74E-08 O.OOE+00 TE-129M 9.96E+08 3.72E+08 1.58E+08' 3;42E4-08 4.16E+09 O.OOE+OO 5.02E+09 .O.OOE+O0 TE-129 0.00E+OO 0.00E+00 O.OE+00, O.OOE+00 0.00E+00 0.OOE+00 O.OOE+OO O.OOE+00 RSP-0008 REV -12 PAGE 86 OF 103
ATTACHMENT 28 PAGE 2 OF 2 TABLE 1-14: DOSE FACTOR TABLE: R (1 - ADULT, MEAT Nuclide Bone Liver Thody Thyroid Kidney LuLU GI Tract Skin TE-131M 4.57E+02 2.23E+02 1.86E+02 3.54E+02 2.26E+03 O.OOE+00 2.22E+04 0.OOE+00 TE-131 O.OOE+00 0.00E+O0 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+OO O.OOE+00 O.OOE+00 TE-132 1.43E+06 9.22E+05 8.66E+05 1.02E+06 8.88E+06 O.OOE+0O 4.36E+07 O.OOE+00 1-130 2.18E-06 6.42E-06 2.53E-06 5.44E-04 I.OOE-05 0.00E+00 5.52E-06 0.0OE+00 1-131 1.06E+07 1.51E+07 8.66E+06 4.95E209 2.59E+07 0.00E+00 3.99E+06 O.OOE+00 1-132 O.OOE+00 0.OOE++O 0.002+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 1-133 3.72E-01 6.47E-01 1.972-01 9.51E+01 1.13E+00 O.OOE+00 5-82E-01 O.OOE+00 1-134 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 1-135 4.69E-17 1.23E-16 4.53E-17 8.10E-15 1.97E-16 0.002+00 1.39E-16 O.OOE+00 CS-134 5.13E+08 1.22E+09 9.98E+08 O.OOE+00 3.95E+08 1.31E+08 2.14E+07 O.OOE+00 CS-136 1.15E+07 4.54E+07 3.27E+07 O.OOE+00 2.53E+07 3.46E+06 5.16E+06 O.OOE+00 CS-137 6.75E+08 9.23E+08 6.05E+08 O.OOE+00 3.132+08 1.04E+08 1.79E+07 O.OOE+00 CS-138 O.OOE+00 O.OOE+00 O.OOE+O0 0.00E+00 0.OOE+00 0.0OE+00 O.OOEt00 0.00E+00 BA-139 O.OOE+OO O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OO+00 O.OOE+00 O.OOE+00 BA-140 2.75E+07 3.45E+04 1.80E+06 O.OOE+00 1.17E+04 1.98E+04 5.66E+07 O.OOE+00 BA-141 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 0.002+00 O.OOE+00 BA-142 O.OOE+0O O.OOE+00 O.OOE+00 0.002+00 O.OOE+00 O.OOE+00 O.OOE+0O O.OOE+00 LA-140 3.74E-02 1.89E-02 4.98E-03 O.OOE+00 O.OOE+00 O.OOE+0O 1.38E+03 0.00E+00 LA- 42 O.OOE+00 O.OOE+0O O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 CE-141 1.24E+04 8.37E+03 9.49E+02 O.OOE+00 3.89E+03 0.00E+00 3.20E+07 0.00E+00 CE-143 2.03E-02 1.50E+01 1.66E-03 O.OOE+00 6.61E-03 O.OOE+00 5.61E+02 .OOOE+00 CE-144 1.15E+06 4.81E+05 6.18E+04 O.OOE+00 2.85E+05 O.OE+00 3.89E+08 0.00E+00 PR-143 2.00E+04 8.00E+03 9.89E+02 O.OOE+00 4.622+03 O.OOE+00 8.74E+07 O.OOE+00 PR-144 O.OOE+00 O.OOE+00 0.00+00 0.OOE+00 0.OOE+00 O.OOE+00 0.00+00 0.00E+00 ND-147 6.84E+03 7.90E+03 4.73E+02 O.OOE+00 4.62E+03 O.OOE+00 3.79E+07 0.OOE+00 W-187 2.08E-02 1.74E-02 6.09E-03 0.00E+00 0.O02+00 O.OO+00 5.70E+00 0.OOE+00 NP-239 2.61E-01 2.56E-02 1.41E-02 O.OOE+00 8.00E+02 O.OOE+00 5.26E+03 O.OOE+00 RSP-0008 RSP-0008 REV - 12 REV t2 PAGE 87 OF 103
ATTACHMENT 29 PAGE 1 OF 2 TABLE 1-15: DOSE FACTOR TABLE: R (1) - TEEN, MEAT TABLE I-15 DOSE FACTOR TABLE: R (i) - Teen, meat Units are m2 *mrem/yr per pCi/sec Nuclide Bone Liver Tbody Thyroid Kidney Lung GI Tract Sldn H-3 O.OOE+OO 1.20E+02 1.20E+02 1.ZOE+02 1.20E+02 1.20E+02 1.20E+02 O.OOE+OO C-14 2.81E+OS 5.62E+04 5.62E+04 5.62E+04 5.62E+04 5.62E+04 5.62E+04 O.OOE+OO NA-24 -1.I1E-03 1.IIE-03 1.IlE-03 1.lIE-03 I.IIE-03 1.lIB-03 I.IIE-03 O.OOE+OO P-32 3.73E+09 2.3 1E+08 1.45E+08 O.OOE+OO O.OOE+OO O.OOE+OO 3.13E+08 O.OOE+OO CR-51 O.OOE+OO O.OOE+OO 5.04E+03 2.80E+03 1.1OE+03 7.19E+03 8.46E+05 O.OOE+OO MN-54 O.OOE+OO 5.52E+06 1.09E+06 O.OOE+OO 1.65E+06 O.OOE+OO 1.13E+07 O.OOE+OO MN-56 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO FE-55 1.85E+08 1.3 1E+08 3.07E+07 O.OOE+OO O.OOE+OO 8.34E+07 5.69E+07 O.OOE+OO FE-59 1.82E+08 4.25E+08 1.64E+08 O.OOE+OO O.OOE+OO 1.34E+08 1.OIE+09 O.OOE+OO CO-57 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.0E+OQ O.OOE+OO C0-58 O.OOE+OO 1.17E+07 2.69E+07 O.OOE+OOO O.OOE-O0 O.OOE+OO 1.61E+08 O.OOE+OO CO-60 O.OOE+OO 4.53E+07 1.02B+08 O.OOE+OO O.OOE+OO O.OOE+OO 5.90E+08 O.OOE+OO Nl-63 1.18E+10 8.30E+08 3.98E+08 O.OOE+OO O.OOE+OO O.OOE+OO 1.32E+08 O.OOE+OO NI-65 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO CU-64 O.OOE+OO 2;28E-07 1.07E-07 O.OOE+OO 5.76E-07 O.OOE+OO 1.77E-05 O.OOE+OO ZN-65 1.98E+08 6.88E+08 3.21E+08 O.OOE+OO 4.40E+08 O.OOE+OO 2.91E+08 O.OOE+OO ZN-69 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO ZN-69M O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+/-OO BR-82 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO BR-83 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+0 O.OOE+OO O.OOE+OO O.OOE+OO BR-84 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO BR-85 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE-OO O.OOE+OO O.OOE+OO RB-86 O.OOE+OO 3.77E+08 1.77E+08 O.OOE+OO O.OOE+OO O.OOE+OO 5.57E-07 O.OOE+OO RB-88 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO RB-89 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO SR-89 2.16E+Q8 O.OOE+OO 6.20E+06 O.OOE+OO O.OOE+OO O.OOE+OO 2.58E+07 O.OOE+OO SR-90 6.23E+09 O.OOE+OO 1.54E+09 O.OOE+OO O.OOE+OO O.OOE+OO 1.75E+08 O.OOE+OO SR-91 1.33E-10 O.OOE+OO 5.29E-12 O.OOE+OO O.OOE+OO O.OOE+OO 6.30-10 O.OOE+OO SR-92 O.OOE+OO O.OOE+0O O.OOE+OO O.OOE+OO O.OOE+OO O.OOB+0O O.OOE+OO O.OOE+OO Y-90 9.IIE+OI O.OOE+OO 2.45E+OO O.OOE+OO O.OOE+OO 0.OOE+OO 7.SIE+05 O.OOE+OO Y-91M O.OOE+OO Q.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-91 8.03E+05 O.OOE+OO 2.15E+04 0.OOE+OO O.OOE+O0 O.OOE+OO 3.29E+08 O.OOE+OO Y-92 O.OOE+OO 0.OG+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE0 O.OOE+OO
+OO O.OO+OO Y-93 411E-12 O.OOE+OO 1.13E-13 O.OOE+OO O.OOE+0O O.OOE+OO 1.26E07 0.OOE+OO ZR-95 1.25E+06 3.96E+05 2.72E+05 O.-OOE+OO 5.82E+05 O.OOE+OO 9.13E+08 O.OOE+-OO ZR-97 1.76E-05 3.49E-06 1.61E-06 O.OOE+0O 5.29E-06 O.OOE+0O 9.44E-O1 O.OOE+OO NB-95 1.57E+06 8.71E+05 4.79E+05 O.OOE+OO 8.44E+05 O.OOE+0O 3.72E+09 O.OOE+OO NB-97 O.OOE+OO O.OOE+OO O .OOE+O0.OOE+OO O O.OOE+OO O.OOE+OO O.OOE+OO MO-99 O.OOE+00 8.31-E+04 1.58E+04 O.OOE+OO I.90E+S05 O.OOE+-O0 lA9E+05 0.BOE+OO TC-99M 3.77E-21 1.05E-20 1.36E-19 O.OOE+OO 1.57E-19 5.83E-21 6.90E-18 O.O0E+-O TC-O101 0.0B--O 0.OOE+OO O.OOE+O0 O.GOE+OO O.OOE+OO 0-f-GO O.OOE+OO O.OOE+OO RU-103 7.43E+07 0.OOE+OO 3.17E+07 O.OOE+OO 2.62E+08 O.OOE+OO 6.20B+09 O.OOE+OO RU-IOS 5.27E-28 0.OOE+OO 2.04E-28 O.OOE+OO 6.65E-27 0.OOE+OO 4.25E-25 0.0OE+OO RU-106 1.85E+09 O.OOE+OO 2.34E+08 0.OOE+OO 3.57E+O9 O.OOE+O0 8.89E+10 O.OOE+OO AG-iI OM 4.OOE+06 3.79E+06 2.3 1E+06 O.OOE+OO 7.23E+06 O.OOE+OO 1.06E+09 O.OOE+OO SB-124 O.OOE+OO O.OOE+O O O.OOE00 0.OOE+OO O.OOOE+EO O.OOE+0O O.OOE+0O O.OOE+OO SB-125 O.OOE+00 0.GOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOEG-O O.OB-+OO O.OOE+OO TE-125M 2.55E+08 9.19E+07 3.41EE+07 7.13E+07 O.O0E+OO O.OOE+OO 7.53E+08 0.ooe+oo.
TE-127M 7.65E+08 2.71E+08 9.10E+07 1.82E+08 3.1OE+09 O.OOEGOO 1.91E+09 QOAOE+OO.
TE-127 1.8BE- 10 6.65E-11 4.04E-I1 1.29E-10 7.60E-10 O.OOE+OO 1.45E-08 O.OOE+OO TE-129M 8.34E+08 3.1OE+08 1.32E+08' 2.69E+08 3.49E+09 O.GOE+OO 3.13E+09 O.OOB+OO TE-129 O:OOE+OO -. OOE+OO O.OOB+OO O.OOE+OO
. O.OOE+OO O.OOE+OO O.OOE+OO O.OOB+GO RSP-0008 REV- 12 PAGE 88 OF 103
ATTACHMENT 29 PAGE 2 OF 2 TABLE 1-15: DOSE FACTOR TABLE: R (p - TEEN, MEAT Nuclide Bone Liver Tbody Thyroid Kidney hLu- GI Tract Skin TE-131M 3.81E+02 1.83E+02 1.52E+02 2.75E+02 1.90E+03 O.OOE+00 I.472+04 O.OOE+00 TE-131 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 TE-132 1.17E+06 7.39E+05 6.95E+05 7.79E+05 7.09E+06 O.OOE+00 2.34E+07 0.002+00 1-130 1.75E-06 5.07E-06 2.02E-06 4.13E-04 7.80E-06 0.OOE+00 3.89E-06 0.00E+00 1-131 8.78E+06 1.23E+07 6.60E+06 3.59E+09 2.12E+07 O.OOE+00 2.43E+06 0.OOE+00 1-132 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00+00 I-133 3.1IE-01 5.28E-01 1.61B-01 7.37E+01 9.26E-01 O.OOE+00 3.99E-01 O.OOE+00 1-134 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE00 OO.OOE+00 0.00E+00 0.O0+00 O.OOE+00 1-135 3.82E-17 9.82E-17 3.64E-17 6.32E-15 1.55E-16 0.00E+00 1.09E-T6 0.00+00 CS-134 4.08E408 9.60E+08 4.45E+08 O.OOE+00 3.05E+08 1.16E+08 1.19E+07 O.OOE+00 CS-136 8.97E+06 3.53E+07 2.37E+07 O.OOB+00 1.92E+07 3.03E+06 2.84E+06 0.00E+00 CS-137 5.60E+08 7.46E+08 2.60E+08 O.OOE+00 2.54E+08 9.86E+07 1.06E+07 O.OOE+00 CS-138 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 BA-139 O.OOE+00 0.OOB+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 BA-140 2.27E+07 2.7SE+04 1.46E+06 O.OOE+00 9.44E+03 1.87E+04 3.50E+07 O.OOE+00 BA-141 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 BA-142 O.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00+00 LA-140 3.OSE-02 1.51lE-02 4.02E-03 O.OOE+00 0.OOE+00 O.OOE+00 8.69E+02 O.OOE+00 LA-142 0.OOE+00 0.OOE+00 0.OOE+00 0.00+00 O.OOE+00 0.00E+00 O.OOE+00 0.OOE+00 CE-141 1.04E+04 6.94B+03 7.97E+02 O.OOE+00 3.27E+03 O.OOE+00 1.98E+07 O.OOE+00 CE-143 1.71E-02 1.24E+01 1.39E-03 O.OOE+00 5.58E-03 0.OOE+00 3.74E+02 O.OOE+00 CE-144 9.70E+05 4.01E+05 5.21E+04 O.OOE+00 2.40E+05 0.00E+00 2.44E+08 O.OOE+00 PR-143 1.68E+04 6.70E+03 8.36E+02 O.OOE+00 3.90E+03 0.00E+00 5.52E+07 0.002+00 PR-144 O.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00+00 ND-147 6.02E+03 6.55E+03 3.92E+02 O.OOE+00 3..85E+03 O.OOE+00 2.36E+07 0.00+00 W-187 1.74E-02 1.42E-02 4.98E-03 O.OOE+00 O.OOE+00 0.00E+00 3.85E+00 O.OOE+00 NP-239 2.28E-01 2.15E-02 1.19E-02 O.OOE+00 6.75E-02 0.00+00 3.46E+03 O.OOB+00 RSP-0008-RS 0 RE PA G 89-EV .1OF 10 Y2:AE89O 0
ATTACHMENT 30 PAGE 1 OF 2 TABLE 1-16: DOSE FACTOR TABLE: R (1)- CHILD, MEAT TABLE 1-16 DOSE FACTOR TABLE: R (i) - Child, meat Units are mZ*mrem/yr per tCi/sec Nucide Bone Liver Tbody Thyroid Kidney Lung __ Tract Skin H-3 0.00E+00 1.45E+02 1.45E+02 1.45E+02 1.45E+02 1.45E+02 1.45E+02 0.00+00 C-14 5.29E+05 1.06E+05 1.06E+05 1.06E+05 1.06E+05 1.06E+05 1.06E+05 O.OOE+00 NA-24 1.77E-03 1.77E-03 1.77E-03 1.77E-03 1.77E-03 1.77E-03 1.77E-03 O.OOE+O0 P-32 7.03E+09 3.29E+08 2.71E+08' O.OOE+00 O.OOE+00 0.00+00 1.94E+08 0.00E+00 CR-51 0.00E+O0 0.OOE+00 7.85E+03 4.368+03 1.19E+03 7.96E+03 4.16E+05 0.00E+00 MN-54 O.OOE+00 6.31B+06 1.68E+06 O.OOE+00 1.77E+06 O.OOE+00 5.30E+06 O.OOE+00 MN-56 O.OOB+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.008+00 0.00E+00 FE-55 3.56B+08 1.89E+08 5.85E+07 O.OOE+0O O.OOE+00 1.07B+08 3.50E+07 0.00+00 FE-59 3.23E+08 5.23E+08 2.60E+08 O.OOE+00 0.00E+00 1.51 E+08 5.44E+08 O.OOE+00 CO-57 O.OOE+00 O.OOE+00 0.008+00 O.OOE+00 O.OOE+00 0.008+00 O.OOE+00 O.OOE+00 CO-58 O.OOE+00 1.36E+07 4.18E+07 0.008+00 O.OOE+00 O.OOE+00 7.96E+07 O.OOE+00 CO-60 O.OO+00 5.38E+07 1.59E+08 O.O+00 0.OOE*+O 0.0OE+00 2.98E+08 0.008+00 NI-63 2.25E+10 1.21E+09 7.668+08 O.OOE+00 0.008+00 O.OOE+00 8.13E+07 0.008+00 NI-65 0.O08+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00+00 O.OOE+00 O.OOE+ 0.00E+00 CU-64 O.OOE+00 3.06E-07 1.85E-07 O.OOE+00 7.398-07 O.OOB+00 1.44E-05 0.00+00 ZN-65 2.97E+08 7.92E+08 4.93E+08 O.OOE+00 4.99E+08 0.008+00 1.39E+08 0.00E+00 ZN-69 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00+00 0.00+00 ZN-69M O.OOE+00 0.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOB+00 O.OOE+00 BR-82 O.OOB+00 0.00E+00 0.008+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 0.00+00 BR-83 0.OOE+OO 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00+00 0.00E+00 BR-84 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.OOE+OO 0.00E+00 BR-85 0.OOE+OO O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 0.00E+OO RB3-86 O.OOE+00 5.34E+08 3.28E+08 O.OOE+00 O.OOE+00 0.OOE+00 3.44E+07 O.OOE+00 RB-88 0.OOE+00 0.00+00 O.OOE+00 O.OOE+00 0.OOE+00 0.008+00 0.00+00 O.OOE+O0 RB-89 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+OO O.OOE+00 0.00E+00 SR-89 4.10E+08 O.OOE+00 1.17E+07 O.OOE+00 O.OOE+00 0.008+00 1.59E+07 0.OOE+00 SR-90 8.05E+09 O.OOE+00 2.04E+09 0.00E+00 O.OOE800 0.8OE+0 1.08E+08 O.OOE+00 SR-91 2.50E-10 0.00E+00 9.42E-12 0.008+00 0.008E+0 0.00E+00 5.51E-10 o.0E8+00 SR-92 O.OOE+00 O.OOE+00 0.00E+O0 0.008E+0 0.008E+0 O.OOE+00 0.00E+00 O.OOE+00 Y-90 1.72E+02 O.OOE+00 4.61E+00 O.OOE+00 0.00E+00 0.008E+0 4.91E+05 0.00E+00 Y-91M O.OOE+OO 0.00E+00 0.00+00 O.OOE+00 O.OOE+08 O.OE+.000 0.00E+00 0.008+00 Y-91 1.52B+06 O.OOE+00 4.05E+04 0.00E+00 0.008+00 0.008+00 2.02E+08 0.00+00 Y-92 0.00+00 Q.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 Y-93 7.73E-12 O.OOE+00 2.12E-13 O.OOE+00 O.OOE+00 O.OOE800 1.15E-07 O.OOE+00 ZR-95 2.23E+06 4.90E+05 4.36E+05 0.00E+00 7.018+05 0.008+00 5.11 E+08 0.00E+00 ZR-97 3.28E-05 4.748-06 2.808-06 0.00E+00 6.80E-06 0.00E+00 7.18E-01 O.OOE00 NB-95 2.71E+06 1.06E+06 7.54E+05 0.008E+0 9.92E+05 0.00E+00 1.95E+09 0.00E+00 NB-97 O.OOE+00 Q.OOE+00 O.OOE+00 O.OOE+OO O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 MO-99 O.OOE+00 1.16E+05 2.86E+04 O.0OE+OO 2.47E+05 O.OOE+00 9.56E+04 0.00E+00 TC-99M 6.61E-21 1.30E-20 2.158-19 0.008+00 1.88E-19 6.58E-21 7.37E-18 0.00+00 TC-101 O.OOE+00 O.OOt+00 O.OOE+00 0008E+00 O.OOE+0 0.008E+00 0.00+00 O.OOB+00 RU-103 1.34E+08 O.OOE+00 5.16E+07 0.00+00 3.38E+08 O.OO8+00 3.47E+09 0.00E+OO RU-105 9.83E-28 0.0OE+O0 3.57E-28 0.00+00 8:64E-27 O.OOE+00 6.42E-25 O.OOE+00 RU-106 3.49E+09 O.OOE+00 4.35E+08 0.00+00 4.71E+09 0.00E+OO 5.43E+10 O.OOE+00 AG-IIOM 6.64E+06 4.49E+06 3.59E+06 0.00E+OO 8.36E+06 0.00E+00 5.34E+08 0.008+00 SB-124, O.O+00 O.OOE+00 O.OOE+00 O.OOE+00 0.8OE+00 0.008E+0 0.00+00 O.OOE+O0 SB-125 O.OOE+00 O.OOE+00 O.OOE+0 0.OOE+00 O.OOE+00 O.OOE+OO O.OOE+00 O.OOE00 TB-125M 4.79E+08 1.308+08 6.39E+07 1.34E+08 O.OOE+0 .OOE+00 4.62E+08 0.00E+O0 TE-127M 1.44B+09 3.88E+08 1.71E+08 3.45E+08 4.11E+09 0.00E+00 1.17E+09 O.OOE+00 TE-127 3.53E-10 9.51E-11 7.57E-11 2.44E-10 1.00E-09 O.OOE+00 1.38E-08 O.OOE+00 TE-129M 1.57E+09 4.39E+08 2.44E+0 5.07E+08 4.628+09 O.OOE+00 1.92E+09 0.00E+00 TE-129 0.008+00 0.00E+00 0.008E+ 0.00+00 0.008+00 0.008E+O O.OOE00 0.00E+OO RSP-0008 REV- 12 PAGE 90 OF 103
AflACHMENT 30 PAGE 2 OF 2 TABLE 1-16: DOSE FACTOR TABLE: R (I) - CURD, MEAT Nuclide Bone Liver Tbody Thyroid y lUdne GI Tract Skin TE-131M 7.09E+02 2.45E102 2.61B+02 5.0411+02 2.37E+03 0.00E+00 9.94E+03 0.00E+00 TE-131 0.00+00 O.OOE+OO O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 0.00+00 0.0011+00 TE-132 2.13E+06 9.43E+05 1.14E+06 1.37E+06 8.75E+06 O.OOE+00 9.49B+06 O.OOE+00 1-130 3.13E-06 6.33E-06 3.26E-06 6.97E-04 9.46E,-06 O.OOE+00 2.96E-06 O.OOE+00 1-131 1.63E+07 1.64E+07 9.30E+06 5.41E+09 2.69E+07 0.0OE+00 1.46E+06 O.OOE+00 1-132 0.00+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 1-133 5.78E-01 7.151-01 2.70E-01 1.33E+02 1.19E+00 O.OOE+00 2.88E-01 O.OOE+00
[-134 O,OOE+00 0.00E+00 0.00+00 O.OOE+00 0.0011+00 0.0OE+0O 0.00+00 O.OOE+00 I-135 6.91E-17 1.24E-16 5;88E-17 1.10E-14 1.91E-16 O.OOE+00 9.47E1-17 O.OOE+00 CS-134 7.19E+08 1.18E+09 2.49E+08 O.OOE+00 3.66E+08 1.31E+08 6.36E+06 O.OOE+00 CS-136 1.55E+07 4.25E+07 2.75E+07 O.OOB+00 2.27E+07 3.38E+06 1.50E+06 0.0011+00 CS-137 1.03E+09 9.88E+08 1.46E+08 O.OO+00 3.22E+08 1.16E+08 6.19E+06 O.OOE+00 CS-138 0.00E+00 O.OOE+00 O.OOE+00 0.01E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+0 O BA-139 0.00+00 O.OOE+00 0.00E+00 0.OOE+00 O.OOE+00 O.OOE+00 O.01+00 O.OOE+00 BA-140 4.19E+07 3.67E+04 2.45E+06 O.OOE+00 1.20E+04 2.19E+04 2.12E+07 O.OOE+00 BA-141 O.OOE+00 0.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 BA-142 O.OOE+00 O.OOE+00 0.00+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OO+00 O.OOE+00 LA-140 5.64E-02 1.97E-02 6.64E-03 0.00E+00 0.00E+00 0.OOE+00 5.49E+02 0.00E+00 LA-142 0.001+00 O.0OE+00 O.OOE+00 O.OOE+00 0.00E+00 0.001+00 0.00E+00 0.00E+00 CE-141 1.96E+04 9.76E+03 1.45E1+03 O.OOE+00 4.2811+03 0.00E+00 1.22E+07 O.OOE+00 CE- 143 3.21E-02 1.74E+01 2.52E-03 OOOE+00 7.29E-03 O.OOE+00 2.55E+02 O.OOE+00 CE-144 1.83E+06 5.73E+05 9.76E+04 O.OOE+00 3.17E+05 O.OOE+00 1.49E+08 0.00E+00 PR-143 3.181E+04 9.54E+03 1.58E+03 O.OOE+00 5.17E+03 O.OOE+00 3.43E+07 O.OOE+00 PR-144 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 0.0011+00 0.00+00 0.00OE+00 ND-147 1.13E+04 9.16E+03 7.09E+02 O.OOE+00 5.02E+03 0.00E+0O 1.45E+07 0.00E+00 W-187 3.23E-02 1.91E-02 8.59E-03 0.00E+00 0.00E+OO 0.OOE+00 2.69E+00 O.OOE+00 NP-239 4.29E-01 3.081-02 2.161-02 O.OOE+00 8.90E-02 O.OOE+00 2.28E+03 O.OOE+00 RSP-0008 ,REV -12 PAGE 91 OF 103
ATTACHMENT 31 PAGE 1 OF2 TABLE 1-17: DOSE FACTOR TABLE: R (I) - ADULT, VEGETATION TABLE 1-17 DOSE FACTOR TABLE: R (i)- Adult, vegetation Units are m2*mrem/yr per MCi/sec Nuclide Bone Liver Tbodv Thvroid Kidney Lung Gl Tract Skin H-3 O.OOE+00 1.40E+03 1.40E+03 1.40E+03 1.401+03 1.40E1+03 1.40E+03 O.OOE+00 C-14 8.97E+05 1.79E1+05 1.79E+05 1.79E+05 1.79E+05 1.79E+05 1.79E+05 O.OOE+00 NA-24 2.68E+05 2.68E+05 2.68E+05 2.68E+05 2.68E+05 2.68E+05 2.68E+05 O.OOE+00 P-32 1.40E+09 8.72E+07 5.42E1+07 O.OOE+00 O.OOE+00 O.OOE+00 1.58E+08 O.OOE+00 CR-51 0.OOE+0O 0.00E+00 4.64E+04 2.771E+04 1.02E+04 6.15E+04 1.17E+07 O.OOE+00 MN-54 O.OOE+00 3.101E+08 5.92E+07 O.OOE+00 9.23E+07 O.OOE+00 9.50E+08 0.00E+00 MN-56 O.OOE+00 1.54E+01 2.74E+00 O.OOE+00 1.96B+OI0 O.OOE+00 4.92E+02 O.OOE+00 FE-55 2.08E+08 1.43E+08 3.34E+07 0.001+00 O.OOE+00 8.00E+07 8.23E+07 O.OOE+00 FE-59 1.26B+08 2.96E+08 1.13E+08 - 0.00+00 O.OOE+00 8.26E+07 9.85E+08 0.00E+00 CO-57 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 CO-58 O.OOE+00 3.06E+07 6.86E+07 O.OO+00 0.0011+00 O.OOE+OO 6.20E+08 0.00E+00 CO-60 0.QOE+00 1.65E+08 3.65E+08 O.OOE+00 O.OOE+00 O.OOE+00. 3.1 IE+09 0.00E+00 NI-63 1.03E+10 7.14B+08 3.45E+08 O.OOE+00 O.OOE+00 O.OOE+00 1.49E+08 O.OOE+00 NI-65 5.96E+01 7.75E+00 3.54E+00 O.OOE+00 O.OOE+00 O.OOE+00 1.97E+02 O.OOE+00 CU-64 0.OOE+00 9.14E+03 4.29E+03 O.OOE+00 2.311E+04 0.00E+00 7.79E+05 0.00E+00 ZN-65 3.15E+08 1.00E+09 4.53E+08 O.OOE+00 6.70E+08 O.OOE+00 6.311E+08 O.OOE+00 ZN-69 5.06E-06 9.67E-06 6.72E-07 O.OoE+00 6.28E-06 O.OOE+00 1.45E-06 O.OOE+00 ZN-69M O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 BR-82 O.OOE+0O O.OOE+00 0.00E+00 O.OOE1+0 0.00E+00 0.00+00 0.00E+00 0.00E+00 BR-83 O.OOE+00 O.OOE+00 3.01E+00 0.001+00 O.OOE+00 O.OOE+00 4.33E+00 0.00E+00 BR-84 O.OOE+00 O.OOB+00 2.141-1I O.OO+00 O.OOE+00 O.OOE+00 1.68E- 16 O.OOE+00 BR-85 O.OOE+00 0.00E+00 O.OOE+00 O.OO+00 O.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 RB-86 O.OO+00 2.19E+08 1.02E+08 0.OOE+00 0.00E+00 O.OOE+00 4.32E+07 O.OOE+00 RB-88 0.00E+00 2.64E-22 1.40E-22 O.OOE+00 0.00E+00 O.OOE+00 3.65E-33 O.OOE+00 RB-89 O.OOE+00 2.88E-26 2.03E-26 O.OOE+00 O.01E+00 O.OOE+00 O.OOE+00 O.OOE+00 SR-89 9.94E+09 O.OO+00 2.85E+08 O.OOE+00 O.OOE+00 O.OOE+00 1.59E1+09 0.00E+00 SR-90 5.98E+1 I O.OO+00 1.47E+I I O.OOE+00 0.001+00 O.OOE+00 1.73E+10 O.OOE+00 SR-91 3.02E+05 O.OOE+00 1.22E+04 0.001+00 0.00E+00 0.00O+00 1.44E+06 0.00E+00 SR-92 4.15E+02 O.OOE+00 1.79E+01 O.OOE+00 O.OOE+00 O.OOE+00 8.21E+03 O.OOE+00 Y-90 1.33E+04 O.OOE+00 3.56E+02 0.00E+00 O.OO+00 O.OOE+00 1.41 E+08 0.00E+00 Y-91M 4.76M-09 O.OOE+00 1.84E-10 O.OOE+00 O.OOE+00 O.OOE+00 1.40E-08 O.OOE00 Y-91 5.09E+06 O.OOE-+-00 1.36E+05 0.00E+00 O.OOE+00 0.00E+00 2.80E+09 0.(0f+00 Y-92 8.96E-01 O.OOE+00 2.62E-02 0.00E+00 O.OOE+00 O.OOE+00 1.57E+04 O.OOE+00 Y-93 1.68E+02 0.00+00 4.65E+00 0.001+00 O.OOE+00 O.OOE+00 5.34E+06 O.OOE+00 ZR-95 1.17E+06 3.75E+05 2.54E+05 O.OOE+00 5.89E+05 O.OOE+00 1.19E+09 O.OOE+00 ZR-97 3.36E+02 6.78E+01 3.iOE+01 0.0011+00 1.02E+02 0.OOE00 2.10B1+07 0.00E+00 NB-95 1.42E+05 7.90E104 4.25B+04 O.OOE+O0 7.811E+04 0.OOE+00 4.80E+08 O.OOE+00 NB-97 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 MO-99 O.OOE+00 6.144E+06 1.17E+06 O.OOE+00 1.39E+07 O.OOE+00 1.42E1+07 O.OOE+00 TC-99M 3.06E+00 8.66E+00 1.11OE+02 O.OOE+00 1.31E+02 4.24E+00 5. 12E+03 O.OOE+00 TC-l01 5.93E-31 8.55E-31 8.39E-30 0.001E+00 1.54E-29 4.37E-31 O.OOE+00 0.00E+00 RU-103 4.761+06 O.OOE+00 2.05E+06 O.OOE+00 1.82E+07 O.OOE+00 5.56E1+08 O.OO+00 RU-105 5.29E+01 0.00E+00 2.09E+01 O.OOE+00 6.84E+02 O.OOE+00 3.24B+04 O.OOE+00 RU-106 1.91E+08 O.OOE+00 2.42E+07 O.OOE+00 3.69E+08 O.OOE+00 1.24B+10 O.OOE+00 AG-lIOM 1.05E+07 9.67E+06 5.74E+06 O.OO+0O 1.90E+07 O.OOE+00 3.95E+09 O.OO+00 SB-124 0.0011+00 O.OOE+00 00011+00 0.00+00 O.OOE+00 0.00+O0 0.001+00 O.OOE+00 SB-125 O.OOE+00 0.OOE+00 0.001+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 TE-125M 9.62E+07 3.49E+07 1.29E+07 2.891+07 3.91E+08 O.OOE+00 3.84E+08 0.00E+00 TE-127M 3.47E+08 1.241+08 4.23E+07 8.87E+07 1.41E+09 O.OOE+00 1.16E1+09. 0.00E+0O TE-127 5.611E+03 2.02E+03 1.21E+03 4.161E+03 2.29E+04 0.00E+00 4.43E+05 0.OOE+00 TE-129M 2.51E+08 9.3611+07 3.97E+07 8.611E+07 1.05B+09 0.OOE+00 1.26E+09 O.OOB+00 TE-129 7.13E-04 2.68E-04 1.74E-04 5.48E-04 3.00E-03 O.OOB+00 5.3 BB-04 O.OO+00 RSP-0008 REV -12 PAGE 92 OF 103
ATTACHMENT 31 PAGE 2 OF 2 TABLE 1-17: DOSE FACTOR TABLE: R (1) - ADULT, VEGETATION Nuclide Bone Liver Tbody Thyroid Kidney Lune G0 Tract Skin TE-131M 9.10B+05 4.45E+05 3.711E+05 7.05E+05 4.51E+06 O.OOE+00 4.42E+07 O.OOE+00 TE-131 1.25E-15 5.21E-16 3.94E-16 1.03E-15 5.471-15 o.ooe400 1.77E-16 O.OOE+00 TE-132 4.30E+06 2.78E+06 2.61 E+06 3.07E+06 2.6BE+07 O.OOE+00 1.31E+08 O.OOE+00 1-130 3.90E+05 1.15E+06 4.54E+05 9.75E+07 1.79E+06 O.OO+00 9.90E+05 O.OOE+00 1-131 8.07E+07 1.15E+08 6.61B+07 3.78E+10 1.98E+08 O.OOE+00 3.04E+07 O.OOE+00 1-132 5.57E+01 1.49E+02 5.21E+01 5.21E+03 2.37E+02 O.OOE+00 2.80E+01 O.OOE+00 1-133 2.08E+06 3.611E+06 1.IOE+06 5.31E+08 6.31E+06 O.OOE+00 3.25E+06 O.OOE+00 1-134 8.84E-05 2AOE-04 8.59E-05 4.16E-03 3.82E-04 O.OOE+00 2.09E-07 O.OOE+00 1-135 3.85E+04 1.01E+05 3.72E+04 6.65E+06 1.62E+05 O.OOE+00 1.14E+05 O.OOE+00 CS-134 4.62E+09 1.10E+10 8.99E+09 O.OOE+00 3.56E+09 1.18E+09 192E+08 O.OOE+00 CS-136 4.26E+07 1.68E+08 1.21E+08 O.OOE+00 9.37E+07 1.28E+07 1.9 11E+07 O.OO.+00 CS-137 6.29E+09 8.61E+09 5.64E+09 O.OOE+00 2.92E+09 9.71E+08 1.67E+08 0.00E+00 CS-138 3.39E-11 6.70E-11 3.32E-II O.OOE+00 4.92E-11 4.86E-12 2.86E-16 0.00E+00 BA-139 2.70E-02 1.92E-05 7.91E-04 0.00E+00 1.80E-05 1.09E-05 4.79E-02 O.OOE+00 BA-140 1.28E+08 1.61E+05 8.41E+06 O.OOE+00 5.48E+04 9.23E+04 2.64E+08 O.OO+00 BA-141 8.94E-22 6.76E-25 3.02E-23 0.00+00 6.28E-25 3.83E-25 4.21E-31 O.OOE+00 BA-142 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 LA-140 1.97E+03 9.95E+02 2.63E+02 O.OOE+00 O.OOE+00 O.OOE+00 7.30E+07 0.00+-00 LA-142 1.92E-04 8.75E-05 2.18E-05 O.OOE+00 0.00E+0 0.001E+00 6.39E-01 0.OOE+00 CE-141 1.97E+05 1.33E+05 1.51E+04 O.OOE+00 6.18E+04 0.00E+00 5.09E+08 .01OE+OO CE-143 9.95E+02 7.36E+05 8.14E+01. 0.00E+00 3.24E+02 O.OOE+00 2.75E+07 O.OOE+00 CE-144 3.26E+07 1.36E+07 1.75E+06 O.OOE+00 8.09E+06 O.OO1+00 1.10E+10 O.OOE+00 PR-143 6.25E+04 2.5 11E+04 3.101E+03 0.00E+00 1.45E+04 O.OOE+00 2.74E+08 O.OOE+00 PR-144 2.36E-26 9.811E-27 1.20E-27 O.OOE+00 5.531E-27 O.OOE+00 3.40E-33 O.OOE+00 ND-147 3.33E+04 3.85E+04 2.30E+03 0.008+00 2.25E+04 O.OOE+00 1.85E+08 O.OOE+00 W-187 3.79E+04 3.17E+04 1.11E1+04 O.OOE+00 0.001+00 O.OOE+00 1.04E+07 O.OOE+00 NP-239 1.43E+03 1.40E+02 7.73E+01 O.OOE+00 4.37E+02 O.OOE+00 2.881+07 O.OOE+00 RSP-0008 REV -12 PAGE 93 OF 103
ATTACHMENT 32 PAGE 1 0F2 TABLE 1-18: DOSE FACTOR TABLE: R (1) - TEEN, VEGETATION TABLE 1-18 DOSE FACTOR TABLE: R (i)- Teen, vegetation Units are m2 *mremlyr per gCi/sec Nuclide Bone Liver Tbody Thyroid Kidney Lung GI Tract Sidn H-3 O.OOE+00 1.60E+03 1.60E+03 1.60E+03 1.60E+03 1.60E+03 1.60E+03 O.OOE+OO C-14 1.45E+06 2.91E+05 2,91E+05 2.91E+05 2.91E+05 2.91E+05 2,9tE+05 O.OOE+OO NA-24 2.38E+05 2.38B+05 2.38E+05 2.38E+05 2.38E+05 2.38E+05 2.38E+05 O.OOE+00 P-32 1.61E+09 9.95E+07 6.23E+07 O.OOE+OO O.OOE+OO 0.00E+OO 1.35E+08 0.OOB+O0 CR-51 O.OOE+O O.OOE+0O 6.16E+04 3.42E+04 1.35E+04 8.79E+04 1.03B+07 O.OOE+00 MN-54 O.OOE+OO 4.51 E+08 8.94E+07 0.OOE+OO 1.34B+08 o.0o0+00 9.24E+08 O.OOE+O0 MN-56 O.OOE+00 1.392+01 2.47E+00 O.OOE+00 1.76E+01 O.0OE+OO 9.16E+02 O.OOE+00 FE-55 3.23E+08 2.29E+08 5.34E+07 O.OOE+OO O.OOB+OO 1.45E+08 9.90E+07 O.OOE+OO FE-59 1.79E+08 4.17E+08 1.61E+08 O.OOE+00 O.OOE+00 1.32E+08 9.87E+08 O.OOE+O0 CO-57 O.OOE+OO O.OOE+00 0.OOE+OO O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+O0 O.OOE+OO CO-58 O.OOE+0O 4.34E+07 1.OOE+08 0.OOE+O0 O.OOE+OO O.OOE+0 O 5.98E+08 0.OOE+00 CO-60 0.00B+00 2.46E+08 5.54B+08 O.OOE+OO O.OO+00 O.OOE+00 3.21E+09 0.OOB+00 NI-63. 1.59E+10 1.12E+09 5.39E+08 O.OOE+OO O.OOE+00 O.0OE+O0 1.79E+08 O.OOE+00 NI-65 5.55E+01 7.09E+00 3.23E+00 O.OOE+OO O.O0E+OO O.O0E+O0 3.85E+02 O.OOE+00 CU-64 O.OOE+00 8.28E+03 3.902+03 O.OOE200 2.10E+04 O.OOE+00 6.43E+05 O.OOE+00 ZN-65 4.202+08 1.46E+09 6.81SE+08 0.OOE+OO 9.34E+08 O.O0E+O0 6.18E+08 O.OOE+OO ZN-69 4.73E-06 9.022-06 6.31E-07 0.OOE+OO 5.89E-06 O.OOE+OO 1,66E-05 O.OOE+0O ZN-69M O.OOE+OO 0.00E+00 O.OOE+0O O.OOE+00 O.OOE+OO O.OOE+00 O.OOE+00 O.OOE+00 BR-82 O.OE+00 O.OE+OO 0.00E+OO 0.OOE+OO O.OOE+O0 0.00E+00 OOOE+00 O.OOE+O0 BR-83 O.OOE+00 O.0OE+O0 2.82E+00 O.OOE+00 O.00E+0 O.0OE+OO O.OE+OO O.OOE00 BR-84 O.OOE+OO O.OOE+00 1.95E-1 I O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 .0OE+OO BR-85 O.OOE+OO O.OOE+OO O.O0E+O0 O.O0E+OO O.OOE+00 0.OO+OO O.0OE+OO O.OOE+00 RB-86 O.OOE+OO 2.732+08 1.28E+08 O.OOE+00 O.OO+OO O.OOE+00 4.04E+07 O.OOE+O0 RB-88 0.0OE+OO 2.442-22 1.302-22 O.O0E+0O O.OOE+00 0.OOE+OO 2.09E-29 O.O2E+00 RB-89 O.OOE+OO 2.59E-26 1.83E-26 O.OOE+00 O.OOE+00 O.OOE+00 3.98E-05 O.OOE+O0 SR-89 1.51E+10 0.OOE+00 4.32E+08 O.OOE+OO O.OE+00 O.OOE+00 1.80E+09 0.0OE+00 SR-90 7.43E+ I O.OOE+00 1.84E+11 0.OOE+OO O.0OE+OO O.OO+0 2.09E+10 O.OOE+00 SR-91 2.82E+05 0.OOE+O0 1.12E+04 O.OE+O0 O.OE+OO o00
.Oo+o0 1.28E+06 O.OOE+00 SR-92 3.862+02 OOOE+00 1.652+01 O.OOE+00 O.OOE+OO O.OOE+00 9.83E+03 O.OE+OO Y-90 1.24E+04 O.O0E+OO 3.34E+02 O.0OE+O0 O.OOE+O0 O.OO+OO 1.02E+08 O.0OE+OO Y-91M 4.43E-09 O.OOE+OO 1.69E-10 O.0OE+OO O.OOE+00 o.oOE+oo 2.09E-07 O.OOE+00 Y-91 7.81E+06 0.00+00 2.09E+05 O.2OE+OO O.O0E+00 O.OOE+OO 3.20E+09 O.OOE+00 Y-92 8.42E-01 O.O0E+OO 2.43E-02 0.OOE+OO 0.OOE+OO O.OOE+OO 2.31E+04 O.0OE+OO Y-93 1.58E+02 O.OOE+OO 4.33E+00 O.00E+O0 OOOE+OO O.OOE+00 4.822+06 O.OOE+00 ZR-95 1.71E+06 5.41E+05 3.72E+05 O.OOB+00 7.95E+05 O.OOE+00 1.25E+09 O.OOE+00 ZR-97 3.11E+02 6.15E+01 2.83E+01 O.OOE+00 9.33E+01 O.OOE+OO 1.67E+07 0.002+00 NB-95 1.92E+05 1.06E+05 5.86E+04 O.OOE+00 1.03E+05 0.0OE+OO 4.55E+08 O.OOE+OO NB-97 O.OOE+OO O.OOE+00 O.0OE+0O O.0OE+OO O.OOE+00 O.OOE+OO O.OOE+00 O.OOE+00 MO-99 O.OO2+00 5.64E+06 1.08E+06 O.OO2+00 1.29E+07 0.0OE+00 1.01E+07 O.OOE+00 TC-99M 2.70E+00 7.54E+00 9.77E+O O.OOE+00 1.12E+02 4.18E+00 4.95E+03 O.2OE+00 TC-101 5.52E-31 7.852-31 7.71E-30 O.O0+OO 1.42E-29 4.78E-31. 1.34E-37 O.OOE+O0 RU-103 6.802+06 O.OOE+00 2.91E+06 O.00E+OO 2.40E+07 O.OOE+OO 5.682+08 O.OOE+O0 RU-105 4.92E+01 O.OOE+00 1.91 EOI O.OO2+00 6.20E+02 O.OOE+00 3.97E+04 O.OOE+OO RU-106 3.07E+08 O.OOE+00 3.87E+07 O.OOE+00. 5.92E+08 O.OOE+OO 1.47E+10 O.OOE+O0 AG-I OM l.50B+07 1.42E+07 8.65E+06 O.OOE+00 2.71E+07 O.O0E+OO 4.00E+09 O.OOE+00 SB-124 O.OOE+OO O.OOE+00 O.OOE+00 O0.OOE+OO O.OOE+00 0.OOB+00 O.OOE+00 O.OOE+OO SB-125 0.OOE+00 O.00E+O0 O.OOB+00 O.OOE+OO O.OOE+O0 O.OOE+00 O.OO+OO O.OOE+00 TE125M 1.48E+08 5.32E+07 1.97E+07 4.13E+07 0.00E+00 O.OOE+0O 4.36E+08 O.OOE+OO TE-127M 5.48E+08 1.94E+08 6.522+07 1.302+08 2.22E+09 O.OOE+00 1.37E+09 O.O0E+O0 TE-127 5.29E+03 1.88E+03 1.14E+03. 3.65E+03 2.14E+04 O.OOE+OO 4.09E+05 O.O0+O0 TE-129M 3.61E+08 1.34E+08 5.71E+07' 1.16E+08 1.51E+09 O.OOE+OO 1.35B+09 O.OOE+OO TE-129 6.68E-04 2.49E-04 1.63E-04, 4.77E-04 2.802-03 O.OOE+OO 3.652-03 O.OOE+00 RSP-0008_ REV -12 PAGE 94 OF 103
ATTACHMENT 32 PAGE 2 OF 2 TABLE 1-18: DOSE FACTOR TABLE: R ( - TEEN, VEGETATION Nuclide Bone Liver Tbody Thyroid Kidney Lunt GI Tract Skin TE-131M 8.42E+05 4.04E+05 3.37E+05 6.07E+05 4.21E+06 O.OOE+00 3.24E+07 0.OOE+00 TE-131 1.16E-15 4.78E-16 3.62E-16 8.93E-16 5.07E-15 O.0OE+00 9.52E-17 O.OOE+00 TE-132 3.90E+06 2.47E+06 2.33E+06 2.61E+06 2.37E+07 O.OOE+00 7.83E+07 0.00E+00 1-130 3.49E+05 1.01E+06 4.03E+05 8.22E+07 1.55E+06 O.OOE+00 7.75E+05 0.00E+OO 1-131 7.67E+07 1.07E+08 5.77E+07 3.14E+10 1.85E+08 O.OO+00 2.13E+07 O.OOE+00 I-132 5.02E+01 1.31E+02 4.72E+01 4.43E+03 2.07E+02 O.OOE+O0 5.72E+01 O.OOE+00 1-133 1.93E+06 3.27E+06 9.99E+05 4.57E+08 5.74E+06 0.00E+00 2.48E+06 O.OOE+00 1-134 7.99E-05 2.12E-04 7.61E-05 3.53E-03 3.34E-04 0.008+00 2.79E-06 O.OOE+00 1-135 3.48E+04 8.96E+04 3.32E+04 5.76E+06 1.42E+05 O.OO0+OO 9.93E+04. O.OOE+00 CS-134 7.03E+09 1.66E+10 7.68B+09 O.OOE+00 5.26E+09 2.01E+09 2.06E+08 0.OOE+00 CS-136 4.37B+07 1.72E+08 1.15E+08 O.OOE+00 9.36E+07 1.47E+07 1.38E+07 O.OOE+00 CS-137 1.00E+10 1.33E+10 4.65E+O9 0.00E+OO 4.54E+09 1.76E+09 1.90E+08 0.00£+00 CS-138 3.13E-1I 6.01E-11 3.00E-1I 0.00E+OO 4.44E-11 5,16E-12. 2.736-14 O.OOE+00 BA-139 2.54E-02 1.79B-05 7.40E-04 O.OOE+00 1.69E-05 1.23E-05 2.27E-01 O.OOE+00 BA-140 1.38E+08 1.698+05 8.898+06 0.008+00 5.73E+04 1.14E+05 2.13E+08 O.OOE+00 BA- 141 8.36E-22 6.248-25 2.798-23 O.OOE+00 5.79E-25 4.278-25 1.78E-27 O.0OE+00 BA-142 0.00+00 0.008+00 O.OOE+00 0.008+00 O.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 LA-140 1.80B+03 8.868+02 2.36E+02 O.OOE+00 0.00E+OO 0.00E+OO 5.09E+07 O.OOE+00 LA-142 1.77E-04 7.84E-05 1.95E-05 O.OOE+00 0.00E+0O O.OOE+00 2.39E+00 0.008+00 CE-141 2.82E+05 1.89E+05 2.17E+04 0.00E+OO 8.87E+04 0.00E+00 5.39E+08 0.00E+OO CE-143 9.30E+02 6.77E+05 7.56E+01 O.OOE+00 3.048+02 O.OOE+00 2.04E+07 0.008+00 CE-144 5.23E+07 2.16E+07 2.81E+06 O.OOE+00 1.29E+07 O.OOE+00 1.32E+10 0.008+00 PR-143 6.99E+04 2.79E+04 3.48E+03 0.00E+OO 1.62E+04 O.OOE+00 2.30E+08 O.OOE+00 PR-144 2.22E-26 9.07E-27 1.12E-27 O.OOE+00 5.20E-27 O.OOE+00 2.44E-29 O.OOE00 ND-147 3.62E+04 3.93E+04 2.36E+03 O.OOE+00 2.31E+04 O.OOE+00 1.42E+08 O.OOE+00 W-187 3.52E+04 2.87E+04 1.01E+04 O.OOE+00 O.OOE+00 O.OOE+00 7.77E+06 O.OOE+00 NP-239 1.38E+03 1.318+02 7.25E+01 O.OOE+00 4.10E+02 O.OOE+00 2.10E+07 O.OOE+00 RSP-0008 REV - 12 PAGE 95 OF 103 PAGE9SOF1O3 RSP-OOO8 REV-fl
ATTACHMENT 33 PAGE 1 0F2 TABLE 1-19: DOSE FACTOR TABLE: R (I) - CHILD, VEGETATION TABLE 1-19 DOSE FACTOR TABLE: R (i)- Child, vegetation Units are m2 *mremlyr per jiCi/sec Nuclide Bone Liver Tbody Thyroid Kidney Lung GI Tract Skin H-3 O.OOE+00 2.49E+03 2.49E+03 2.49E+03 2.49E+03 2.49E+03 2.49E+03 O.OOE+00 C-14 3.50E+06 7.01E+05 7.01E+05 7.01E+05 7.01E+05 7.01E+05 7.0 1E+05 O.OOE+00 NA-24 3.71E+05 3.71E+05 3.712+05 3.71E+05 3.71E+05 3.71E+05 3.7IE+05 O.OOE+00 P-32 3.36E+09 1.57E+08 1.30E+08 O.OOE+00 O.OOE+00 O.OOE+00 9.30e+07 O.OOE+00 CR-51 0.00E+00 0.OOE+00 1.17E+05 6.49E+04 1.77E+04 1.18E+05 6.20E+06 0.00E+00 MN-54 0.00E+00 6.59E+08 1.76E+08 O.OOE+00 1.85E+08 O.OOE+O0 5.53E+08 O.OOE+00 MN-56 0.00+00 1.82E+01 4.1 1E+00 O.OOE+00 2.20E+01 O.OOE+00 2.64E+03 0.OOE+0O FE-55 7.94E+08 4.21E+08 1.30E+08 O.OOE+00 O.OOE+00 2.38E+08 7.80E+07 O.OOE+00 FE-59 3.96E+08 6.41B+08 3.19E+08 0.OOE+0O 0.OOE+00 1.86E+08 6.68E+08 O.OOE+00 CO-57 O.OOE+00 O.OOE+00 O.OOE+OO O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 CO-58 O.OOE+00 6.41E+07 1.96E+08 O.OOE+OO O.OOE+00 O.OOE+00 3.74E+08 O.OOE+00 CO-60 O.OOE+O0 3.75E+08 1.10E+09 O.OOE+00 0.00E+00 0.00E+00 2.07E+09 0.OOE+00 NI-63 3.91E+10 2.09E+09 1.33E+09 O.OOE+00 O.OOE00 O.OOE+00 1.41E+08 O.OOE+00 NI-65 1.02E+02 9.59E+00 5.60E+00 O.OOE+00 0.00E+00 0.00E+O0 1.17E+03 0.00+00 CU-64 0.OOE+OO 1.09E+04 6.60E+03 O.OOE+00 2.64E+04 0.00E+00 5.13E+05 O.OOE+00 ZN-65 8.06B+08 2.15E+09 1.34E+09 0.00+00 1.35E+09 O.OOE+00 3.77E+08 O.00B+00 ZN-69 8.73E-06 1.26E-05 1.17E-06 O.OOE+00 7.66E-06 O.OOB+00 7.96E-04 O.OOE+00 ZN-69M O.OOE+00 O.OOE+00 O.OOE+OO O.OOE+00 O.OOE+00 0.00+00 O.OOE+00 O.OOE+0O BR-82 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O,OOE+00 O.OOE+00 BR-83 O.OOE+00 O.OOE+00 5.20E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.002+00 BR-84 O.OOE+00 0.00+00 3.30E- I O.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 BR-85 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 0.OOE+00 O.OOE+0O RB-86 O.OOEtO0 4.51E+08 2.78E+08 O.OOE+00 O.OOE+00 O.OOE+00 2.90E+07 0.00+00 RB-88 O.OOE+00 3.77E-22 2.34B-22 O.OOE+00 O.OOE+00 0.OOE+00 1.65E-23 O.OOE+00 RB-89 0.00+O0 3.42E-26 3.04E-26 0.00B+00 0.OOE+00 O.OOE+00 2.98E-28 O.OOE+00 SR-89 3.58E+10 O.OOE+00 1.02E+09 O.OOE+00 0.OOE+OO 0.OOE+00 1.39E+09 O.OOE+00 SR-90 1.23E+12 0.0OE+00 3.12E+11 0.00E+00 0.00+00 0.OOE+00 1.66E+10 0.0OE+00 SR-91 5.20E+05 O.OOE+00 1.96B+04 O.OOE+00 O.OOE+00 O.OOE+00 1.15E+06 O.OOE+00 SR-92 7.07B+02 O.OOE+00 2.84E+01 O.OOE+00 O.OOE+00 O.OOE+00 1.34E+04 O.OOE+00 Y-90 2.30E+04 O.OOE+00 6.17E+02 0.00+00 O.OOE+00 O.OOE+00 6.56E+07 O.OO+00 Y-91M 8.12E-09 O.OOE+00 2.95E-10 O.OOE+0O 0.00E+00 O.OOE+00 1.59E-05 O.OOE+00 Y-91 -1.6E+07 O.OOE+00 4.97B+05 O.OOE+00 O.OOE+00 0.00E+O0 2.47E+09 O.OOE+0O Y-92 1.55E+00 O.OOE+0O 4.43B-02 0.002+/-00 O.OOE+00 O.OOE+00 4.48E+04 0.002+00 Y-93 2.91E+02 O.OOE+00 7.98E+00 O.OOE+00 O.OO+00 O.OOE+00 4.34E+06 0.002+00 ZR-95 3.84E+06 8.44E+05 7.52E+05 O.OOE+00 1.21E+06 O.OOE+00 8.81E+08 0.00E+00 ZR-97 5.68E+02 8.20E+01 4.84E+01 0.00+00 1.18E+02 0.00+OO 1.24E+07 O.OOE+00 NB-95 4;09E+05 1.59E+05 1.14E+05 O.OOE+0O 1.50E+05 0.OOE+00 2.95E+08 O.OOE+00 NB-97 O.OOE+00 O.OOE+00 0.OOE+OO 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 MO-99 0.00+00 7.70E+06 1.91E+06 O.OOE+00 1.64E+07 O.OOE+00 6.37E+06 O.OOE+00 TC-99M 4.65E+00 9.12E+00 1.51E+02 0.00+00 1.32E+02 4.63E+00 5.19E+03 o.ooE+00 TC-101 1.02E-30 1.06E-30 1.35E-29 O.OOE+0O 1.81E-29 5.62E-31 3.38E-30 O.OOE+00 RU--103 1.53E+07 O.OOE+00 5.88E+06 O.OOE+00 3.85E+07 O.OOE+00 3.95E+08 O.OOE+00 RU-105 9.01E+01 O.OOE+OO 3.27E+01 O.OOE+00 7.92E+02 O.OOE+00 5.88E+04 O.OO+00 RU-106 7.39E+08 O.OOE+OO 9.22E+07 0.00E+00 9.98B+08 0.OOE+00 1.15E+10 O.OOE+00 AG-110M 3.19E+07 2.15E+07 1.72E+07 O.OOE+00 4.01E+07 O.OOE+00 2.56E+09 O.OOE+00 SB-124. 0.OOE+00 O.OOB+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OO+00 0.00+00 SB-125 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 TE-125M 3.49B+08 9.47E+07 4.66E+07 9.80E+07 O.OO+00 0.00+00 3.37E+08 O.OOE+00 TE-127M 1.31E+09 3.54B+08 1.56E+08 3.14E+08 3.75E+09 O.OOE+OO 1.06E+09 0.OOE+00 TE-127 9.76B+03 2.63E+03 2.09E+03 6.76E+03 2.78E+04 .OOE+00 3.81E+05 O.OOE+00 TE-129M 8.39E+08 2.34E+08 1.30E+08 2.71E+08 2.46E+09 0.00E+00 1.02E+09 O.OOE+00 TE-129 1.24E-03 3.45E-04 2.94E-04 8.82E-04 3.62E-03 O.OOE+00 7.70E-02 0.00E+00 RSP-OO0O REV -12 PAGE 96 OF 103
ATTACHMENT 33 PAGE 2 OF 2 TABLE 1-19: DOSE FACTOR TABLE: R (I) - CHID, VEGETATION Nulicde RBone Liver Tbody Thyroid Kidney Lung CI Tract Skin TE-131M 1.54E+06 5.32E+05 5.66E+05 1.09E+06 5.15E+06 O.OOE+00 2.16E+07 O.OOE+00 TE-131 2.142-15 6.51B-16 6.35E-16 1.63B-15 6.46E-15 O.OOE+00 1.12E- 14 O.OOE+00 TE-132 6.99E+06 3.10E+06 3.74E+06 4.51E+06 2.87E+07 O.OOE+00 3.12E+07 O.OOE+00 I-130 6.12E+05 1.24E+06 6.37E+05 1.36E+08 1.85E+06 0.002+00 5.78E+05 0.002+00 1-131 1.43E+08 1.44E+08 8.16E+07 4.75E+10 2.36E+08 O.OOE+O0 1.28E+07 0.002+00 1-132 8.91E+01 1.64E+02 7.53E+01 7.60E+03 2.5 1E+02 O.OOE+00 1.93E+02 O.OOE+00 I-133 3.522+06 4.35E+06 1.65E+06 8.08E+08 7.25E+06 0.002+00 1.75E+06 0.00+00 1-134 1.42E-04 2.64E-04 1.21E-04 6.07E-03 4.03E-04 O.OOE+00 1.75E-04 O.OOE+00 1-135 6.18E+04 1.1I E+05 5.26E+04 9.86E+06 1.71E+05 0.00E+00 8.48E+04 O.OOE+00 CS-134 1.59E+10 2.61E+10 5.50E+09 O.OOE+00 8.08E+09 2.90E+09 1.41E+08 O.OO+00 CS-136 8.23E+07 2.26E+08 1.46E+08 0.00E+00 1.20E+08 1.80E+07 7.95E+06 O.OOE+00 CS-137 2.37E+10 2.27E+10 3.35E+09 0.002+00 7.39E+09 2.66E+09 1.42E+08 O.OOE+00 CS-138 5.69E-11 7.91E-II 5.02E-11 O.OOE+00 5.57E-11 5.99E-12 3.64E-I I 0.00+00 BA-139 4.69E-02 2.50E-05 1.36E-03 O.OOE+00 2.18E-05 1.47E-05 2.70E+00 0.00E+00 BA-140 2.76E+08 2.42E+05 1.60E+07 O.OOE+00 7.88E+04 1.44E+05 1.40E+08 0.00+00 BA-141 1.54E-21 8.64E-25 5.02E-23 O.OOE+00 7.47E-25 5.072-24 8.79E-22 0.002+00 BA-142 O.OOE+00 O.OO+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00+00 LA-140 3.24E+03 1.13E+03 3.82E+02 O.OOE+00 0,00E+00 O.OOE+00 3.16E+07 O.OOE+O0 LA-142 3.20E-04 1.02E-04 3.19E-05 0.00E+00 O.OOE+00 O.OOE+00 2.02E+01 0.OOE+O0 CE-141 6.55E+05 3.26E+05 4.85E+04 O.OOE+00 1.43E+05 O.OO+00 4.07E+08 O.OOE+00 CE-143 1.71E+03 9.29E+05 1.35E+02 O.OOE+00 3.902+02 O.OOE+00 1.36E+07 O.OOE+00 CE-144 1.26E+08 3.95E+07 6.73E+06 O.OOE+00 2.19E+07 O.OOE+00 1.03E+10 O.OOE+00 PR-143 1.45E+05 4.36B+04 7.21E+03 O.OOE+00 2.36E+04 O.OOE+00 1.572+08 O.OOE+00 PR-144 4.11E-26 1.27E-26 2.07E-27 0.00+00 6.732-27 0.00+00 2.742-23 0.00E+00 ND-147 7.14E+04 5.78E+04 4.48E+03 O.OOE+00 2.17B+04 O.OO+00 9.16E+07 0.002+00 W-187 6.41E+04 3.79E+04 1.70E+04 O.OOE+00 O.OOE+00 O.OOE+00 5.33E+06 O.OOE+00 NP-239 2.56E+03 1.83E+02 1.29B+02 O.OOE+00 5.31E+02 O.OOE+00 1.362+07 O.OO+00 RSP-0008 REV- 12 PAGE 97 OF 103
ATTACHMENT 34 PAGE I OF I FIGURE 1: RESTRICTED AREA AND NEAR-FIELD ENVIRONMENTAL MONITORING LOCATIONS C
(NE)
I(ENE)
E (E)
F (ESE, I%G N (SE)
I I 'S I %
I I 'S I H l (SSE)
___ FIGURE 1I I
A 1 Ak uuiplm 71 .n wj swnflq Wei- upgraiit MV -wp Wei - Dmwnrdhi*t GMI onameaal RSP-0008 REV PAGE 98 OF
.E-1 103 iE9OF RSP000
ATTACHMENT 35 PAGE I OF 1 FIGURE 2: SCHEMATIC OF GASEOUS RADWASTE SYSTEM RSP-0008 RFV - 12 PA.GF 99 OF 103 PAGE99OFIfI3 RSP-0008 REV-fl
qAE.3 wflUEfit kCL*Em IrqT3 -
not 00,
.. w 50 MOVE . OSOPY at
< act (
- FOR INFORMATiON ONLY - NOTA PERMANENT RECORD
- 4 n
C 9
z 0 n zm l
A 0It t"
0--4 to
(.I!i 0-4 tv 9
O" 1-3 m
a W 0-i w
9 4
ATTACHMENT 38 PAGE l OF 1 FIGURE 5: FAR-FIELD RADIOLOGICAL ENVIRONMENTAL MONITORING LOCATIONS a I /
8 C (NW) I (M#E) / (NE) f I
i I
f
.- D (ENE)
/ Jacksonf /
. 1 -~
E N (E)
(W) p 1 . (ESE)
(IM 1
J J I
/
I G
L I ,,..(SE,
/ I (SW) I i
K
/
(SSw)
F1?URE 5 I I I'
- W SON adlbo I IFws E6 hduk Lacuhg I 1W .0 e .. _:w AC Air Sampler Control I A S Air Sampler Special I i 1. ", . -
T I TLD Indicators TC 'TLDControls .I TS Special TLDs I GQC Vegetation Control SWU Upstream Surface Water SWD Downstream Surfce Water SEDD Downstream Sediment FU Upstream Fish/Invertebrates Ii FD Downstream Fish/Invertebrates (5) (SSE)
RSP-0008 EV- 12 PAGE 102 OF 103
ATTACHMENT 39 PAGE 1 OF I FIGURE 6: SCHEMATIC OF THE SOLID WASTE TREATMENT SYSTEM Fuel I Pool DeminSpent Rens 17 GPD Permanent Portabe (2 I Radwaste Auto Strainer 13 400 GPD I Radwaste Filter Sludge 2004 GPD MTo Waste Deweter I Fuel Pool Filter Sludge 29 GPD WteSystem (40828P0) Plant Connection I RW Demnin Spent Resin Slucgo a Stand 18GPD Tank S Cond Demin Spent Resin 747 GPD TooSoridficaion)
S RWCU Filter! Demin Sludge 323 GPD .i I Dcon & Lab Drains (3) 600 GPD Compressable Waste (NotAvailabe) 55 Gailon Drum NOTE: (1)Flowrat Include Transfer Waer and Sdids
() Refer oTopical Report Cns1-2 (43114.013540OPA For Details (3)Suspend Solids are Assumed to bo Negligible, and ae Not Consideed RSP-0008 REV- 12 PAGE 103 OF 103
TRACPING NO. RSP-0008R1tPR-12 EPAR PAGE 1 OF 1 PROCEDURE ACTION REQUEST PROCEDURE NO CURRENT REV PROCEDURE TITLE RSP-t008 11 Offite Dose Calclaton Maual (ODCLM TYPE OF ACTION:
IY PROCEDURE REVISION (PR) OI EDITORIAL CHANGE (EC) O INCORP EC D&AEDIATELY O NEW PROCEDURE (NP) O COMMENT (CM)
O CHANGE NOTICE (CN) Q OTHER a CANCEL PROCEDURE (CX)
Ckange Notice () isnot allowed if there is a Change ofintent 0 COMPUTER PROGRAM CHANGE PROCEDURE AcION BASIS (po'idedtaddcripionoftheodrece and the basis forthat chaarwe Indlude reference to awflcaMe d cs change: adtaci co M sheets if necessary):
- Attachment 14 - Add a sttement to evaluate the National Guard and/or State Police dose while they are stationed on site as members of the public.
- Change the components of Steps 7.2 and 73 which refer to 10CER 20 to TRM 3.11.1.1 which is approved by LAR 2003-07.
- Step 7.2.21, page 11, change the (ECLfi reference from Appendix A to Attachment 2.
- Formula 7.2-2.1-1, page 11- Add minus sign (-) in the denominator to the fl calculattio K SAFETY EVALUATION SCREENING RVI (KCN/DATE)
Must be 50.59 qwUfied tach apZ(cablefrmsfo -101) 1 VERIFY LICENSEE COMMITMENTS (All changes) TRAINING PROGRAM AFFECTED 0 Yes, TEAR#_ _
El No CHANGE TO THIE TECH SPEC / SIW LSFT CROSS REFERENCE MATRIX TRAINING REQUIRED:
O Yes (Attach change requesfifomADM-001S ifappicable) O Before Issue ONo Date tlaining completed: _
O After Issue E None CROSS DISCIPLINE REVIEW REQUIRED:
E Yes Cl No REVEW AND APPROVAL:
SIGNAYUR/KCN/DATE SIGTU K /
1AM4 AI~ '/Z o~ VALIDATION SUPVITECH VERIF* / 4ZO
'-j,?FRCREVIEW V Oy) _ .RC
_ _ F__ MEETING NO (9003_OI1)
APPROVAL I? 3g5 PROOFER (CNhwop)
COMP'UTER PROGRAM UPDATE EFFECTIVE DATE: MAR 1 2003
- cMastbe an id-idua othrmthnte preperei)
REV22 (4112/01)
EN-S NUCLEAR QuALrY ReLATED -1401 Revision 2 MANAGEMENT ADmimsTRArivE Enterg MANUAL UsE Page 1 of 6 ATTACHMENT 9.1 50.59 REVIEW FORM Page of
- 1. OVERVIEW I SIGNATURES Facility: River Bend Station Document Reviewed: RSP-0008 Change/Rev. 12 System Designator(s)IDescription: Offisite Dose Calculation Manual (ODCM) Changes Description of Proposed Change
- 1. Editorial and tIooaraphical chances as defined in Section 5.2,2.1
- a. Attachment 14 - Add a statement to evaluate the dose to the National Guard and/or State Police while they are stationed on site as members of the public.
- b. Ste2 7.2.2.1. Daae 11. change the (ECL)1 reference from Apoendix A to Attachment 2.
- c. Add minus sin -) to the denominator of the definition for fain Formula 7 2.2.1-1.
- 2. Incorporate chances from previously evaluated LAR 2002-07. Modify Sections 7.2 and 7.3 to sugwort this chance.
If the proposed activity, in its entirety, Involves any one of the criteria below, check the appropriate box, provide a justification/basis in the Description above, and forward to a Reviewer. No further 50.59 Review is required. If none of the criteria is applicable, continue with the 50.59 Review.
E The proposed activity Is editorial I typographical as defined in Section 5.2.2.1.
0 The proposed activity represents an UFSAR-only" change as allowed in Section 5.2.2.2. (Insert item #
from Section 5.2.2.2).
a3 The proposed activity Is controlled by another regulation per Section 5.2.2.a If further 50.59 Review is required, check the applicable review(s): (Only the sections indicated must be included in the Review.)
El SCREENING Sections 1,11, and III required E 50.59 EVALUATION EXEMPTION Sections 1,11, HI, and IV required o 50.59 EVALUATION (#: ) Sections 1,II, Ill, and V required Preparer: /o JfP0 Name (print) / Signature I C&pahy Depa~rment I Date Reviewer. /.&(,t1*~/ ~?ifg/ /P°T C/
Name (pint) I Signat ~r5omfany I Department I Date
/ 3 S63 OSRC:
Chairman's Name (print) / Signature I Date
[Required only for Programmatic Exclusion Screenings (see Section 5.8) and 50.59 Evaluations.]
Ust of AssistinglContnbuting Personnel:
Name: Scope of Assistance:
Greg Norris 50.59 Preparation C,4t<K h,-c.LJ -Sc0 5'?~P8drF4,"761%
- EN-S NUCLEAR QUAUTYRELATD LI-101 Revision 2 E MANAGEMENT AcTRFTivA L77CTfY I MANUAL PRPERENCEUsE Page 2 of 6 ATTACHMENT 9.1 50.59 REVIEW FORM Page II. SCREENING A. Licensing Basis Document Review
- 1. Does the proposed activity impact the facility or a procedure as described in any of the following Licensing Basis Documents? (Check "NIAW for those documents that are not applicable to the facility.)
Operating UcenW YES NO NIA CHANGE# andor SECTIONS IMPACTED Operaing License _.,
TS CI _
NRC Orders D3 a If "YES", obtain NRC approval prior to he change. (See Section 5.1.13 for exceptions.)
tiplne LBDs controlled under 50.69 YES NO NIA CHANGE # (if applicable) and/or SECTIONS IMPACTED FSAR Ei 0 TS Bases D2 Technical Reqiurements Manual 13 E Core Operating Umits Report 03 0 Offlte Dose Calculatrons Manual El 3 YeT-auJ5 1.72 7.3 & 4AT72camfwr i4*
NRC Safety Evaluation Raports1 01 I "YES", perfoun an Exemption Review per Section IV perlorn a 50.5 Evaluation per Section V.
LBDs controlled under other regulations YES NO WA CHANGE # (if applicable) and/or SECTIONS IMPACTED 2
Quajty Assurance Program ManUal D 0 2
Emergency Plan E0 3
Securlty panZ 0E 4
Fre Protection Program 03 i l (Includes the Fire Hazards Analysis)
IF 'YES", evaluatelprocess any changes in accordance with the appropriate regulation.
- 2. Does the proposed activity involve a test or experiment not described in the E3 Yes FSAR? No If "yes," perform an Exemption Review per Section V OR perform a 50.59 Evaluation per Section V. 0
- 3. Does the proposed activity potentially impact equipment, procedures, or Yes facilities utilized for storing spent fuel at an Independent Spent Fuel Storage No Installation? 0 N/A (Check UNIA7 If dry fuel storage is not applicable to the facility.)
If "yes," perform a 7ZA8 Review in accordance with NMM Procedure U-I12.
(See Sections 1.5 and 5.3.1.5 of the EOI I0CFR50.59 Review Program Guidelines.)
If' YES, see Section 5.1.5.
2 If 'YES,' notify the rsosib department and ensure a 50.54 Evaluation Is performed.
3 The Security Pkan is classified as safeguards and can only be reviewed by personnel with the appropriate security clearance. The Preparer should notify the security department of potertial changes to the Security Plan.
4 If 'YES,' evaluate the change in accordance with the requirements of the facility's Operating License Condition.
EN4 NUCLEAR L4l01 Revision 2 a I MANAGEMENT QAUTYRW.ATM ADBRAT1Va JEFrgy CE USE Page 3 of 6 IE I IATTACHMEN 9.150.59 REVIEW FORMPaeo B. Basis (Provide a clear, concise basis for the answers given in the applicable sections above. Adequate basis must be provided within the Screening such that a third-party reviewer carl reach the same conclusions. Simply stating that the change does not affect TS or the FSAR is not an acceptable basis.)
The changes to the ODCM are to 1) revise Sections 7.2 and 7.3 to be in line with TLCO 3.11.1.1 and Technical Soecification 5.5.4.b. 2) add the National GuardlState Police to the dose to the public evaluation in Attachment 14 nd 3) Sten 7.2.2.1. paue 11, change the ECL)j reference from Aooendlx A to Attachment 2 The wording of TLCO 3.11.1.1 was changed in LAR 2003-07 to read. iThe congentration of radioactive Material released In kiguid effluents to UNRESTRICTED AREAS (see USAR Section 2.1) shall be limited to ten times the concentrations soecified.in 10 CFR 20. Appendix S. Table 2.
Column 2 for radionuclides other than dissolved or entrained noble oases. For dissolved or entrained noble oases the concentration shall be limited to 2 x 107 microcuriesfmi total activity The limits in TS 5,5.4.b essentially have the same nunerical limits that the site had orior to the Imrroved Technical Snecification fITS) and the 10CFR20 chanue. The ITS Section 5.5.4.b was approved by the NRC which allowed RBS to have limits on the concentrations of radioactive material released in liquid effluents to unrestricted areas to ten times the concentration values in 10 CFR 20 Apoendix B. Table 2. Column 2. This chance was to allow operational flexibility compatible with considerations of health and safety and maintaining dose to the public ALARA, The site is required by I 0CFR50 to maintain control over radioactive mnaterial produced in normal reactor operations as low as reasonably achievable (ALARA). The dose limits in 1QCFR50 Anoendix I are smaller than the limits found in 10CFR20. The site exhibited the ability prior to ITS to operate and meet limits similar to TS 5.5.4.b.
The addition to Attachment 14 is to add a reminder to evaluate the dose to the National Guard or State Police while stationed within the site boundary and nerformino non-emeruency duties. The change of the Step 7.2.2.1 reference is editorial. The chance to Formula 7.2.2.1-1 is trooaraghical. The changes to the ODCM do not impact the facility. There is no change to the faciltiv as described in the SAR. The dose limits from liquid effluents are discussed in the SARI however, this chanue does not change the information presented in the SAR. This chanae is not a test or experiment. The Porammatic controls for lquid effluent releases are established.
impLemented. and maintained In operatinag Procedures to control radioactive effluents consistent with the requirements of 10 CFR 20.1302. 40 CFR Part 190. 10 CFR 50.36a. and 10 CFR Part 50.
ADwendix }.
C. References
[Discuss the methodology for performing the LED search. State the location of relevant licensing document information and explain the scope of the review such as electronic search criteria used (e.g., key words) or the general extent of manual searches per Section 5.3.6.4 of U-01.]
LBDslDocuments Reviewed: Keywords:
SER Amendment No. 81. Amendment No. ODCM. O.D.C.M.. unrestricted area, liguid 81a. 40CFR190: I OCFR20: IOCFR50 effluent, Pathway, offsite dose. off site dose.
ADpendix 1: Technical Requirement Manual IOCFR2M. 10 CFR 20. Agoendix B. 40CFR1 90.
(Definitions. 3.11. Chanter 5): Technical 40 cfr 190. 1.109. Member of the ublic. RETS, Specification Chaoter 5. USAR 2. 11. 15): release Reulatory Guide 11097- RPP0097: NUREG-0543. NUREG -0133
_ EN-S NUCLEAR QUATY RBATED LI-101 Revision 2 MANAGEMENT ADM mwt'A~mE lEnte i MAUAL __ REENECE USE Page 4 of ATTACHMENT 9.1 60.59 REVIEW FORM Page of D. Is the validity of this Review dependent on any other Cl Yes change? (See Section 5.3.4 of the E1O10CFR50.59 Program E No Review Guidelines.)
If "Yes," list the required changes.
Ill. ENVIRONMENTAL SCREENING If any of the following questions is answered "yes," an Environmental Review must be performed in accordance with NMM Procedure EV-115, "Environmental Evaluations," and attached to this 50.59 Review.
Will the proposed Change being evaluated:
Yes No a El Involve a land disturbance of previously disturbed land areas in excess of one acre (i.e.,
grading activities, construction of buildings, excavations, reforestation, creation or removal of ponds)?
- RI Involve a land disturbance of undisturbed land areas (i.e., grading activities, construction, excavations, reforestation, creating, or removing ponds)?
O 21 Involve dredging activities in a lake, river, pond, or stream?
O El Increase the amount of thermal heat being discharged to the river or lake?
O El Increase the concentration or quantity of chemicals being discharged to the river, lake, or air?
C] El Discharge any chemicals new or different from that previously discharged?
O 21 Change the design or operation of the intake or discharge structures?
0 El Modify the design or operation of the cooling tower that will change water or air flow characteristics?
o 21 Modify the design or operation of the plant that will change the path of an existing water discharge or that will result in a new water discharge?
O1 21 Modify existing stationary fuel burning equipment (i.e., diesel fuel oil, butane, gasoline, propane, and kerosene)?'
o 21 Involve the installation of stationary fuel burning equipment or use of portable fuel burning equipment (i.e., diesel fuel oil, butane, gasoline, propane, and kerosene)?1 o 21 Involve the installation or use of equipment that will result in an air emission discharge?
0 21 Involve the installation or modification of a stationary or mobile tank?
Cl El Involve the use or storage of oils or chemicals?
E 121 Involve burial or placement of any solid wastes in the site area that may effect runoff, surface water, or groundwater?
' See NMM Procedure EV-1 17, 'Air Emissions Management Program,- for guidance In answering this question.
EN-S NUCLEAR QUALM RELATEDI 1I01 Revision 2 MANAGEMENT Aiomiwam L*Entes MANUAL ATACMET .USE Page 6 of _
HMENT 9.1 50.69 REVIEW FORM Page of IV. 50.59 EVALUATION EXEMPTION Enter this section only if a "yes" box was checked in Section IhA, above.
A. Check the applicable boxes below. If any of the boxes are checked, a 50.59 Evaluation is not required. If none of the boxes are checked, perform a 50.59 Evaluation In accordance with Section V. Provide supporting documentation or references as appropriate.
0 The proposed acfivity meets all of the following criteria regarding design function per Section 5.5.1.1:
The proposed activty does not adversely affect the design function of an SSC as described in the FSAR; AND The proposed activity does not adversely affect a method of performing or controlling a design function of an SSC as described in the FSAR; AN The proposed activity does not adversely affect a method of evaluation that demonstrates intended design function(s) of an SSC described in the FSAR will be accomplished.
E An approved, valid 50.59 Review(s) covering associated aspects of the proposed activity already exists per Section 5.5.1.2. Reference 50.59 Evaluation # LAR 2003-07 (if applicable) or attach documentation. Verify the previous 50.59 Review remains valid.
1 The NRC has approved the proposed activity or portions thereof per Section 5.5.1.3.
Reference:
Amendment No. 81a. LAR 1993-014 B. Basis (Provide a clear, concise basis for determining the proposed activity may be exempted such that a third-party reviewer can reach the same conclusions. See Section 5.5.6 of the EOI 10CFR50.59 Review Program Guidelines for guidance.)
LAR 2003 The ODCM sections 7.2 and 7.3 are applicable to this LAR_ This LAR chanaed TLCO 3.11.1 1 to equal the limits in RBS Technical Specification 5.5.4.b. RBS chose not to implement this chagge when the site implemented Imprved Technical Specifications. See the Basis in Section II B above for more details. No chances have occurred at the site or in the regulations to revoke the original approval of this amendment.
ATTACIMENT 4 PAGE I OF 1 CROSS-DISCIPLINE REVIEW FORM, TYPICAL PROCEDURE a-o REVISION PART 1 CROSS DISCIPLINE REVIEW Cross Discipline Review Group Cross Discipline Reviewer PART 2 RETURN RtETURlNTO < '° MA CO1DE: /- t ) BsY: Z g PARtT 3 RtEVIEW SUAMMARY YES NO [] Submitted procedure changes are consistent with departmental processes. If'no", comment bWow:
Comments1 YES 2 NO 5 Changes to other department procedures must be made due to the submitted procedure change. If "yes, list description of required changes and tracking numbers below:
Description of required procedure changes (preparershould identify effectedproceduresfirst1 reviewer should identify any additionalprocedures):
Other Comments:
REVGNWED BY:KN/DT ° SIGNATURE KCN/DATE